FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU de Sousa, RAL
   de Lima, EV
   da Silva, TP
   de Souza, RV
   Figueiredo, CP
   Passos, GF
   Clarke, JR
AF de Sousa, Ricardo A. L.
   de Lima, Emanuelle V.
   da Silva, Tamara P.
   de Souza, Renata V.
   Figueiredo, Claudia P.
   Passos, Giselle F.
   Clarke, Julia R.
TI Late Cognitive Consequences of Gestational Diabetes to the Offspring, in
   a New Mouse Model
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE S961; Gestational diabetes; Learning; Memory; Offspring; Programing
ID HIGH-FAT DIET; INSULIN-RECEPTOR ANTAGONIST; BETA-CELL MASS; INFLAMMATORY
   RESPONSE; MEMORY PERFORMANCE; GLUCOSE-TOLERANCE; INDUCED OBESITY;
   MATERNAL-CARE; RISK-FACTORS; TNF-ALPHA
AB Gestational diabetes mellitus (GD) is a form of insulin resistance triggered during gestation, which affects approximately 10% of pregnant women. Although previously considered a transient condition with few long-term consequences, growing evidence suggest that GD may be linked to permanent metabolic and neurologic changes in the offspring. Currently available GD models fail to recapitulate the full spectrum of this disease, thus providing limited information about the true burden of this condition. Here, we describe a new mouse model of GD, based on the administration of an insulin receptor antagonist (S961, 30 nmol/kg s.c. daily) during pregnancy. Pregnant mice developed increased fasting glycemia and glucose intolerance in the absence of maternal obesity, with a return to normoglycemia shortly after parturition. Moreover, we showed that the adult offspring of GD dams presented pronounced metabolic and cognitive dysfunction when exposed to short-term high-fat diet (HFD). Our data demonstrate that S961 administration to pregnant mice comprises a valuable approach to study the complex pathophysiology of GD, as well as strategies focused on prevention and treatment of both the mother and the offspring. Our findings suggest that the offspring of GD mothers are more susceptible to metabolic and cognitive impairments when exposed to high-fat diet later in life, thus indicating that approaches to prevent and treat these late effects should be pursued.
C1 [de Sousa, Ricardo A. L.; de Lima, Emanuelle V.; da Silva, Tamara P.; de Souza, Renata V.; Figueiredo, Claudia P.; Passos, Giselle F.; Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP Clarke, JR (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM juclarke@gmail.com
RI De Sousa, Ricardo Augusto Leoni/C-8540-2015; Clarke, Julia/AAF-9434-2019
OI De Sousa, Ricardo Augusto Leoni/0000-0003-2622-032X; 
FU Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Institutos Nacionais de Pesquisa - Inovacao em Medicamentos e
   Identificacao de Novos Alvos Terapeuticos; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro (E.V.L., C.P.F., G.F.P., J.R.C.), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (C.P. F., J.R.C.), Institutos
   Nacionais de Pesquisa - Inovacao em Medicamentos e Identificacao de
   Novos Alvos Terapeuticos (C.P.F., G.F.P.), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (R.A.L.).
CR Bilbo SD, 2012, FRONT NEUROENDOCRIN, V33, P267, DOI 10.1016/j.yfrne.2012.08.006
   Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Burlina S, 2019, J MATERN-FETAL NEO M, V32, P687, DOI 10.1080/14767058.2017.1387893
   Cabrera-Pastor A, 2016, BRAIN BEHAV IMMUN, V57, P360, DOI 10.1016/j.bbi.2016.05.011
   Carson MP, 2013, PRIM CARE DIABETES, V7, P177, DOI 10.1016/j.pcd.2013.04.007
   Chandna AR, 2015, NEUROSCIENCE, V303, P241, DOI 10.1016/j.neuroscience.2015.06.063
   Chen PL, 2015, CELL BIOCHEM BIOPHYS, V71, P689, DOI 10.1007/s12013-014-0248-2
   Cieniewicz AM, 2017, DIABETES, V66, P206, DOI 10.2337/db16-0633
   Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183
   Colomina MT, 1997, PHYSIOL BEHAV, V61, P455, DOI 10.1016/S0031-9384(96)00462-3
   Dabelea D, 2007, DIABETES CARE, V30, pS169, DOI 10.2337/dc07-s211
   Dahlhoff M, 2014, BBA-MOL BASIS DIS, V1842, P304, DOI 10.1016/j.bbadis.2013.11.021
   Daraki V, 2017, EUR CHILD ADOLES PSY, V26, P703, DOI 10.1007/s00787-016-0934-2
   de Castro VLSS, 2007, NEUROTOXICOLOGY, V28, P1249, DOI 10.1016/j.neuro.2007.06.001
   De Sousa RAL, 2018, AN ACAD BRAS CIENC, V90, P2279, DOI 10.1590/0001-3765201720170264
   DeBoer T, 2005, DEV MED CHILD NEUROL, V47, P525, DOI 10.1017/S0012162205001039
   DeSisto CL, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130415
   DORNER G, 1976, ENDOKRINOLOGIE, V68, P121
   Fortuna JTS, 2017, BEHAV BRAIN RES, V333, P150, DOI 10.1016/j.bbr.2017.06.047
   Francis DD, 1999, ANN NY ACAD SCI, V896, P66, DOI 10.1111/j.1749-6632.1999.tb08106.x
   Franks B, 2015, DEV PSYCHOBIOL, V57, P809, DOI 10.1002/dev.21326
   Garcia-Vargas L, 2012, CARDIORENAL MED, V2, P134, DOI 10.1159/000337734
   GAUGUIER D, 1990, DIABETES, V39, P734, DOI 10.2337/diabetes.39.6.734
   Georgieff MK, 2008, BIOCHEM SOC T, V36, P1267, DOI 10.1042/BST0361267
   Gilmartin AH, 2008, REV OBSTET GYNECOL, V1, P129
   Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507
   Gutierrez JC, 2010, ENDOCR RES, V35, P59, DOI 10.3109/07435801003641939
   Hami J, 2013, BRAIN STRUCT FUNCT, V218, P73, DOI 10.1007/s00429-011-0377-y
   Holemans K, 2004, AM J OBSTET GYNECOL, V190, P858, DOI 10.1016/j.ajog.2003.09.025
   Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003
   Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273
   Kahraman S, 2014, AM J PHYSIOL-ENDOC M, V307, pE906, DOI 10.1152/ajpendo.00210.2014
   KAUFMANN RC, 1981, AM J OBSTET GYNECOL, V141, P479, DOI 10.1016/S0002-9378(15)33263-4
   Kim SY, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110249
   Kim SY, 2010, AM J PUBLIC HEALTH, V100, P1047, DOI 10.2105/AJPH.2009.172890
   Kleiner S, 2018, P NATL ACAD SCI USA, V115, pE7642, DOI 10.1073/pnas.1721418115
   Kothari V, 2017, BBA-MOL BASIS DIS, V1863, P499, DOI 10.1016/j.bbadis.2016.10.006
   Li HP, 2013, INT J CLIN EXP PATHO, V6, P650
   Liang CY, 2010, METABOLISM, V59, P943, DOI 10.1016/j.metabol.2009.10.015
   Medeiros R, 2010, BEHAV BRAIN RES, V209, P165, DOI 10.1016/j.bbr.2010.01.040
   Melo AM, 2014, METABOLISM, V63, P682, DOI 10.1016/j.metabol.2014.02.002
   Mitanchez D, 2014, J PEDIATR-US, V164, P445, DOI 10.1016/j.jpeds.2013.10.076
   Morisset J, 2000, PANCREAS, V21, P321, DOI 10.1097/00006676-200010000-00015
   Neves FS, 2018, MOL NEUROBIOL, V55, P435, DOI 10.1007/s12035-016-0307-3
   Pasek RC, 2013, AM J PHYSIOL-ENDOC M, V305, pE1327, DOI 10.1152/ajpendo.00425.2013
   Plows JF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113342
   Poston L, 2011, PROG BIOPHYS MOL BIO, V106, P315, DOI 10.1016/j.pbiomolbio.2010.11.011
   Poston L, 2010, BEST PRACT RES CL EN, V24, P541, DOI 10.1016/j.beem.2010.05.007
   Reis AR, 2014, BEHAV BRAIN RES, V265, P216, DOI 10.1016/j.bbr.2014.02.036
   Riggins T, 2010, ADV CHILD DEV BEHAV, V38, P73
   Rom S, 2019, MOL NEUROBIOL, V56, P1883, DOI 10.1007/s12035-018-1195-5
   Ruiz-Palacios M, 2017, ANN NUTR METAB, V70, P16, DOI 10.1159/000455904
   Sacks KN, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.03.030
   Santillan ME, 2010, NUTRITION, V26, P423, DOI 10.1016/j.nut.2009.06.005
   Schaffer L, 2008, BIOCHEM BIOPH RES CO, V376, P380, DOI 10.1016/j.bbrc.2008.08.151
   Serradas P, DIABETE METAB, V15, P30
   SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611
   Sims-Robinson C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163883
   Steculorum SM, 2011, ENDOCRINOLOGY, V152, P4171, DOI 10.1210/en.2011-1279
   Tang XW, 2015, CELL BIOCHEM BIOPHYS, V71, P549, DOI 10.1007/s12013-014-0233-9
   Torres-Espinola FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133010
   Van Der Kooij MA, 2015, NEUROSCIENCE, V311, P508, DOI 10.1016/j.neuroscience.2015.10.058
   Van Lieshout RJ, 2008, J PSYCHIATR NEUROSCI, V33, P395
   Vikram A, 2010, BIOCHEM BIOPH RES CO, V398, P260, DOI 10.1016/j.bbrc.2010.06.070
   Vuong B, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0859-9
   Wadhwa M, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0998-z
   Walker JM, 2017, NEUROBIOL DIS, V100, P87, DOI 10.1016/j.nbd.2017.01.004
   Wicklow BA, 2018, JAMA PEDIATR, V172, P724, DOI 10.1001/jamapediatrics.2018.1201
   Yamashita H, 2003, PEDIATR RES, V53, P411, DOI 10.1203/01.PDR.0000049667.58071.7D
   Yessoufou A, 2011, EXP DIABETES RES, DOI 10.1155/2011/218598
   ZBINDEN G, 1981, ARCH TOXICOL, V48, P69, DOI 10.1007/BF00310480
   Zhang CL, 2016, DIABETOLOGIA, V59, P1385, DOI 10.1007/s00125-016-3979-3
NR 73
TC 2
Z9 2
U1 2
U2 6
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD NOV
PY 2019
VL 56
IS 11
BP 7754
EP 7764
DI 10.1007/s12035-019-1624-0
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA JH3JJ
UT WOS:000492663600036
PM 31115777
DA 2020-12-08
ER

PT J
AU Figueiredo, CP
   Barros-Aragao, FGQ
   Neris, RLS
   Frost, PS
   Soares, C
   Souza, INO
   Zeidler, JD
   Zamberlan, DC
   de Sousa, VL
   Souza, AS
   Guimaraes, ALA
   Bellio, M
   de Souza, JM
   Alves-Leon, SV
   Neves, GA
   Paula-Neto, HA
   Castro, NG
   De Felice, FG
   Assuncao-Miranda, I
   Clarke, JR
   Da Poian, AT
   Ferreira, ST
AF Figueiredo, Claudia P.
   Barros-Aragao, Fernanda G. Q.
   Neris, Romulo L. S.
   Frost, Paula S.
   Soares, Carolina
   Souza, Isis N. O.
   Zeidler, Julianna D.
   Zamberlan, Daniele C.
   de Sousa, Virginia L.
   Souza, Amanda S.
   Guimaraes, Andre Luis A.
   Bellio, Maria
   de Souza, Jorge Marcondes
   Alves-Leon, Soniza V.
   Neves, Gilda A.
   Paula-Neto, Heitor A.
   Castro, Newton G.
   De Felice, Fernanda G.
   Assuncao-Miranda, Iranaia
   Clarke, Julia R.
   Da Poian, Andrea T.
   Ferreira, Sergio T.
TI Zika virus replicates in adult human brain tissue and impairs synapses
   and memory in mice
SO NATURE COMMUNICATIONS
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; A-BETA OLIGOMERS; ACTIVATION; INFECTION;
   COMPLICATIONS; MICROGLIA; EPIDEMIC; DISEASE; IMPACT
AB Neurological complications affecting the central nervous system have been reported in adult patients infected by Zika virus (ZIKV) but the underlying mechanisms remain unknown. Here, we report that ZIKV replicates in human and mouse adult brain tissue, targeting mature neurons. ZIKV preferentially targets memory-related brain regions, inhibits hippocampal long-term potentiation and induces memory impairment in adult mice. TNF-alpha upregulation, microgliosis and upregulation of complement system proteins, C1q and C3, are induced by ZIKV infection. Microglia are found to engulf hippocampal presynaptic terminals during acute infection. Neutralization of TNF-alpha signaling, blockage of microglial activation or of C1q/C3 prevent synapse and memory impairment in ZIKV-infected mice. Results suggest that ZIKV induces synapse and memory dysfunction via aberrant activation of TNF-alpha, microglia and complement. Our findings establish a mechanism by which ZIKV affects the adult brain, and point to the need of evaluating cognitive deficits as a potential comorbidity in ZIKV-infected adults.
C1 [Figueiredo, Claudia P.; Barros-Aragao, Fernanda G. Q.; Frost, Paula S.; Soares, Carolina; Souza, Isis N. O.; Zamberlan, Daniele C.; de Sousa, Virginia L.; Guimaraes, Andre Luis A.; Paula-Neto, Heitor A.; Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Barros-Aragao, Fernanda G. Q.; Frost, Paula S.; Soares, Carolina; Neves, Gilda A.; Castro, Newton G.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Neris, Romulo L. S.; Bellio, Maria; Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Zeidler, Julianna D.; De Felice, Fernanda G.; Da Poian, Andrea T.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Souza, Amanda S.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [de Souza, Jorge Marcondes; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Div Neurosurg, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [de Souza, Jorge Marcondes; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Epilepsy Program, Div Neurol, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza V.] Queens Univ, Fed Univ Rio de Janeiro State, Grad Program Neurol, Kingston, ON, Canada.
   [De Felice, Fernanda G.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.
   [De Felice, Fernanda G.] Queens Univ, Dept Psychiat, Kingston, ON, Canada.
RP Figueiredo, CP (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.; Da Poian, AT; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM claudia@pharma.ufrj.br; dapoian@bioqmed.ufrj.br;
   ferreira@bioqmed.ufrj.br
RI Neves, Gilda A./K-7573-2012; Ferreira, Sergio/AAZ-1576-2020; Clarke,
   Julia/AAF-9434-2019; de Oliveira Souza, Isis Nem/AAA-3423-2019; Castro,
   Newton G/C-3263-2009; BELLIO, MARIA/N-8525-2018
OI Neves, Gilda A./0000-0002-7027-3851; Ferreira,
   Sergio/0000-0001-7160-9866; de Oliveira Souza, Isis
   Nem/0000-0002-0335-2541; Castro, Newton G/0000-0001-9570-7428; Zeidler,
   Julianna D./0000-0003-3168-1518; Souza, Amanda/0000-0002-7561-8150;
   Gomes de Queiroz Barros-Aragao, Fernanda/0000-0002-1663-8346; da Silva
   Frost, Paula/0000-0002-3814-999X; BELLIO, MARIA/0000-0002-3360-2740
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Alves-Leon SV, 2019, MULT SCLER J, V25, P427, DOI 10.1177/1352458518781992
   Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018
   Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bellesi M, 2017, J NEUROSCI, V37, P5263, DOI 10.1523/JNEUROSCI.3981-16.2017
   Bido-Medina R, 2018, ANN CLIN TRANSL NEUR, V5, P752, DOI 10.1002/acn3.575
   Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183
   Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Ennaceur A, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.223
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Ferreira J, 2005, PAIN, V117, P171, DOI 10.1016/j.pain.2005.06.001
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Figueiredo CP, 2011, J ALZHEIMERS DIS, V24, P61, DOI 10.3233/JAD-2010-101320
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Gonzalez-Dunia D, 2000, J VIROL, V74, P3441, DOI 10.1128/JVI.74.8.3441-3448.2000
   Greter M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00249
   Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373
   Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14
   Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54
   Kuno R, 2005, J NEUROIMMUNOL, V162, P89, DOI 10.1016/j.jneuroim.2005.01.015
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   Mamik MK, 2016, J NEUROSCI, V36, P10683, DOI 10.1523/JNEUROSCI.1287-16.2016
   Matheus FC, 2016, MOL NEUROBIOL, V53, P3891, DOI 10.1007/s12035-015-9330-z
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Nazerai L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00593
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Piacentini R, 2015, SCI REP-UK, V5, DOI 10.1038/srep15444
   Presumey J, 2017, ADV IMMUNOL, V135, P53, DOI 10.1016/bs.ai.2017.06.004
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Risher WC, 2014, ELIFE, V3, DOI 10.7554/eLife.04047
   Ronca SE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00959
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Souza INO, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020060
   STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203
   Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036
   Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14
   Torres-Platas SG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-12
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
   World Health Organization, 2017, ZIK VIR MICR GUILL B
NR 59
TC 20
Z9 20
U1 2
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD SEP 5
PY 2019
VL 10
AR 3890
DI 10.1038/s41467-019-11866-7
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IU9SV
UT WOS:000483921700001
PM 31488835
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Souza, INO
   Barros-Aragao, FGQ
   Frost, PS
   Figueiredo, CP
   Clarke, JR
AF Souza, Isis N. O.
   Barros-Aragao, Fernanda G. Q.
   Frost, Paula S.
   Figueiredo, Claudia P.
   Clarke, Julia R.
TI Late Neurological Consequences of Zika Virus Infection: Risk Factors and
   Pharmaceutical Approaches
SO PHARMACEUTICALS
LA English
DT Review
DE microcephaly; arbovirus; flavivirus; drug development; neurodevelopment;
   therapy; drug screening; pregnancy; Food and Drug Administration (FDA);
   encephalitis
ID GUILLAIN-BARRE-SYNDROME; FDA-APPROVED DRUG; ANTIVIRAL ACTIVITY;
   IN-VITRO; NEURAL PROGENITORS; VIRAL DYNAMICS; STEM-CELLS; BRAIN;
   NICLOSAMIDE; REPLICATION
AB Zika virus (ZIKV) infection was historically considered a disease with mild symptoms and no major consequences to human health. However, several long-term, late onset, and chronic neurological complications, both in congenitally-exposed babies and in adult patients, have been reported after ZIKV infection, especially after the 2015 epidemics in the American continent. The development or severity of these conditions cannot be fully predicted, but it is possible that genetic, epigenetic, and environmental factors may contribute to determine ZIKV infection outcomes. This reinforces the importance that individuals exposed to ZIKV are submitted to long-term clinical surveillance and highlights the urgent need for the development of therapeutic approaches to reduce or eliminate the neurological burden of infection. Here, we review the epidemiology of ZIKV-associated neurological complications and the role of factors that may influence disease outcome. Moreover, we discuss experimental and clinical evidence of drugs that have shown promising results in vitro or in vitro against viral replication and and/or ZIKV-induced neurotoxicity.
C1 [Souza, Isis N. O.; Barros-Aragao, Fernanda G. Q.; Frost, Paula S.; Figueiredo, Claudia P.; Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, Brazil.
   [Barros-Aragao, Fernanda G. Q.; Frost, Paula S.; Figueiredo, Claudia P.; Clarke, Julia R.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, Brazil.
RP Figueiredo, CP; Clarke, JR (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, Brazil.; Figueiredo, CP; Clarke, JR (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, Brazil.
EM isis.de.o@gmail.com; fernandaqbarros@gmail.com;
   paulafrostufrj@gmail.com; claufig@gmail.com; juliaclarke@pharma.ufrj.br
RI Figueiredo, Claudia P/F-8424-2012; de Oliveira Souza, Isis
   Nem/AAA-3423-2019; Clarke, Julia/AAF-9434-2019
OI de Oliveira Souza, Isis Nem/0000-0002-0335-2541; Clarke,
   Julia/0000-0002-6777-2051; Gomes de Queiroz Barros-Aragao,
   Fernanda/0000-0002-1663-8346; da Silva Frost, Paula/0000-0002-3814-999X
FU Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Institutos Nacionais de Pesquisa-Inovacao em Medicamentos e
   Identificacao de Novos Alvos Terapeuticos; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Financiadora de
   Estudos e ProjetosCiencia Tecnologia e Inovacao (FINEP)
FX Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (to I.N.O.S.,
   C.P.F. and J.R.C.), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (P.S.F., F.G.Q.B.-A., C.P.F. and J.R.C.), Institutos
   Nacionais de Pesquisa-Inovacao em Medicamentos e Identificacao de Novos
   Alvos Terapeuticos (to C.P.F.), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (to I.N.O.S.) and Financiadora de Estudos e
   Projetos (to C.P.F. and J.R.C.).
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   [Anonymous], 2017, IEEE T POWER SYSTEMS, VPP, P1, DOI DOI 10.1109/IEEESTD.2017.7920364
   Arumugasaamy N, 2018, ANN BIOMED ENG, V46, P1963, DOI 10.1007/s10439-018-2090-y
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Barbeito-Andres J, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006592
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bassi MR, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00380-18, 10.1128/aac.00380-18]
   Bayer, 1988, YOM PACK INS
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Baz M, 2017, ANTIVIR THER, V22, P613, DOI 10.3851/IMP3180
   Bernatchez JA, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00725-18
   Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Borges MC, 2013, MEM I OSWALDO CRUZ, V108, P596, DOI 10.1590/S0074-02762013000500010
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cai L, 2017, ARCH VIROL, V162, P2847, DOI 10.1007/s00705-017-3436-8
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Cairns DM, 2018, BIOL OPEN, V7, DOI 10.1242/bio.031807
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chang AY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0151-9
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Mello CPP, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01983-17
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   DECLERCQ E, 1984, ANTIVIR RES, V4, P119, DOI 10.1016/0166-3542(84)90012-3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delgado FG, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090480
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Eyer L, 2017, ANTIVIR RES, V142, P63, DOI 10.1016/j.antiviral.2017.03.012
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FDA, 2011, COP PACK INS
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Food and Drug Administration, 2012, ZITHROMAXR AZ TABL A, P2011
   Food and Drug Administration, 2003, FDA LAB NAM MEM HCI
   Han YS, 2018, J MED VIROL, V90, P796, DOI 10.1002/jmv.25031
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hermanns K, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0199-6
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Janssen Pharmaceutica, 2015, REM PACK INS
   Jaruratanasirikul S, 1996, ANTIMICROB AGENTS CH, V40, P825, DOI 10.1128/AAC.40.3.825
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Kao JC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006715
   Kim JA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020072
   Kim S, 2019, NUCLEIC ACIDS RES, V47, pD1102, DOI 10.1093/nar/gky1033
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanko K, 2017, ANTIVIR RES, V145, P82, DOI 10.1016/j.antiviral.2017.07.010
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leonardi W, 2016, SCI REP-UK, V6, DOI 10.1038/srep34475
   Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lim S.-Y., 2016, OPEN FORUM INFECT DI, DOI [10.1093/ofid/ofw195.05, DOI 10.1093/OFID/OFW195.05]
   Limonta D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110646
   Lin CK, 2016, ONCOTARGET, V7, P8993, DOI 10.18632/oncotarget.7113
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   Lo MK, 2016, ANTIVIR RES, V130, P46, DOI 10.1016/j.antiviral.2016.03.013
   Magalhaes T, 2018, INSECTS, V9, DOI 10.3390/insects9040177
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Medina FA, 2019, J INFECT DIS, V219, P31, DOI 10.1093/infdis/jiy462
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   OFORIADJEI D, 2008, INT J RISK SAF MED, V20, P113, DOI DOI 10.3233/JRS-2008-0440
   Ojha CR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208543
   Souto IO, 2018, ENFERM INFEC MICR CL, V36, P21, DOI 10.1016/j.eimc.2016.10.009
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   PAHO/WHO, 2018, ZIK CAS CONG SYNDR A
   Pan JX, 2012, CHIN J CANCER, V31, P178, DOI 10.5732/cjc.011.10290
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pfizer, 2015, IBRANCE PALB FACT SH
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Prata-Barbos A, 2019, J PEDIAT-BRAZIL, V95, pS30, DOI 10.1016/j.jped.2018.10.016
   Pressler R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00036
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Raboni SM, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12700
   de Araujo PSR, 2019, J INFECT PUBLIC HEAL, V12, P97, DOI 10.1016/j.jiph.2018.04.010
   Ramsey PS, 2003, AM J OBSTET GYNECOL, V188, P714, DOI 10.1067/mob.2003.141
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Ribeiro MR, 2018, ARCH VIROL, V163, P2687, DOI 10.1007/s00705-018-3911-x
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Sisk JM, 2015, ACS INFECT DIS, V1, P401, DOI 10.1021/acsinfecdis.5b00089
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Snyder B, 2018, J MED VIROL, V90, P8, DOI 10.1002/jmv.24932
   Souza AI, 2018, PUBLIC HEALTH REP, V133, P461, DOI 10.1177/0033354918777256
   Stagni F, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00265
   Taylor WRJ, 2004, DRUG SAFETY, V27, P25, DOI 10.2165/00002018-200427010-00003
   The Lancet, 2018, Lancet, V392, P532, DOI 10.1016/S0140-6736(18)31801-4
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vliet SM, 2018, TOXICOL SCI, V166, P306, DOI 10.1093/toxsci/kfy214
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Wiwanitkit S, 2017, ASIAN PAC J TROP MED, V10, P682, DOI 10.1016/j.apjtm.2017.06.012
   World Health Organization, ZIK FACT SHEET
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu YH, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006848
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang XW, 2015, J MICROENCAPSUL, V32, P496, DOI 10.3109/02652048.2015.1057251
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 134
TC 3
Z9 3
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD JUN
PY 2019
VL 12
IS 2
AR 60
DI 10.3390/ph12020060
PG 21
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA IL0ZM
UT WOS:000477028700015
PM 30999590
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU de Oliveira, CAR
   Araujo, TD
   Aguiar, GD
   da Silva, JA
   Vettorazzi, JF
   Freitas, IN
   de Oliveira, KM
   Boschero, AC
   Bonfleur, ML
   Clarke, JR
   Henriques, HN
   Ribeiro, RA
AF Roso de Oliveira, Cremilda Amaral
   Araujo, Thiago dos Reis
   Aguiar, Gesily de Souza
   da Silva Junior, Joel Alves
   Vettorazzi, Jean Franciesco
   Freitas, Israelle Netto
   de Oliveira, Kenia Moreno
   Boschero, Antonio Carlos
   Bonfleur, Maria Lucia
   Clarke, Julia Rosauro
   Henriques, Helene Nara
   Ribeiro, Rosane Aparecida
TI Combined oral contraceptive in female mice causes hyperinsulinemia due
   to beta-cell hypersecretion and reduction in insulin clearance
SO JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article
DE Endocrine disrupters; Thinyl estradiol; Drospirenone; Insulin
   degradation; Glucose homeostasis; Hormonal contraception
ID ETHINYL ESTRADIOL; IN-VIVO; PROGESTERONE; SECRETION; RECEPTOR;
   DROSPIRENONE; ESTROGEN; METABOLISM; PROTEIN; RAT
AB Oral contraception is the most commonly used interventional method in the world. However, several women employ the continuous use of these hormones to avoid pre- and menstruation discomforts. Some studies indicate that oral contraceptives are associated with disturbances in glycemia and the effects of the use of a continuous regime are poorly elucidated. Herein, we evaluated the effects of the continuous administration of a combined oral contraceptive (COC) composed by ethinyl estradiol (EE) and drospirenone (DRSP) on glucose homeostasis in female mice. Adult Swiss mice received 0.6 mu g EE and 60 mu g DRSP (COC group) or vehicle [control (CTL)] daily by gavage for 35 days. COC treatment had no effect on body weight or adiposity, but increased uterus weight and induced hepatomegaly. Importantly, COC females displayed normal glycemia and glucose tolerance, but hyperinsulinemia and lower plasma C-peptide/insulin ratio, indicating reduced insulin clearance. Furthermore, COC mice displayed reduced protein content of the beta subunit of the insulin receptor (IR beta) in the liver. Additionally, pancreatic islets isolated from COC mice secreted more insulin in response to increasing glucose concentrations. This effect was associated with the activity of steroid hormones, since INS-1E cells incubated with EE plus DRSP also secreted more insulin. Therefore, we provide the first evidence that the continuous administration of EE and DRSP lead to hyperinsulinemia, due to enhancement of insulin secretion and the reduction of insulin degradation, which possibly lead to the down-regulation of hepatic IR beta. These findings suggest that the continuous administration of COC could cause insulin resistance with the prolongation of treatment.
C1 [Roso de Oliveira, Cremilda Amaral; Aguiar, Gesily de Souza; da Silva Junior, Joel Alves; de Oliveira, Kenia Moreno; Henriques, Helene Nara; Ribeiro, Rosane Aparecida] Univ Fed Rio de Janeiro, Campus UFRJ Macae Prof Aloisio Teixeira, Macae, RJ, Brazil.
   [Araujo, Thiago dos Reis; Vettorazzi, Jean Franciesco; Freitas, Israelle Netto; Boschero, Antonio Carlos] Univ Estadual Campinas, Inst Biol, Dept Biol Estrutural & Func, Campinas, SP, Brazil.
   [Bonfleur, Maria Lucia] Univ Estadual Oeste Parana UNIOESTE, Ctr Ciencias Biol & Saude, Cascavel, PR, Brazil.
   [Clarke, Julia Rosauro] Univ Fed Rio de Janeiro, Fac Farm, Nucleo Neurociencias, Campus UFRJ Ilha Fundao, Rio De Janeiro, RJ, Brazil.
RP Ribeiro, RA (corresponding author), Campus UFRJ Macae,Rua Alcides da Conceicao 159, BR-27930480 Macae, RJ, Brazil.
EM rosaneribeirobio@gmail.com
RI Clarke, Julia/AAF-9434-2019
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
   [001]; Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/203.249/2017]; Ftmdacao de Amparo
   Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP)
FX This study forms part of the M.Sc. Thesis of Cremilda Amaral Roso de
   Oliveira and was supported by grants from: Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Finance Code 001);
   Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ: E-26/203.249/2017) and Ftmdacao de Amparo Pesquisa do Estado de
   Sao Paulo (FAPESP).
CR Adeyanju OA, 2018, CAN J PHYSIOL PHARM, V96, P577, DOI 10.1139/cjpp-2017-0630
   Ahmed IS, 2010, J BIOL CHEM, V285, P24775, DOI 10.1074/jbc.M110.134585
   Archer DF, 2015, CONTRACEPTION, V92, P439, DOI 10.1016/j.contraception.2015.07.014
   Armani A, 2014, FASEB J, V28, P3745, DOI 10.1096/fj.13-245415
   Batista MR, 2005, AM J PHYSIOL-REG I, V289, pR1064, DOI 10.1152/ajpregu.00311.2005
   Blode H, 2000, Eur J Contracept Reprod Health Care, V5, P256, DOI 10.1080/13625180008500407
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Campion J, 1998, MOL CELL BIOCHEM, V185, P177, DOI 10.1023/A:1006871309864
   Caprio M, 2011, ENDOCRINOLOGY, V152, P113, DOI 10.1210/en.2010-0674
   De Leo V, 2016, HUM REPROD UPDATE, V22, P634, DOI 10.1093/humupd/dmw016
   Dong FQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24859
   Edelman A, 2006, HUM REPROD, V21, P573, DOI 10.1093/humrep/dei377
   Fawcett J, 2009, DIABETOLOGIA, V52, P1457, DOI 10.1007/s00125-009-1414-8
   Freitas GC, 2013, CIENC RURAL, V43, P297, DOI 10.1590/S0103-84782013000200017
   Gallo MF, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003987.pub4
   Giribela CRG, 2015, GYNECOL ENDOCRINOL, V31, P912, DOI 10.3109/09513590.2015.1062860
   Gaspard U, 2004, CONTRACEPTION, V69, P271, DOI 10.1016/j.contraception.2003.11.003
   GODSLAND IF, 1992, J CLIN ENDOCR METAB, V74, P64, DOI 10.1210/jc.74.1.64
   Gronich N, 2011, CAN MED ASSOC J, V183, pE1319, DOI 10.1503/cmaj.110463
   Grossman D, 2011, OBSTET GYNECOL, V117, P558, DOI 10.1097/AOG.0b013e31820b0244
   Hampton KK, 2018, MOL PHARMACOL, V94, P665, DOI 10.1124/mol.117.110510
   Janzen DM, 2013, STEM CELLS, V31, P808, DOI 10.1002/stem.1337
   KOJIMA T, 1993, AM J OBSTET GYNECOL, V169, P1540, DOI 10.1016/0002-9378(93)90432-I
   Krattenmacher R, 2000, CONTRACEPTION, V62, P29, DOI 10.1016/S0010-7824(00)00133-5
   Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816
   Luther JM, 2011, DIABETOLOGIA, V54, P2152, DOI 10.1007/s00125-011-2158-9
   MEDLOCK KL, 1994, P SOC EXP BIOL MED, V205, P146, DOI 10.3181/00379727-205-43690
   Miller BH, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2013.00195
   Momoeda M, 2017, INT J WOMENS HEALTH, V9, P295, DOI 10.2147/IJWH.S134576
   Morch LS, 2018, NEW ENGL J MED, V378, P1265, DOI 10.1056/NEJMc1800054
   NEWBURGER J, 1983, AM J OBSTET GYNECOL, V146, P80, DOI 10.1016/0002-9378(83)90931-6
   Nolte I, 2000, BBA-PROTEIN STRUCT M, V1543, P123, DOI 10.1016/S0167-4838(00)00188-6
   Nunes VA, 2014, J ENDOCRINOL, V221, P273, DOI 10.1530/JOE-13-0202
   Olatunji L A, 2012, Pathophysiology, V19, P29, DOI 10.1016/j.pathophys.2011.09.001
   Panicker S, 2014, J FAM PLAN REPROD H, V40, P133, DOI 10.1136/jfprhc-2013-100600
   Ribeiro RA, 2012, AMINO ACIDS, V43, P1791, DOI 10.1007/s00726-012-1263-5
   Rizzo MR, 2014, AGE, V36, P265, DOI 10.1007/s11357-013-9554-7
   Root-Bernstein R, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00118
   Roper AB, 2012, STEROIDS, V77, P951, DOI 10.1016/j.steroids.2012.01.015
   Rorsman P, 2018, PHYSIOL REV, V98, P117, DOI 10.1152/physrev.00008.2017
   Sharma G, 2011, ENDOCRINOLOGY, V152, P3030, DOI 10.1210/en.2011-0091
   Sitruk-Ware R, 2011, REV ENDOCR METAB DIS, V12, P63, DOI 10.1007/s11154-011-9182-4
   SMITH MS, 1975, ENDOCRINOLOGY, V96, P219, DOI 10.1210/endo-96-1-219
   Soriano S, 2009, MOL ENDOCRINOL, V23, P1973, DOI 10.1210/me.2009-0287
   Straub SG, 2001, BIOSCIENCE REP, V21, P653, DOI 10.1023/A:1014773010350
   Tokarz VL, 2018, J CELL BIOL, V217, P2273, DOI 10.1083/jcb.201802095
   Vettorazzi JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13974-0
   Viengchareun S, 2009, MOL ENDOCRINOL, V23, P1948, DOI 10.1210/me.2009-0095
   Wang HD, 2015, J STEROID BIOCHEM, V154, P254, DOI 10.1016/j.jsbmb.2015.09.003
NR 49
TC 2
Z9 2
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-0760
J9 J STEROID BIOCHEM
JI J. Steroid Biochem. Mol. Biol.
PD JUN
PY 2019
VL 190
BP 54
EP 63
DI 10.1016/j.jsbmb.2019.03.018
PG 10
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA IC6MX
UT WOS:000471087300007
PM 30923014
DA 2020-12-08
ER

PT J
AU Frost, PS
   Barros-Aragao, F
   da Silva, RT
   Venancio, A
   Matias, I
   Silva, NMLE
   Kincheski, GC
   Pimentel-Coelho, PM
   De Felice, FG
   Gomes, FCA
   FerreiraiEi, ST
   Figueiredo, CP
   Clarke, JR
AF Frost, Paula S.
   Barros-Aragao, Fernanda
   da Silva, Rachel T.
   Venancio, Aline
   Matias, Isadora
   Lyra e Silva, Natalia M.
   Kincheski, Grasielle C.
   Pimentel-Coelho, Pedro M.
   De Felice, Fernanda G.
   Gomes, Flayia C. A.
   FerreiraiEi, Sergio T.
   Figueiredo, Claudia P.
   Clarke, Julia R.
TI Neonatal infection leads to increased susceptibility to A beta
   oligomer-induced brain inflammation, synapse loss and cognitive
   impairment in mice
SO CELL DEATH & DISEASE
LA English
DT Article
ID DEPRESSIVE-LIKE BEHAVIOR; ALZHEIMERS-DISEASE; MEMORY IMPAIRMENT; INNATE
   IMMUNITY; SEX-DIFFERENCES; MOUSE MODEL; LIPOPOLYSACCHARIDE; MECHANISMS;
   MICROGLIA; SYSTEM
AB Harmful environmental stimuli during critical stages of development can profoundly affect behavior and susceptibility to diseases. Alzheimer disease (AD) is the most frequent neurodegenerative disease, and evidence suggest that inflammatory conditions act cumulatively, contributing to disease onset. Here we investigated whether infection early in life can contribute to synapse damage and cognitive impairment induced by amyloid-beta oligomers (A beta Os), neurotoxins found in AD brains. To this end, wild-type mice were subjected to neonatal (post-natal day 4) infection by Escherichia coli (1 x 10(4) CFU/g), the main cause of infection in low-birth-weight premature infants in the US. E. coil infection caused a transient inflammatory response in the mouse brain starting shortly after infection. Although infected mice performed normally in behavioral tasks in adulthood, they showed increased susceptibility to synapse damage and memory impairment induced by low doses of A beta Os (1 pmol; intracerebroventricular) in the novel object recognition paradigm. Using in vitro and in vivo approaches, we show that microglial cells from E. col/-infected mice undergo exacerbated activation when exposed to low doses of A beta Os. In addition, treatment of infected pups with minocycline, an antibiotic that inhibits microglial pro-inflammatory polarization, normalized microglial response to A beta Os and restored normal susceptibility of mice to oligomer-induced cognitive impairment. Interestingly, mice infected with by E. coli (1 x 10(4) CFU/g) during adolescence (post-natal day 21) or adulthood (post-natal day 60) showed normal cognitive performance even in the presence of A beta Os (1 pmol), suggesting that only infections at critical stages of development may lead to increased susceptibility to amyloid-beta-induced toxicity. Altogether, our findings suggest that neonatal infections can modulate microglial response to A beta Os into adulthood, thus contributing to amyloid-beta-induced synapse damage and cognitive impairment.
C1 [Frost, Paula S.; Barros-Aragao, Fernanda; da Silva, Rachel T.; Figueiredo, Claudia P.; Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Frost, Paula S.; Barros-Aragao, Fernanda; Matias, Isadora; Gomes, Flayia C. A.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Venancio, Aline] Univ Fed Santa Catarina, BR-88040900 Florianopolis, SC, Brazil.
   [Lyra e Silva, Natalia M.; Kincheski, Grasielle C.; De Felice, Fernanda G.; FerreiraiEi, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Pimentel-Coelho, Pedro M.; FerreiraiEi, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Ctr Neurosci Studies, Dept Psychiat, Kingston, ON, Canada.
RP Figueiredo, CP; Clarke, JR (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM claufig@gmail.com; juliaclarke@pharma.ufrj.br
RI Figueiredo, Claudia P/F-8424-2012; Clarke, Julia/AAF-9434-2019;
   Pimentel-Coelho, Pedro M/K-1994-2015; Pimentel-Coelho, Pedro
   Moreno/AAM-9106-2020
OI Pimentel-Coelho, Pedro M/0000-0002-2414-3386; Pimentel-Coelho, Pedro
   Moreno/0000-0002-2414-3386; da Silva Frost, Paula/0000-0002-3814-999X;
   Figueiredo, Claudia/0000-0001-9467-9891
FU Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Institutos Nacionais de Pesquisa-Instituto Nacional de
   Neurociencia Translacional; Institutos Nacionais de Pesquisa-Inovacao em
   Medicamentos e Identificacao de Novos Alvos Terapeuticos; Conselho
   Nacional de Desenvolvimento Cientifico e TecnologicoNational Council for
   Scientific and Technological Development (CNPq); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
FX This study was funded by the following brazilian agencies: Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (P.M.P.C., F.G.D.F.,
   F.C.A.G., S.T.F.,C.P.F. and J.R.C.), Institutos Nacionais de
   Pesquisa-Instituto Nacional de Neurociencia Translacional (F.G.D.F.,
   F.C.A.G., S.T.F.), Institutos Nacionais de Pesquisa-Inovacao em
   Medicamentos e Identificacao de Novos Alvos Terapeuticos (C.P.F.),
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (F.B.A.,
   I.M., F.G.D.F., F.C.A.G., S.T.F., C.P.F. and J.R.C.) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (P.S.F., N.L.S.).
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001
   Adams-Chapman I, 2006, CURR OPIN INFECT DIS, V19, P290, DOI 10.1097/01.qco.0000224825.57976.87
   Aktas O, 2007, ARCH NEUROL-CHICAGO, V64, P185, DOI 10.1001/archneur.64.2.185
   Bale TL, 2015, NAT REV NEUROSCI, V16, P332, DOI 10.1038/nrn3818
   Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005
   Bilbo SD, 2005, J NEUROSCI, V25, P8000, DOI 10.1523/JNEUROSCI.1748-05.2005
   Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009
   Billiards SS, 2006, BIOL NEONATE, V90, P258, DOI 10.1159/000094146
   Borenstein AR, 2006, ALZ DIS ASSOC DIS, V20, P63, DOI 10.1097/01.wad.0000201854.62116.d7
   Cai ZW, 2000, PEDIATR RES, V47, P64, DOI 10.1203/00006450-200001000-00013
   Chu LS, 2007, ACTA PHARMACOL SIN, V28, P763, DOI 10.1111/j.1745-7254.2007.00578.x
   Curley JP, 2016, FRONT NEUROENDOCRIN, V40, P52, DOI 10.1016/j.yfrne.2015.11.001
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108
   Dinel AL, 2014, PSYCHONEUROENDOCRINO, V40, P48, DOI 10.1016/j.psyneuen.2013.10.014
   Dunn N, 2005, ALZ DIS ASSOC DIS, V19, P91, DOI 10.1097/01.wad.0000165511.52746.1f
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155
   Guillot-Sestier MV, 2015, NEURON, V85, P534, DOI 10.1016/j.neuron.2014.12.068
   Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5
   Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880
   Hoeijmakers L, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00398
   Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373
   Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962
   Kincheski GC, 2017, BRAIN BEHAV IMMUN, V64, P140, DOI 10.1016/j.bbi.2017.04.007
   Kitazawa M, 2012, CURR PHARM DESIGN, V18, P1131, DOI 10.2174/138161212799315786
   Krstic D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-151
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016
   Lee BK, 2015, BRAIN BEHAV IMMUN, V44, P100, DOI 10.1016/j.bbi.2014.09.001
   Lim MM, 2014, NEURODEGENER DIS MAN, V4, P351, DOI [10.2217/NMT.14.33, 10.2217/nmt.14.33]
   Liverman CS, 2006, NEUROSCI LETT, V399, P220, DOI 10.1016/j.neulet.2006.01.064
   Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006
   Mattson MP, 2015, AGEING RES REV, V20, P37, DOI 10.1016/j.arr.2014.12.011
   Moraes CA, 2015, MOL NEUROBIOL, V52, P653, DOI 10.1007/s12035-014-8868-5
   Mucke L, 2012, COLD SPRING HARBOR P, V2, P1
   Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018
   Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028
   Paintlia MK, 2004, J NEUROSCI RES, V78, P347, DOI 10.1002/jnr.20261
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   PARKKINEN J, 1988, J CLIN INVEST, V81, P860, DOI 10.1172/JCI113395
   Pawlosky R. J., 2017, J NEUROCHEM, V12, P3218
   Prince M, 2016, ALZHEIMERS DIS INT, P1, DOI [10.13140/RG.2.2.22580.04483.5, DOI 10.13140/RG.2.2.22580.04483.5]
   Rajendran L, 2018, J NEUROSCI, V38, P2911, DOI 10.1523/JNEUROSCI.1136-17.2017
   Rantakallio P, 1997, INT J EPIDEMIOL, V26, P837, DOI 10.1093/ije/26.4.837
   Rutter M, 2003, J CHILD PSYCHOL PSYC, V44, P1092, DOI 10.1111/1469-7610.00194
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Shah FA, 2013, AM J RESP CRIT CARE, V188, P586, DOI 10.1164/rccm.201212-2154OC
   Sparkman NL, 2008, NEUROIMMUNOMODULAT, V15, P323, DOI 10.1159/000156474
   Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810
   Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357
   Strahan JA, 2017, DEV NEUROBIOL, V77, P753, DOI 10.1002/dneu.22457
   SUSSER ES, 1992, ARCH GEN PSYCHIAT, V49, P983
   Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010
   Viola KL, 2015, ACTA NEUROPATHOL, V129, P183, DOI 10.1007/s00401-015-1386-3
   Wang J, 2017, NAT REV NEUROL, V13, P612, DOI 10.1038/nrneurol.2017.111
   Wendeln AC, 2018, NATURE, V556, P332, DOI 10.1038/s41586-018-0023-4
   Williamson LL, 2011, J NEUROSCI, V31, P15511, DOI 10.1523/JNEUROSCI.3688-11.2011
NR 63
TC 9
Z9 8
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD APR 11
PY 2019
VL 10
AR 323
DI 10.1038/s41419-019-1529-x
PG 13
WC Cell Biology
SC Cell Biology
GA HZ2DU
UT WOS:000468660000004
PM 30975983
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Lourenco, MV
   Frozza, RL
   de Freitas, GB
   Zhang, H
   Kincheski, GC
   Ribeiro, FC
   Goncalves, RA
   Clarke, JR
   Beckman, D
   Staniszewski, A
   Berman, H
   Guerra, LA
   Forny-Germano, L
   Meier, S
   Wilcock, DM
   de Souza, JM
   Alves-Leon, S
   Prado, VF
   Prado, MAM
   Abisambra, JF
   Tovar-Moll, F
   Mattos, P
   Arancio, O
   Ferreira, ST
   De Felice, FG
AF Lourenco, Mychael V.
   Frozza, Rudimar L.
   de Freitas, Guilherme B.
   Zhang, Hong
   Kincheski, Grasielle C.
   Ribeiro, Felipe C.
   Goncalves, Rafaella A.
   Clarke, Julia R.
   Beckman, Danielle
   Staniszewski, Agnieszka
   Berman, Hanna
   Guerra, Lorena A.
   Forny-Germano, Leticia
   Meier, Shelby
   Wilcock, Donna M.
   de Souza, Jorge M.
   Alves-Leon, Soniza
   Prado, Vania F.
   Prado, Marco A. M.
   Abisambra, Jose F.
   Tovar-Moll, Fernanda
   Mattos, Paulo
   Arancio, Ottavio
   Ferreira, Sergio T.
   De Felice, Fernanda G.
TI Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory
   defects in Alzheimer's models
SO NATURE MEDICINE
LA English
DT Article
ID DEPRESSIVE-LIKE BEHAVIOR; AMYLOID-BETA OLIGOMERS; HIPPOCAMPAL
   INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; MOUSE MODEL; EIF2-ALPHA KINASES;
   GENE-EXPRESSION; ENERGY-INTAKE; BRAIN; DISEASE
AB Defective brain hormonal signaling has been associated with Alzheimer's disease (AD), a disorder characterized by synapse and memory failure. Irisin is an exercise-induced myokine released on cleavage of the membrane-bound precursor protein fibronectin type III domain-containing protein 5 (FNDC5), also expressed in the hippocampus. Here we show that FNDC5/irisin levels are reduced in AD hippocampi and cerebrospinal fluid, and in experimental AD models. Knockdown of brain FNDC5/irisin impairs long-term potentiation and novel object recognition memory in mice. Conversely, boosting brain levels of FNDC5/irisin rescues synaptic plasticity and memory in AD mouse models. Peripheral overexpression of FNDC5/irisin rescues memory impairment, whereas blockade of either peripheral or brain FNDC5/irisin attenuates the neuroprotective actions of physical exercise on synaptic plasticity and memory in AD mice. By showing that FNDC5/irisin is an important mediator of the beneficial effects of exercise in AD models, our findings place FNDC5/irisin as a novel agent capable of opposing synapse failure and memory impairment in AD.
C1 [Lourenco, Mychael V.; Frozza, Rudimar L.; de Freitas, Guilherme B.; Kincheski, Grasielle C.; Ribeiro, Felipe C.; Clarke, Julia R.; Beckman, Danielle; Guerra, Lorena A.; Forny-Germano, Leticia; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Lourenco, Mychael V.; Kincheski, Grasielle C.; Ribeiro, Felipe C.; Guerra, Lorena A.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Lourenco, Mychael V.; Zhang, Hong; Staniszewski, Agnieszka; Berman, Hanna; Arancio, Ottavio] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.
   [Frozza, Rudimar L.] Fiocruz MS, Oswaldo Cruz Fdn, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
   [de Freitas, Guilherme B.; Goncalves, Rafaella A.; De Felice, Fernanda G.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, Rio De Janeiro, Brazil.
   [Meier, Shelby; Wilcock, Donna M.; Abisambra, Jose F.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.
   [de Souza, Jorge M.; Alves-Leon, Soniza] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Div Neurosurg, Rio De Janeiro, Brazil.
   [de Souza, Jorge M.; Alves-Leon, Soniza] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Epilepsy Program, Div Neurol, Rio De Janeiro, Brazil.
   [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada.
   [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.
   [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada.
   [Tovar-Moll, Fernanda; Mattos, Paulo] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Mattos, Paulo] Univ Fed Rio de Janeiro, Inst Psychiat, Rio De Janeiro, Brazil.
   [Arancio, Ottavio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.
   [Arancio, Ottavio] Columbia Univ, Dept Med, New York, NY 10027 USA.
   [De Felice, Fernanda G.] Queens Univ, Dept Psychiat, Kingston, ON, Canada.
RP Ferreira, ST; De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.; Arancio, O (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.; De Felice, FG (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.; Arancio, O (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.; Arancio, O (corresponding author), Columbia Univ, Dept Med, New York, NY 10027 USA.; De Felice, FG (corresponding author), Queens Univ, Dept Psychiat, Kingston, ON, Canada.
EM oa1@cumc.columbia.edu; ferreira@biof.ufrj.br;
   fernanda.defelice@queensu.ca
RI Forny-Germano, Leticia/L-6639-2019; Clarke, Julia/AAF-9434-2019; Prado,
   Vania Ferreira/K-7630-2013; de Mattos, Paulo Eduardo Luiz/D-2328-2014;
   Forny-Germano, Leticia/D-1342-2017; Moll, Fernanda Tovar/N-3320-2018;
   Ferreira, Sergio/AAZ-1576-2020; Leon, Soniza V Alves/J-7786-2012;
   Ribeiro, Felipe Campos/W-9758-2019; Abisambra, Joe/AAP-3269-2020; Prado,
   Marco Antonio Maximo/K-7638-2013; Lourenco, Mychael/G-2614-2014;
   Abisambra, Jose/V-6860-2019; arancio, ottavio/AAB-7959-2019
OI Forny-Germano, Leticia/0000-0001-8301-0711; Prado, Vania
   Ferreira/0000-0003-4994-6393; de Mattos, Paulo Eduardo
   Luiz/0000-0003-0709-3783; Forny-Germano, Leticia/0000-0001-8301-0711;
   Moll, Fernanda Tovar/0000-0002-0292-5985; Ferreira,
   Sergio/0000-0001-7160-9866; Ribeiro, Felipe Campos/0000-0003-3028-3307;
   Prado, Marco Antonio Maximo/0000-0002-3028-5778; Lourenco,
   Mychael/0000-0002-1078-0296; Abisambra, Jose/0000-0001-6341-679X;
   Frozza, Rudimar Luiz/0000-0003-0918-4128; Meier,
   Shelby/0000-0003-1946-9004; De Freitas, Guilherme/0000-0003-4614-4280;
   Berman, Hanna/0000-0002-8616-8167
FU Alzheimer Society of Canada; Weston Brain Institute; National Institute
   for Translational Neuroscience (INNT/Brazil) [465346/2014-6]; Human
   Frontier Science ProgramHuman Frontier Science Program; International
   Society for Neurochemistry (CAEN 1B); National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [NIH-R01NS049442]; Canadian Institutes
   of Health ResearchCanadian Institutes of Health Research (CIHR) [CIHR
   MOP 136940, MOP 89919]; Brazilian funding agency Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [451195/2017-5,
   406436/2016-9, 473324/2013-0]; Brazilian funding agency Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [202.817/2016, 201.432/2014, 202.944/2015];
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq); Comissao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES/Brazil)CAPES [001]; NIH T32 grantUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [AG057461]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND
   STROKEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01NS091329, R01NS091329, R01NS091329]
   Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute on Aging (NIA) [P30AG028383, P30AG028383,
   P30AG028383, P30AG028383, P30AG028383, P30AG028383, T32AG057461,
   P30AG028383, P30AG028383, P30AG028383, P30AG028383, P30AG028383,
   T32AG057461, P30AG028383, P30AG028383, P30AG028383, P30AG028383,
   P30AG028383, P30AG028383, P30AG028383, P30AG028383, P30AG028383,
   T32AG057461, P30AG028383, P30AG028383, P30AG028383, P30AG028383,
   P30AG028383, P30AG028383, P30AG028383, P30AG028383, P30AG028383,
   T32AG057461, P30AG028383] Funding Source: NIH RePORTER
FX This work was supported by grants from Alzheimer Society of Canada (to
   F.G.D.F.) and the Weston Brain Institute (to F.G.D.F.), National
   Institute for Translational Neuroscience (INNT/Brazil) (465346/2014-6 to
   S.T.F. and F.G.F.), Human Frontier Science Program (to F.G.D.F.),
   International Society for Neurochemistry (CAEN 1B to M.V.L.), National
   Institutes of Health (NIH-R01NS049442 to O.A.), Canadian Institutes of
   Health Research (CIHR MOP 136940 and MOP 89919 to V.F.P. and M.A.M.P.),
   and from the Brazilian funding agencies Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (451195/2017-5 to
   M.V.L., 406436/2016-9 to S.T.F., and 473324/2013-0 to F.G.D.F.) and
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ) (202.817/2016 to M.V.L., 201.432/2014 to S.T.F., and
   202.944/2015 to F.G.D.F.). R.L.F, G.B.d.F., G.C.K., F.C.R., J.R.C.,
   D.B., and L.F.-G. were supported by fellowships granted by FAPERJ, CNPq,
   or Comissao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/Brazil; financial code 001). S.M. was supported by an NIH T32
   grant (AG057461). We acknowledge the University of Kentucky Alzheimer's
   Disease Center and its Neuropathology Core, which is supported by
   NIH/NIA P30 AG028383, for brain samples. We thank W.L. Klein
   (Northwestern University) for the kind gift of oligomer-specific NU4
   antibodies, B.M. Spiegelman (Harvard University) for sharing AdGFP and
   AdFNDC5 adenoviral constructs, and J. Wang (Queen's University, Canada)
   for help with mass spectrometry analyses. We also thank A. Lepelley, M.
   Oliveira, M. Melo, A.C. Rangel, and the CENABIO team for technical
   and/or administrative assistance.
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275
   Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889
   Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307
   Beckman D, 2015, J BIOL CHEM, V290, P20488, DOI 10.1074/jbc.M115.666156
   Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189
   Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35
   Chen K, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao6298
   Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Colaianni G, 2015, P NATL ACAD SCI USA, V112, P12157, DOI 10.1073/pnas.1516622112
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2014, ALZHEIMERS DEMENT, V10, pS26, DOI 10.1016/j.jalz.2013.12.004
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   Drummond C, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00096
   During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919
   Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831
   Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046
   Grillo CA, 2015, DIABETES, V64, P3927, DOI 10.2337/db15-0596
   Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097
   Irving AJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0155
   Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3
   Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001
   Katsnelson A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aal2074
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016
   Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017
   Lepeta K, 2016, J NEUROCHEM, V138, P785, DOI 10.1111/jnc.13713
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lourenco MV, 2015, PROG NEUROBIOL, V129, P37, DOI 10.1016/j.pneurobio.2015.03.003
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486
   Madeira C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.52
   Martin KC, 1996, NEURON, V17, P567, DOI 10.1016/S0896-6273(00)80188-9
   Mattson MP, 2012, CELL METAB, V16, P706, DOI 10.1016/j.cmet.2012.08.012
   McEwen BS, 2015, P NATL ACAD SCI USA, V112, P15544, DOI 10.1073/pnas.1521416112
   Mendes ND, 2018, J NEUROSCI METH, V307, P203, DOI 10.1016/j.jneumeth.2018.05.021
   Moon HY, 2016, CELL METAB, V24, P332, DOI 10.1016/j.cmet.2016.05.025
   Mucke L, 2012, COLD SPRING HARB PER, V2
   Muller S, 2018, ALZHEIMERS DEMENT, V14, P1427, DOI 10.1016/j.jalz.2018.06.3059
   Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011
   Okonkwo OC, 2014, NEUROLOGY, V83, P1753, DOI 10.1212/WNL.0000000000000964
   Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007
   Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009
   Schaefer N, 2017, J NEUROCHEM, V142, P790, DOI 10.1111/jnc.14107
   Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/nmeth.1314, 10.1038/NMETH.1314]
   Schumacher MA, 2013, J BIOL CHEM, V288, P33738, DOI 10.1074/jbc.M113.516641
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   da Silva GSS, 2017, J BIOL CHEM, V292, P7395, DOI 10.1074/jbc.M116.753525
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Sleiman SF, 2016, ELIFE, V5, DOI 10.7554/eLife.15092
   Smith RW, 2007, PROTEOMICS, V7, P4171, DOI 10.1002/pmic.200700573
   Suwabe K, 2018, P NATL ACAD SCI USA, V115, P10487, DOI 10.1073/pnas.1805668115
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364
   Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254
   Trinh MA, 2013, NEUROBIOL LEARN MEM, V105, P93, DOI 10.1016/j.nlm.2013.04.013
   van Praag H, 2014, J NEUROSCI, V34, P15139, DOI 10.1523/JNEUROSCI.2814-14.2014
   Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199
   Wadman M, 2012, NATURE, V485, P426, DOI 10.1038/485426a
   Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008
   Yang WZ, 2016, NEUROBIOL AGING, V41, P19, DOI 10.1016/j.neurobiolaging.2016.02.005
   Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106
NR 70
TC 110
Z9 113
U1 20
U2 109
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD JAN
PY 2019
VL 25
IS 1
BP 165
EP +
DI 10.1038/s41591-018-0275-4
PG 26
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA HG5OR
UT WOS:000455027700034
PM 30617325
OA Green Accepted
DA 2020-12-08
ER

PT J
AU De Sousa, RAL
   Torres, YS
   Figueiredo, CP
   Passos, GF
   Clarke, JR
AF De Sousa, Ricardo A. L.
   Torres, Yasmin S.
   Figueiredo, Claudia P.
   Passos, Giselle F.
   Clarke, Julia R.
TI Consequences of gestational diabetes to the brain and behavior of the
   offspring
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE insulin resistance; depression; memory; programing; inflammation;
   hippocampus; learning
ID HIGH-FAT DIET; ENDOPLASMIC-RETICULUM STRESS; IMPAIRED
   GLUCOSE-HOMEOSTASIS; INSULIN-RECEPTOR SUBSTRATE; TERM COGNITIVE
   IMPAIRMENT; BETA-AMYLOID OLIGOMERS; ALZHEIMERS-DISEASE; MEMORY
   PERFORMANCE; METABOLIC SYNDROME; CELL ADAPTATION
AB Gestational diabetes mellitus (GD) is a form of insulin resistance triggered during the second/third trimesters of pregnancy in previously normoglycemic women. It is currently estimated that 10% of all pregnancies in the United States show this condition. For many years, the transient nature of GD has led researchers and physicians to assume that long-term consequences were absent. However, GD diagnosis leads to a six-fold increase in the risk of developing type 2 diabetes (T2D) in women and incidence of obesity and T2D is also higher among their infants. Recent and concerning evidences point to detrimental effects of GD on the behavior and cognition of the offspring, which often persist until adolescence or adulthood. Considering that the perinatal period is critical for determination of adult behavior, it is expected that the intra-uterine exposure to hyperglycemia, hyperinsulinemia and pro-inflammatory mediators, hallmark features of GD, might affect brain development. Here, we review early clinical and experimental evidence linking GD to consequences on the behavior of the offspring, focusing on memory and mood disorders. We also discuss initial evidence suggesting that downregulation of insulin signaling cascades are seen in the brains of GD offspring and could contribute to the consequences on their behavior.
C1 [De Sousa, Ricardo A. L.; Torres, Yasmin S.; Figueiredo, Claudia P.; Passos, Giselle F.; Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, Carlos Chagas Filho St 373,Bldg A,Room 024, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Clarke, JR (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, Carlos Chagas Filho St 373,Bldg A,Room 024, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM juclarke@gmail.com
RI Clarke, Julia/AAF-9434-2019; Figueiredo, Claudia P/F-8424-2012; De
   Sousa, Ricardo Augusto Leoni/C-8540-2015
OI De Sousa, Ricardo Augusto Leoni/0000-0003-2622-032X; Figueiredo,
   Claudia/0000-0001-9467-9891
CR Albrecht SS, 2010, DIABETES CARE, V33, P768, DOI 10.2337/dc09-1801
   Arruda AP, 2011, ENDOCRINOLOGY, V152, P1314, DOI 10.1210/en.2010-0659
   Badehnoosh B, 2018, J MATERN-FETAL NEO M, V31, P1128, DOI 10.1080/14767058.2017.1310193
   Baeyens L, 2016, DIABETES OBES METAB, V18, P63, DOI 10.1111/dom.12716
   Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107
   Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003
   Biessels GJ, 1996, DIABETES, V45, P1259, DOI 10.2337/diabetes.45.9.1259
   BIHOREAU MT, 1986, DIABETES, V35, P979, DOI 10.2337/diabetes.35.9.979
   Boksa P, 2004, BRAIN RES REV, V45, P1, DOI 10.1016/j.brainresrev.2004.01.001
   Bolton JL, 2014, DIALOGUES CLIN NEURO, V16, P307
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Carlson AJ, 1911, AM J PHYSIOL, V27, P323
   Chandna AR, 2015, NEUROSCIENCE, V303, P241, DOI 10.1016/j.neuroscience.2015.06.063
   Cheung NW, 2003, DIABETES CARE, V26, P2005, DOI 10.2337/diacare.26.7.2005
   Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8
   Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7
   Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973
   Cuthbert FP, 1936, AM J PHYSIOL, V115, P480
   Cypryk Katarzyna, 2008, Endokrynol Pol, V59, P393
   Daraki V, 2017, EUR CHILD ADOLES PSY, V26, P703, DOI 10.1007/s00787-016-0934-2
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   DeBoer T, 2005, DEV MED CHILD NEUROL, V47, P525, DOI 10.1017/S0012162205001039
   Demirci C, 2012, DIABETES, V61, P1143, DOI 10.2337/db11-1154
   DeSisto CL, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130415
   DORNER G, 1976, ENDOKRINOLOGIE, V68, P121
   Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194
   Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Frias JL, 2007, AM J MED GENET A, V143A, P2904, DOI 10.1002/ajmg.a.32071
   Friedman JE, 2008, DIABETES, V57, P606, DOI 10.2337/db07-1356
   Garcia-Vargas L, 2012, CARDIORENAL MED, V2, P134, DOI 10.1159/000337734
   Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672
   Gearhart MM, 2006, AACN ADV CRIT CARE, V17, P50, DOI 10.1097/00044067-200601000-00007
   Gharehbaghi MM, 2010, IRAN J PEDIATR, V20, P131
   Gilmartin AH, 2008, REV OBSTET GYNECOL, V1, P129
   Golalipour MJ, 2012, FOLIA MORPHOL, V71, P71
   Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507
   Hami J, 2013, BRAIN STRUCT FUNCT, V218, P73, DOI 10.1007/s00429-011-0377-y
   Hawkes CA, 2015, J PATHOL, V235, P619, DOI 10.1002/path.4468
   Nguyen HTT, 2015, J DIABETES COMPLICAT, V29, P629, DOI 10.1016/j.jdiacomp.2015.03.007
   Hotamisligil GS, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.238
   Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553
   JAWERBAUM A, 1993, PROSTAGLANDINS, V45, P487, DOI 10.1016/0090-6980(93)90124-P
   Jing YH, 2014, INT J DEV NEUROSCI, V37, P15, DOI 10.1016/j.ijdevneu.2014.06.004
   JUNOD A, 1969, J CLIN INVEST, V48, P2129, DOI 10.1172/JCI106180
   Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812
   Kelstrup L, 2012, DIABETES RES CLIN PR, V97, P322, DOI 10.1016/j.diabres.2012.04.023
   Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173
   Kim SY, 2012, CURR OPIN OBSTET GYN, V24, P376, DOI 10.1097/GCO.0b013e328359f0f4
   Kim SY, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110249
   Kinney BA, 2003, EXP BIOL MED, V228, P152, DOI 10.1177/153537020322800204
   Kovacs P, 2009, NEUROPEPTIDES, V43, P283, DOI 10.1016/j.npep.2009.05.006
   Lambin S, 2007, AM J PHYSIOL-ENDOC M, V292, pE262, DOI 10.1152/ajpendo.00308.2006
   Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430
   Lee CC, 2009, NEUROBIOL AGING, V30, P377, DOI 10.1016/j.neurobiolaging.2007.06.014
   LENZEN S, 1988, DIABETOLOGIA, V31, P337, DOI 10.1007/BF02341500
   Linder K, 2015, J CLIN ENDOCR METAB, V100, P4029, DOI 10.1210/jc.2015-2692
   Liu TW, 2015, LIPIDS, V50, P997, DOI 10.1007/s11745-015-4061-5
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Lowe LP, 2010, J CLIN ENDOCR METAB, V95, P5427, DOI 10.1210/jc.2010-1662
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Markowitz J, 1927, AM J PHYSIOL, V79, P553
   Martin SAL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099226
   Melo AM, 2014, METABOLISM, V63, P682, DOI 10.1016/j.metabol.2014.02.002
   NEVES FS, 2016, MOL NEUROBIOL
   Nizari S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21981
   Ott V, 2012, DIABETES OBES METAB, V14, P214, DOI 10.1111/j.1463-1326.2011.01490.x
   Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372
   Pasek RC, 2013, AM J PHYSIOL-ENDOC M, V305, pE1327, DOI 10.1152/ajpendo.00425.2013
   Plagemann A, 1998, DEV BRAIN RES, V109, P201, DOI 10.1016/S0165-3806(98)00083-2
   Plank JL, 2011, ENDOCRINOLOGY, V152, P4589, DOI 10.1210/en.2010-1462
   Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008
   Poston L, 2011, PROG BIOPHYS MOL BIO, V106, P315, DOI 10.1016/j.pbiomolbio.2010.11.011
   Poston L, 2010, BEST PRACT RES CL EN, V24, P541, DOI 10.1016/j.beem.2010.05.007
   Ramanathan M., 2000, Indian Journal of Experimental Biology, V38, P231
   Reisinger S, 2015, PHARMACOL THERAPEUT, V149, P213, DOI 10.1016/j.pharmthera.2015.01.001
   Renault KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133041
   Riggins T, 2010, ADV CHILD DEV BEHAV, V38, P73
   Salkovic-Petrisic M, 2007, J NEURAL TRANSM-SUPP, P217
   Savitz DA, 2008, BJOG-INT J OBSTET GY, V115, P969, DOI 10.1111/j.1471-0528.2008.01763.x
   Semmler A, 2013, J NEUROL NEUROSUR PS, V84, P62, DOI 10.1136/jnnp-2012-302883
   SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611
   Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006
   Steculorum SM, 2011, ENDOCRINOLOGY, V152, P4171, DOI 10.1210/en.2011-1279
   Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107
   Tang XW, 2015, CELL BIOCHEM BIOPHYS, V71, P549, DOI 10.1007/s12013-014-0233-9
   Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004
   Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660
   Torres-Espinola FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133010
   Van Lieshout RJ, 2008, J PSYCHIATR NEUROSCI, V33, P395
   Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792
   Weissmann L, 2014, DIABETES, V63, P3334, DOI 10.2337/db13-1817
   Wojcik M, 2015, ARCH MED SCI, V11, P779, DOI 10.5114/aoms.2015.47692
   WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0
   Wren C, 2003, HEART, V89, P1217, DOI 10.1136/heart.89.10.1217
   Xiang AH, 2015, JAMA-J AM MED ASSOC, V313, P1425, DOI 10.1001/jama.2015.2707
   Yessoufou A, 2011, EXP DIABETES RES, DOI 10.1155/2011/218598
   Zhang H, 2010, DIABETES, V59, P143, DOI 10.2337/db09-0050
   Zhang TY, 2010, ANNU REV PSYCHOL, V61, P439, DOI 10.1146/annurev.psych.60.110707.163625
   Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045
   Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5
NR 102
TC 6
Z9 6
U1 2
U2 6
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PD AUG
PY 2018
VL 90
IS 2
SU 1
BP 2279
EP 2291
DI 10.1590/0001-3765201720170264
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GQ9KZ
UT WOS:000442096300029
PM 28813108
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Souza, IND
   Frost, PS
   Franca, JV
   Nascimento-Viana, JB
   Neris, RLS
   Freitas, L
   Pinheiro, DJLL
   Nogueira, CO
   Neves, G
   Chimelli, L
   De Felice, FG
   Cavalheiro, EA
   Ferreira, ST
   Assuncao-Miranda, I
   Figueiredo, CP
   Da Poian, AT
   Clarke, JR
AF de Oliveira Souza, Isis Nem
   Frost, Paula S.
   Franca, Julia V.
   Nascimento-Viana, Jessica B.
   Neris, Romulo L. S.
   Freitas, Leandro
   Pinheiro, Daniel J. L. L.
   Nogueira, Clara O.
   Neves, Gilda
   Chimelli, Leila
   De Felice, Fernanda G.
   Cavalheiro, Esper A.
   Ferreira, Sergio T.
   Assuncao-Miranda, Iranaia
   Figueiredo, Claudia P.
   Da Poian, Andrea T.
   Clarke, Julia R.
TI Acute and chronic neurological consequences of early-life Zika virus
   infection in mice
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID NEUROPSYCHIATRIC DISORDERS; OXIDATIVE STRESS; CASE SERIES; BRAZIL;
   BRAIN; SEIZURES; INFANTS; GROWTH; HIPPOCAMPUS; INDUCTION
AB Although congenital Zika virus (ZIKV) exposure has been associated with microcephaly and other neurodevelopmental disorders, long-term consequences of perinatal infection are largely unknown. We evaluated short-and long-term neuropathological and behavioral consequences of neonatal ZIKV infection in mice. ZIKV showed brain tropism, causing postnatal-onset microcephaly and several behavioral deficits in adulthood. During the acute phase of infection, mice developed frequent seizures, which were reduced by tumor necrosis factor-alpha (TNF-alpha) inhibition. During adulthood, ZIKV replication persisted in neonatally infected mice, and the animals showed increased susceptibility to chemically induced seizures, neurodegeneration, and brain calcifications. Altogether, the results show that neonatal ZIKV infection has long-term neuropathological and behavioral complications in mice and suggest that early inhibition of TNF-alpha-mediated neuroinflammation might be an effective therapeutic strategy to prevent the development of chronic neurological abnormalities.
C1 [de Oliveira Souza, Isis Nem; Frost, Paula S.; Nascimento-Viana, Jessica B.; Nogueira, Clara O.; Figueiredo, Claudia P.; Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Frost, Paula S.; Franca, Julia V.; Neves, Gilda] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Neris, Romulo L. S.; Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Freitas, Leandro; Pinheiro, Daniel J. L. L.; Cavalheiro, Esper A.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Neurol & Neurosurg, BR-04023062 Sao Paulo, SP, Brazil.
   [Chimelli, Leila] State Inst Brain Paulo Niemeyer, Lab Neuropathol, Rio De Janeiro, Brazil.
   [De Felice, Fernanda G.; Ferreira, Sergio T.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP Figueiredo, CP; Clarke, JR (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.; Assuncao-Miranda, I (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21944590 Rio De Janeiro, RJ, Brazil.; Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM iranaiamiranda@micro.ufrj.br; claufig@gmail.com;
   dapoian@bioqmed.ufrj.br; juliaclarke@pharma.ufrj.br
RI Cavalheiro, Esper/N-3985-2019; Cavalheiro, Esper A/I-3084-2016; Da
   Poian, Andrea T./V-1699-2019; Neves, Gilda A./K-7573-2012; Figueiredo,
   Claudia P/F-8424-2012; de Oliveira Souza, Isis Nem/AAA-3423-2019;
   Ferreira, Sergio/AAZ-1576-2020; Neves, Gilda A./U-1622-2019; Clarke,
   Julia/AAF-9434-2019
OI Cavalheiro, Esper/0000-0002-0854-3582; Cavalheiro, Esper
   A/0000-0002-0854-3582; Neves, Gilda A./0000-0002-7027-3851; de Oliveira
   Souza, Isis Nem/0000-0002-0335-2541; Ferreira,
   Sergio/0000-0001-7160-9866; Figueiredo, Claudia/0000-0001-9467-9891;
   Neris, Romulo/0000-0002-7436-1680; Pinheiro, Daniel/0000-0003-0078-993X;
   da Silva Frost, Paula/0000-0002-3814-999X; Freitas,
   Leandro/0000-0002-0249-2948
FU Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Institutos
   Nacionais de Pesquisa-Instituto Nacional de Neurociencia Translacional;
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Institutos
   Nacionais de Pesquisa-Inovacao em Medicamentos e Identificacao de Novos
   Alvos Terapeuticos; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES; Financiadora de Estudos e ProjetosCiencia Tecnologia e
   Inovacao (FINEP)
FX Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (to F.G.D.F.,
   S.T.F., A.T.D.P., I.A.-M., C.P.F., and J.R.C.), Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (to E.A.C.), Institutos Nacionais de
   Pesquisa-Instituto Nacional de Neurociencia Translacional (to F.G.D.F.,
   E.A.C., and S.T.F.), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (to P.S.F., G.N., F.G.D.F., E.A.C., S.T.F., A.T.D.P.,
   C.P.F., I.A.-M., and J.R.C.), Institutos Nacionais de Pesquisa-Inovacao
   em Medicamentos e Identificacao de Novos Alvos Terapeuticos (to C.P.F.),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (to
   I.N.O.S., J.V.F., L.F., and D.J.L.L.P.), and Financiadora de Estudos e
   Projetos (to A.T.D.P.).
CR Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Assuncao-Miranda I, 2016, J APPL MICROBIOL, V120, P790, DOI 10.1111/jam.13038
   Balosso S, 2013, EXP NEUROL, V247, P267, DOI 10.1016/j.expneurol.2013.05.010
   Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Dalman C, 2008, AM J PSYCHIAT, V165, P59, DOI 10.1176/appi.ajp.2007.07050740
   de Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02790-9
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Edwards MJJ, 2002, NEUROLOGY, V59, P1447, DOI 10.1212/WNL.59.9.1447
   Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Ho YH, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0157-8
   Jiang PF, 2012, BRAIN RES, V1459, P1, DOI 10.1016/j.brainres.2012.03.058
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kirkman NJ, 2010, EPILEPSIA, V51, P454, DOI 10.1111/j.1528-1167.2009.02390.x
   KOVAC S, 2016, REACT OXYGEN SPECIES, V1, P38, DOI DOI 10.20455/ROS.2016.807
   Kramer AH, 2008, CURR TREAT OPTION NE, V10, P201, DOI 10.1007/s11940-008-0022-0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Libbey JE, 2008, EPILEPSIA, V49, P1066, DOI 10.1111/j.1528-1167.2008.01535.x
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Pauletti A, 2017, BRAIN, V140, P1885, DOI 10.1093/brain/awx117
   RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Smith R, 2006, PEDIATRICS, V117, P851, DOI 10.1542/peds.2005-0804
   Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Zhao K, 2010, BIOSCIENCE REP, V30, P233, DOI 10.1042/BSR20090048
NR 51
TC 32
Z9 32
U1 1
U2 15
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD JUN 6
PY 2018
VL 10
IS 444
AR eaar2749
DI 10.1126/scitranslmed.aar2749
PG 10
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA GI5IG
UT WOS:000434403600003
PM 29875203
OA Bronze
DA 2020-12-08
ER

PT J
AU Batista, AF
   Forny-Germano, L
   Clarke, JR
   Silva, NMLE
   Brito-Moreira, J
   Boehnke, SE
   Winterborn, A
   Coe, BC
   Lablans, A
   Vital, JF
   Marques, SA
   Martinez, AMB
   Gralle, M
   Holscher, C
   Klein, WL
   Houzel, JC
   Ferreira, ST
   Munoz, DP
   De Felice, FG
AF Batista, Andre F.
   Forny-Germano, Leticia
   Clarke, Julia R.
   Lyra e Silva, Natalia M.
   Brito-Moreira, Jordano
   Boehnke, Susan E.
   Winterborn, Andrew
   Coe, Brian C.
   Lablans, Ann
   Vital, Juliana F.
   Marques, Suelen A.
   Martinez, Ana M. B.
   Gralle, Matthias
   Holscher, Christian
   Klein, William L.
   Houzel, Jean-Christophe
   Ferreira, Sergio T.
   Munoz, Douglas P.
   De Felice, Fernanda G.
TI The diabetes drug liraglutide reverses cognitive impairment in mice and
   attenuates insulin receptor and synaptic pathology in a non-human
   primate model of Alzheimer's disease
SO JOURNAL OF PATHOLOGY
LA English
DT Article
DE Alzheimer's disease; liraglutide; synapse damage; insulin receptors; PKA
   signaling; non-human primates; diabetes; GLP-1; tau pathology;
   neurodegeneration
ID GLUCAGON-LIKE PEPTIDE-1; AMYLOID-BETA OLIGOMERS; MODULATING TAU
   HYPERPHOSPHORYLATION; CENTRAL-NERVOUS-SYSTEM; A-BETA; INTRANASAL
   INSULIN; MEMORY IMPAIRMENT; IMPROVES MEMORY; PROTEIN-KINASE; MOUSE MODEL
AB Alzheimer's disease (AD) is a devastating neurological disorder that still lacks an effective treatment, and this has stimulated an intense pursuit of disease-modifying therapeutics. Given the increasingly recognized link between AD and defective brain insulin signaling, we investigated the actions of liraglutide, a glucagon-like peptide-1 (GLP-1) analog marketed for treatment of type 2 diabetes, in experimental models of AD. Insulin receptor pathology is an important feature of AD brains that impairs the neuroprotective actions of central insulin signaling. Here, we show that liraglutide prevented the loss of brain insulin receptors and synapses, and reversed memory impairment induced by AD-linked amyloid- oligomers (AOs) in mice. Using hippocampal neuronal cultures, we determined that the mechanism of neuroprotection by liraglutide involves activation of the PKA signaling pathway. Infusion of AOs into the lateral cerebral ventricle of non-human primates (NHPs) led to marked loss of insulin receptors and synapses in brain regions related to memory. Systemic treatment of NHPs with liraglutide provided partial protection, decreasing AD-related insulin receptor, synaptic, and tau pathology in specific brain regions. Synapse damage and elimination are amongst the earliest known pathological changes and the best correlates of memory impairment in AD. The results illuminate mechanisms of neuroprotection by liraglutide, and indicate that GLP-1 receptor activation may be harnessed to protect brain insulin receptors and synapses in AD. (c) 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
C1 [Batista, Andre F.; Forny-Germano, Leticia; Lyra e Silva, Natalia M.; Brito-Moreira, Jordano; Vital, Juliana F.; Gralle, Matthias; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, Rio De Janeiro, Brazil.
   [Boehnke, Susan E.; Coe, Brian C.; Lablans, Ann; Munoz, Douglas P.; De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Winterborn, Andrew] Queens Univ, Anim Care Serv, Kingston, ON, Canada.
   [Marques, Suelen A.] Fluminense Fed Univ, Dept Neurobiol, Niteroi, RJ, Brazil.
   [Martinez, Ana M. B.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Fac Med, Dept Pathol, Rio de Janeiro, Brazil.
   [Holscher, Christian] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England.
   [Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL USA.
   [Houzel, Jean-Christophe] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
RP De Felice, FG (corresponding author), Fed Univ Rio deJaneiro, CCS, Inst Med Biochem, Room H2-019, BR-21944590 Rio De Janeiro, RJ, Brazil.; Munoz, DP (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.
EM doug.munoz@queensu.ca; felice@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; MARTINEZ, Ana/AAE-8358-2019;
   Forny-Germano, Leticia/D-1342-2017; Clarke, Julia/AAF-9434-2019;
   Boehnke, Susan/P-4952-2019; Houzel, Jean Christophe/M-7936-2019;
   Forny-Germano, Leticia/L-6639-2019
OI Ferreira, Sergio/0000-0001-7160-9866; Forny-Germano,
   Leticia/0000-0001-8301-0711; Houzel, Jean
   Christophe/0000-0001-5128-438X; Forny-Germano,
   Leticia/0000-0001-8301-0711; Boehnke, Susan/0000-0002-0726-6659;
   Holscher, Christian/0000-0002-8159-3260; Coe, Brian/0000-0002-3985-0163
FU Alzheimer Society Canada; Human Frontiers Science Program (HFSP)Human
   Frontier Science Program; John Simon Guggenheim Memorial Foundation;
   Canadian Institutes for Health Research (CIHR)Canadian Institutes of
   Health Research (CIHR); Canada Research Chair ProgramCanada Research
   Chairs; Brain Canada; National Institute for Translational Neuroscience
   (INNT/Brazil); Brazilian funding agency Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Brazilian funding
   agency Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPq pre-doctoral fellowships;
   FAPERJ/Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES
FX We thank Drs Claudia P Figueiredo and Olavo B Amaral (Federal University
   of Rio de Janeiro) for technical advice on immunohistochemical and
   statistical analysis, respectively. The CP13 antibody was a generous
   gift from Dr Peter Davies (Albert Einstein College of Medicine, Bronx,
   NY, USA). This work was supported by grants from Alzheimer Society
   Canada, Human Frontiers Science Program (HFSP), and the John Simon
   Guggenheim Memorial Foundation (to FGF); Canadian Institutes for Health
   Research (CIHR) (to DPM and FDF); and Canada Research Chair Program and
   Brain Canada (to DPM). It was further supported by the National
   Institute for Translational Neuroscience (INNT/Brazil) (to STF and FGF)
   and the Brazilian funding agencies Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ) (to STF and FGF). NLS, AFB, JF, and
   JBM were or are supported by CNPq pre-doctoral fellowships. LFG is
   supported by a post-doctoral fellowship from FAPERJ/Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES).
CR Abbas T, 2009, BEHAV BRAIN RES, V205, P265, DOI 10.1016/j.bbr.2009.06.035
   Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999
   Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7
   Akter K, 2011, BRIT J CLIN PHARMACO, V71, P365, DOI 10.1111/j.1365-2125.2010.03830.x
   Alvarez E, 2005, J NEUROCHEM, V92, P798, DOI 10.1111/j.1471-4159.2004.02914.x
   Athauda D, 2017, LANCET, V390, P1664, DOI 10.1016/S0140-6736(17)31585-4
   Athauda D, 2017, J PARKINSON DIS, V7, P451, DOI 10.3233/JPD-171192
   Athauda D, 2016, DRUG DISCOV TODAY, V21, P802, DOI 10.1016/j.drudis.2016.01.013
   Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011
   Bartolotti N, 2016, MOL PSYCHIATR, V21, P1158, DOI 10.1038/mp.2016.111
   Benedict C, 2007, NEUROPSYCHOPHARMACOL, V32, P239, DOI 10.1038/sj.npp.1301193
   Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189
   Cha DS, 2016, CURR MOL MED, V16, P465, DOI 10.2174/1566524016666160429121737
   Chen SH, 2017, COGN SYST RES, V42, P1, DOI 10.1016/j.cogsys.2016.11.001
   Chen YX, 2014, EXP NEUROL, V261, P610, DOI 10.1016/j.expneurol.2014.06.004
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7
   Cholerton Brenna, 2016, Diabetes Spectr, V29, P210
   Cholerton B, 2013, EUR J PHARMACOL, V719, P170, DOI 10.1016/j.ejphar.2013.08.008
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183
   Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791
   Cork SC, 2015, MOL METAB, V4, P718, DOI 10.1016/j.molmet.2015.07.008
   Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112
   Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233
   Dailey MJ, 2013, TRENDS ENDOCRIN MET, V24, P85, DOI 10.1016/j.tem.2012.11.008
   DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, CURR ALZHEIMER RES, V4, P263
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2016, AGEING RES REV, V26, P112, DOI 10.1016/j.arr.2016.01.006
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101
   DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502
   Diniz LP, 2017, J NEUROSCI, V37, P6797, DOI 10.1523/JNEUROSCI.3351-16.2017
   During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919
   Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1
   Fa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19393
   Fadel JR, 2016, CURR OPIN BEHAV SCI, V9, P47, DOI 10.1016/j.cobeha.2015.12.004
   Ferris HA, 2016, DIABETES, V65, P1481, DOI 10.2337/dbi16-0010
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Freiherr J, 2013, CNS DRUGS, V27, P505, DOI 10.1007/s40263-013-0076-8
   Gancheva S, 2015, DIABETES, V64, P1966, DOI 10.2337/db14-0892
   Garber AJ, 2011, DIABETES CARE, V34, pS279, DOI 10.2337/dc11-s231
   Gault VA, 2008, EUR J PHARMACOL, V587, P112, DOI 10.1016/j.ejphar.2008.03.025
   Gejl M, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00108
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Grillo CA, 2015, DIABETES, V64, P3927, DOI 10.2337/db15-0596
   Guerrero-Munoz MJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00464
   Hansen HH, 2015, J ALZHEIMERS DIS, V46, P877, DOI 10.3233/JAD-143090
   Heppner KM, 2015, ENDOCRINOLOGY, V156, P255, DOI 10.1210/en.2014-1675
   Holscher C, 2012, CNS DRUGS, V26, P871, DOI 10.2165/11635890-000000000-00000
   Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373
   Hsu TM, 2015, NEUROPSYCHOPHARMACOL, V40, P327, DOI 10.1038/npp.2014.175
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14
   Kim SH, 2001, J NEURAL TRANSM-SUPP, P263
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Lee CC, 2009, NEUROBIOL AGING, V30, P377, DOI 10.1016/j.neurobiolaging.2007.06.014
   Lee HK, 2017, J ALZHEIMERS DIS, V56, P1015, DOI 10.3233/JAD-161029
   Lee Sarah, 2013, J Alzheimers Dis Parkinsonism, V3, P128
   Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219
   Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012
   Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314
   Liang ZH, 2007, J NEUROCHEM, V103, P2462, DOI 10.1111/j.1471-4159.2007.04942.x
   Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x
   Long-Smith CM, 2013, NEUROMOL MED, V15, P102, DOI 10.1007/s12017-012-8199-5
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Mansur RB, 2017, J AFFECT DISORDERS, V207, P114, DOI 10.1016/j.jad.2016.09.056
   Martinez-Coria H, 2010, AM J PATHOL, V176, P870, DOI 10.2353/ajpath.2010.090452
   Mattson MP, 2003, NAT MED, V9, P1113, DOI 10.1038/nm0903-1113
   McClean PL, 2014, NEUROPHARMACOLOGY, V76, P57, DOI 10.1016/j.neuropharm.2013.08.005
   McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011
   McClean PL, 2010, EUR J PHARMACOL, V630, P158, DOI 10.1016/j.ejphar.2009.12.023
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4
   Nirmalan NJ, 2009, J PATHOL, V217, P497, DOI 10.1002/path.2504
   Norambuena A, 2017, ALZHEIMERS DEMENT, V13, P152, DOI 10.1016/j.jalz.2016.08.015
   Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588
   Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974
   Perry T, 2003, J NEUROSCI RES, V72, P603, DOI 10.1002/jnr.10611
   Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481
   Qi LQ, 2017, AM J TRANSL RES, V9, P247
   Qi LQ, 2016, EUR J PHARMACOL, V783, P23, DOI 10.1016/j.ejphar.2016.04.052
   Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309
   Richards P, 2014, DIABETES, V63, P1224, DOI 10.2337/db13-1440
   Rosenberger AFN, 2016, J ALZHEIMERS DIS, V49, P927, DOI 10.3233/JAD-150429
   Sandoval D, 2008, PHYSIOL BEHAV, V94, P670, DOI 10.1016/j.physbeh.2008.04.018
   SCHEFF SW, 1993, ANN NEUROL, V33, P190, DOI 10.1002/ana.410330209
   Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002
   Scheff SW, 1998, J NEUROPATH EXP NEUR, V57, P1146, DOI 10.1097/00005072-199812000-00006
   Schirra J, 1998, J CLIN INVEST, V101, P1421, DOI 10.1172/JCI1349
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   da Silva GSS, 2017, J BIOL CHEM, V292, P7395, DOI 10.1074/jbc.M116.753525
   Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210
   Sengupta U, 2017, ANN CLIN TRANSL NEUR, V4, P226, DOI 10.1002/acn3.382
   Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323
   Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782
   Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004
   Tai HC, 2012, AM J PATHOL, V181, P1426, DOI 10.1016/j.ajpath.2012.06.033
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   van der Harg JM, 2017, NEUROBIOL DIS, V103, P163, DOI 10.1016/j.nbd.2017.04.005
   Vandal M, 2014, DIABETES, V63, P4291, DOI 10.2337/db14-0375
   Vilsboll T, 2003, REGUL PEPTIDES, V114, P115, DOI 10.1016/S0167-0115(03)00111-3
   Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199
   Wadman M, 2012, NATURE, V485, P426, DOI 10.1038/485426a
   Wang QW, 2009, NEUROBIOL AGING, V30, P1608, DOI 10.1016/j.neurobiolaging.2007.12.004
   Winnay JN, 2016, J CLIN INVEST, V126, P1401, DOI 10.1172/JCI84005
   Yang Y, 2013, J ALZHEIMERS DIS, V37, P637, DOI 10.3233/JAD-130491
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
NR 117
TC 55
Z9 55
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD MAY
PY 2018
VL 245
IS 1
BP 85
EP 100
DI 10.1002/path.5056
PG 16
WC Oncology; Pathology
SC Oncology; Pathology
GA GC9JO
UT WOS:000430113500010
PM 29435980
OA Green Published, Other Gold
DA 2020-12-08
ER

PT J
AU Clarke, JR
   Ribeiro, FC
   Frozza, RL
   De Felice, FG
   Lourenco, MV
AF Clarke, Julia R.
   Ribeiro, Felipe C.
   Frozza, Rudimar L.
   De Felice, Fernanda G.
   Lourenco, Mychael V.
TI Metabolic Dysfunction in Alzheimer's Disease: From Basic Neurobiology to
   Clinical Approaches
SO JOURNAL OF ALZHEIMERS DISEASE
LA English
DT Review
DE Alzheimer's disease; hormones; memory; metabolism; therapy
ID GLUCAGON-LIKE PEPTIDE-1; AMYLOID-BETA OLIGOMERS; HIPPOCAMPAL SYNAPTIC
   PLASTICITY; MILD COGNITIVE IMPAIRMENT; UNFOLDED PROTEIN RESPONSE; BRAIN
   INSULIN-RESISTANCE; EUKARYOTIC INITIATION FACTOR-2-ALPHA;
   ENDOPLASMIC-RETICULUM STRESS; RECEPTOR-DEPENDENT MECHANISM; PERMEABILITY
   TRANSITION PORE
AB Clinical trials have extensively failed to find effective treatments for Alzheimer's disease (AD) so far. Even after decades of AD research, there are still limited options for treating dementia. Mounting evidence has indicated that AD patients develop central and peripheral metabolic dysfunction, and the underpinnings of such events have recently begun to emerge. Basic and preclinical studies have unveiled key pathophysiological mechanisms that include aberrant brain stress signaling, inflammation, and impaired insulin sensitivity. These findings are in accordance with clinical and neuropathological data suggesting that AD patients undergo central and peripheral metabolic deregulation. Here, we review recent basic and clinical findings indicating that metabolic defects are central to AD pathophysiology. We further propose a view for future therapeutics that incorporates metabolic defects as a core feature of AD pathogenesis. This approach could improve disease understanding and therapy development through drug repurposing and/or identification of novel metabolic targets.
C1 [Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, Rio De Janeiro, Brazil.
   [Ribeiro, Felipe C.; De Felice, Fernanda G.; Lourenco, Mychael V.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil.
   [Ribeiro, Felipe C.; Lourenco, Mychael V.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21941902 Rio De Janeiro, Brazil.
   [Frozza, Rudimar L.] Fiocruz MS, Oswaldo Cruz Fdn, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
RP Lourenco, MV (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil.; Lourenco, MV (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21941902 Rio De Janeiro, Brazil.
EM mychael@bioqmed.ufrj.br
RI Lourenco, Mychael/G-2614-2014; Ribeiro, Felipe Campos/W-9758-2019;
   Clarke, Julia/AAF-9434-2019
OI Lourenco, Mychael/0000-0002-1078-0296; Ribeiro, Felipe
   Campos/0000-0003-3028-3307; Frozza, Rudimar Luiz/0000-0003-0918-4128
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/Brazil)National Council for Scientific and Technological
   Development (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); National
   Institute for Translational Neuroscience (INNT/Brazil); Alzheimer's
   Society Canada; International Society for Neurochemistry (ISN)
FX Work in the authors' laboratories has been supported by grants from
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/Brazil), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ), National Institute for Translational
   Neuroscience (INNT/Brazil), Alzheimer's Society Canada, and the
   International Society for Neurochemistry (ISN).
CR AD2000 Collaborative Grp, 2008, LANCET NEUROL, V7, P41
   Aisen PS, 2002, NEUROLOGY, V58, P1050, DOI 10.1212/WNL.58.7.1050
   Albanese Emiliano, 2017, Alzheimers Dement (Amst), V8, P165, DOI 10.1016/j.dadm.2017.05.007
   Alcolea D, 2014, J ALZHEIMERS DIS, V42, P157, DOI 10.3233/JAD-140240
   Alzheimer A, 1911, Z GESAMTE NEUROL PSY, V4, P356, DOI 10.1007/BF02866241
   Appleby BS, 2013, CURR TOP MED CHEM, V13, P2306, DOI 10.2174/15680266113136660162
   Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735
   Arruda AP, 2011, ENDOCRINOLOGY, V152, P1314, DOI 10.1210/en.2010-0659
   Baleriola J, 2014, CELL, V158, P1159, DOI 10.1016/j.cell.2014.07.001
   Baloyannis SJ, 2015, AM J ALZHEIMERS DIS, V30, P478, DOI 10.1177/1533317514556876
   Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753
   Behl C, 1997, CELL TISSUE RES, V290, P471, DOI 10.1007/s004410050955
   Bell KFS, 2013, BIOCHEM SOC T, V41, P1541, DOI 10.1042/BST20130245
   Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003
   Benedict C, 2011, EXP GERONTOL, V46, P112, DOI 10.1016/j.exger.2010.08.026
   Benedict C, 2011, DIABETES, V60, P114, DOI 10.2337/db10-0329
   Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028
   Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714
   Bharadwaj P, 2017, J ALZHEIMERS DIS, V59, P421, DOI 10.3233/JAD-161192
   Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019
   Biessels GJ, 1996, DIABETES, V45, P1259, DOI 10.2337/diabetes.45.9.1259
   Blennow K, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00345, 10.3389/fnins.2015.00345]
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Breitner JC, 2011, ALZHEIMERS DEMENT, V7, P402, DOI 10.1016/j.jalz.2010.12.014
   Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005
   Buffington SA, 2014, ANNU REV NEUROSCI, V37, P17, DOI 10.1146/annurev-neuro-071013-014100
   Butchart J, 2015, NEUROLOGY, V84, P2161, DOI 10.1212/WNL.0000000000001617
   Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x
   Calegari VC, 2011, J BIOL CHEM, V286, P12870, DOI 10.1074/jbc.M110.173021
   Cavadas C, 2016, NAT REV ENDOCRINOL, V12, P723, DOI 10.1038/nrendo.2016.107
   Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011
   Chang RCC, 2002, J NEUROCHEM, V83, P1215, DOI 10.1046/j.1471-4159.2002.01237.x
   Chang R, 2017, MOL PHARMACEUT, V14, P2340, DOI 10.1021/acs.molpharmaceut.7b00200
   CHASE TN, 1984, ANN NEUROL, V15, pS170
   Chatterjee S, 2016, DIABETES CARE, V39, P300, DOI 10.2337/dc15-1588
   Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183
   Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901
   Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791
   Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897
   Cottrell DA, 2001, NEUROLOGY, V57, P260, DOI 10.1212/WNL.57.2.260
   Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233
   Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI 10.1056/NEJMoa1215740
   Cummings J, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0207-9
   Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2016, AGEING RES REV, V26, P112, DOI 10.1016/j.arr.2016.01.006
   De Felice FG, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00094
   De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954
   De Felice FG, 2014, ALZHEIMERS DEMENT, V10, pS26, DOI 10.1016/j.jalz.2013.12.004
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   de la Monte SM, 2012, J ALZHEIMERS DIS, V30, pS231, DOI 10.3233/JAD-2012-111727
   De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   Denis RG, 2010, NEUROSCIENCE, V170, P1035, DOI 10.1016/j.neuroscience.2010.08.013
   Denner LA, 2012, J NEUROSCI, V32, P16725, DOI 10.1523/JNEUROSCI.2153-12.2012
   Devi L, 2014, NEUROBIOL AGING, V35, P2272, DOI 10.1016/j.neurobiolaging.2014.04.031
   Devi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012974
   DuBoff B, 2013, TRENDS NEUROSCI, V36, P325, DOI 10.1016/j.tins.2013.03.002
   Duncan MJ, 2012, EXP NEUROL, V236, P249, DOI 10.1016/j.expneurol.2012.05.011
   Duran-Aniotz C, 2016, CURR BIOL, V26, pR806, DOI 10.1016/j.cub.2016.07.060
   Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225
   Escribano L, 2010, NEUROPSYCHOPHARMACOL, V35, P1593, DOI 10.1038/npp.2010.32
   Ettcheto M, 2017, REDOX BIOL, V13, P345, DOI 10.1016/j.redox.2017.06.003
   Fa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19393
   Fagan AM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007901
   Femminella GD, 2014, ALZHEIMERS DEMENT, V10, pS55, DOI 10.1016/j.jalz.2013.12.012
   Feng L, 2013, J ALZHEIMERS DIS, V34, P649, DOI 10.3233/JAD-121885
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010
   Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0
   Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Freiherr J, 2013, CNS DRUGS, V27, P505, DOI 10.1007/s40263-013-0076-8
   Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200
   Gault VA, 2008, EUR J PHARMACOL, V587, P112, DOI 10.1016/j.ejphar.2008.03.025
   Gold M, 2010, DEMENT GERIATR COGN, V30, P131, DOI 10.1159/000318845
   Goyal MS, 2017, CELL METAB, V26, P353, DOI 10.1016/j.cmet.2017.07.010
   Gralle M, 2017, J NEUROCHEM, V140, P359, DOI 10.1111/jnc.13909
   Grillo CA, 2015, DIABETES, V64, P3927, DOI 10.2337/db15-0596
   Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851
   Gustafson DR, 2012, J ALZHEIMERS DIS, V30, pS97, DOI 10.3233/JAD-2012-120487
   Haj-ali V, 2009, BEHAV NEUROSCI, V123, P1309, DOI 10.1037/a0017722
   Halliday M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.49
   Halliday M, 2017, J NEUROCHEM, V142, P812, DOI 10.1111/jnc.14112
   Halliday M, 2017, BRAIN, V140, P1768, DOI 10.1093/brain/awx074
   Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147
   Harrington C, 2011, CURR ALZHEIMER RES, V8, P592, DOI 10.2174/156720511796391935
   Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786
   He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042
   Hebert-Chatelain E, 2016, NATURE, V539, P555, DOI 10.1038/nature20127
   Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5
   Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102
   Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729
   Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208
   Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010
   Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001
   Holscher C, 2014, ALZHEIMERS DEMENT, V10, pS47, DOI 10.1016/j.jalz.2013.12.009
   Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373
   Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004
   Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814
   Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   HOYER S, 1988, J NEUROL, V235, P143, DOI 10.1007/BF00314304
   HOYER S, 1989, J NEURAL TRANSM, V75, P227, DOI 10.1007/BF01258634
   Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106
   Hunter K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-33
   Imbimbo BP, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00019
   Ishii M, 2015, CELL METAB, V22, P761, DOI 10.1016/j.cmet.2015.08.016
   Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004
   Jahrling JB, 2014, J NEUROSCI, V34, P4054, DOI 10.1523/JNEUROSCI.4024-13.2014
   Janelidze S, 2016, ANN CLIN TRANSL NEUR, V3, P12, DOI 10.1002/acn3.266
   Jiang Z, 2010, J NEUROSCI, V30, P2582, DOI 10.1523/JNEUROSCI.3971-09.2010
   Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103
   Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269
   Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481
   Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615
   Julien C, 2010, NEUROBIOL AGING, V31, P1516, DOI 10.1016/j.neurobiolaging.2008.08.022
   Kerti L, 2013, NEUROLOGY, V81, P1746, DOI 10.1212/01.wnl.0000435561.00234.ee
   Kincheski GC, 2017, BRAIN BEHAV IMMUN, V64, P140, DOI 10.1016/j.bbi.2017.04.007
   Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008
   Lanctot Krista L, 2017, Alzheimers Dement (N Y), V3, P440, DOI 10.1016/j.trci.2017.07.001
   Launer LJ, 2011, LANCET NEUROL, V10, P969, DOI 10.1016/S1474-4422(11)70188-0
   Lauretti E, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.296
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016
   Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4
   Lee CC, 2011, NEUROPHARMACOLOGY, V61, P867, DOI 10.1016/j.neuropharm.2011.06.003
   Lee CC, 2009, NEUROBIOL AGING, V30, P377, DOI 10.1016/j.neurobiolaging.2007.06.014
   Lepeta K, 2016, J NEUROCHEM, V138, P785, DOI 10.1111/jnc.13713
   Lewis J, 2016, ACTA NEUROPATHOL, V131, P27, DOI 10.1007/s00401-015-1507-z
   Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029
   Lim ASP, 2014, BRAIN, V137, P2847, DOI 10.1093/brain/awu222
   Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302
   Liu Y, 2008, FEBS LETT, V582, P359, DOI 10.1016/j.febslet.2007.12.035
   Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6
   Loskutova N, 2010, J ALZHEIMERS DIS, V20, P313, DOI 10.3233/JAD-2010-1364
   Lourenco MV, 2015, PROG NEUROBIOL, V129, P37, DOI 10.1016/j.pneurobio.2015.03.003
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Lourenco MV, 2013, J NEUROSCI, V33, P5083, DOI 10.1523/JNEUROSCI.0172-13.2013
   Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072
   Lutski M, 2017, J ALZHEIMERS DIS, V57, P633, DOI 10.3233/JAD-161016
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Ma T, 2014, J NEUROSCI, V34, P12230, DOI 10.1523/JNEUROSCI.1694-14.2014
   Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486
   Ma T, 2012, J NEUROSCI, V32, P13701, DOI 10.1523/JNEUROSCI.2107-12.2012
   Maeda S, 2016, EMBO REP, V17, P530, DOI 10.15252/embr.201541438
   Mairet-Coello G, 2013, NEURON, V78, P94, DOI 10.1016/j.neuron.2013.02.003
   Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139
   Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012
   Marciniak E, 2017, J EXP MED, V214, P2257, DOI 10.1084/jem.20161731
   Matsuzaki T, 2010, NEUROLOGY, V75, P764, DOI 10.1212/WNL.0b013e3181eee25f
   Maurer I, 2000, NEUROBIOL AGING, V21, P455, DOI 10.1016/S0197-4580(00)00112-3
   Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122
   Mazaheri F, 2017, EMBO REP, V18, P1186, DOI 10.15252/embr.201743922
   McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006
   McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011
   Medeiros R, 2007, J NEUROSCI, V27, P5394, DOI 10.1523/JNEUROSCI.5047-06.2007
   Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009
   Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Moreira PI, 2007, ANTIOXID REDOX SIGN, V9, P1621, DOI 10.1089/ars.2007.1703
   Moreira PI, 2001, BIOSCIENCE REP, V21, P789, DOI 10.1023/A:1015536808304
   Moreira PI, 2002, J NEUROSCI RES, V69, P257, DOI 10.1002/jnr.10282
   Mosconi L, 2013, CLIN TRANSL IMAGING, V1, P217, DOI 10.1007/s40336-013-0026-y
   Musiek ES, 2016, SCIENCE, V354, P1004, DOI 10.1126/science.aah4968
   Musiek ES, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.121
   Neergaard JS, 2017, DIABETES, V66, P1957, DOI 10.2337/db16-1444
   Nenov MN, 2014, J NEUROSCI, V34, P1028, DOI 10.1523/JNEUROSCI.3413-13.2014
   Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5
   Niccoli T, 2016, CURR BIOL, V26, P2291, DOI 10.1016/j.cub.2016.07.017
   Nicholson RM, 2010, BRAIN RES, V1347, P179, DOI 10.1016/j.brainres.2010.05.084
   Nistico R, 2012, NEUROMOL MED, V14, P262, DOI 10.1007/s12017-012-8184-z
   Nunomura A, 1999, J NEUROSCI, V19, P1959
   O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047
   OGOMORI K, 1989, AM J PATHOL, V134, P243
   Oliveira MM, 2016, J NEUROSCI, V36, P1053, DOI 10.1523/JNEUROSCI.4110-15.2016
   Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937
   Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588
   Ott V, 2012, DIABETES OBES METAB, V14, P214, DOI 10.1111/j.1463-1326.2011.01490.x
   Page G, 2006, NEUROSCIENCE, V139, P1343, DOI 10.1016/j.neuroscience.2006.01.047
   Paouri E, 2017, J NEUROSCI, V37, P5155, DOI 10.1523/JNEUROSCI.2484-16.2017
   Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030
   Parthsarathy V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058784
   Pasqualetti P, 2009, AGING CLIN EXP RES, V21, P102, DOI 10.1007/BF03325217
   Pathak D, 2015, J BIOL CHEM, V290, P22325, DOI 10.1074/jbc.M115.656405
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Perez M, 2016, NEUROSCI LETT, V634, P63, DOI 10.1016/j.neulet.2016.09.026
   PERRY EK, 1980, NEUROSCI LETT, V18, P105, DOI 10.1016/0304-3940(80)90220-7
   Piert M, 1996, J NUCL MED, V37, P201
   Pitt J, 2017, MOL BIOL CELL, V28, P2623, DOI 10.1091/mbc.E17-06-0416
   Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009
   Porter DW, 2010, DIABETES OBES METAB, V12, P891, DOI 10.1111/j.1463-1326.2010.01259.x
   Prince M, 2016, WORLD ALZHEIMER REPO
   Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007
   Puzzo D, 2017, ELIFE, V6, DOI 10.7554/eLife.26991
   Reddy VP, 2009, J ALZHEIMERS DIS, V16, P763, DOI 10.3233/JAD-2009-1013
   Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36
   Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100
   Reiman EM, 2000, NEUROREPORT, V11, P987, DOI 10.1097/00001756-200004070-00018
   Rhee YH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.295
   Ritchie K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3885
   Rodriguez-Vieitez E, 2016, BRAIN, V139, P922, DOI 10.1093/brain/awv404
   Sacks CA, 2017, NEW ENGL J MED, V376, P1706, DOI 10.1056/NEJMp1701047
   Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697
   SanMartin CD, 2012, NEURODEGENER DIS, V10, P34, DOI 10.1159/000334901
   Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230
   Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397
   Sato T, 2011, NEUROBIOL AGING, V32, P1626, DOI 10.1016/j.neurobiolaging.2009.10.009
   Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101
   Segev Y, 2015, J NEUROSCI, V35, P12986, DOI 10.1523/JNEUROSCI.5241-14.2015
   Segev Y, 2013, NEUROBIOL AGING, V34, P863, DOI 10.1016/j.neurobiolaging.2012.06.020
   da Silva GSS, 2017, J BIOL CHEM, V292, P7395, DOI 10.1074/jbc.M116.753525
   Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541
   Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460
   Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002
   Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323
   Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053
   Shi QQ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6295
   Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314
   Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498
   Siegrist SE, 2010, CURR BIOL, V20, P643, DOI 10.1016/j.cub.2010.01.060
   Siervo M, 2014, J ALZHEIMERS DIS, V41, P151, DOI 10.3233/JAD-132279
   Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022
   SIMPSON IA, 1994, ANN NEUROL, V35, P546, DOI 10.1002/ana.410350507
   Sindi Shireen, 2017, J Alzheimers Dis, V59, P1459, DOI [10.3233/jad-170123, 10.3233/JAD-170123]
   Smith HL, 2016, ELIFE, V5, DOI 10.7554/eLife.15275
   Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x
   Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0
   Song W, 2017, ALZHEIMERS DEMENT, V13, P381, DOI 10.1016/j.jalz.2016.07.004
   Spangenberg EE, 2016, BRAIN, V139, P1265, DOI 10.1093/brain/aww016
   Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003
   Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004
   STANDAERT DG, 1991, AM J PATHOL, V139, P681
   Stanley M, 2016, J NEUROSCI, V36, P11704, DOI 10.1523/JNEUROSCI.2119-16.2016
   Steculorum SM, 2014, ALZHEIMERS DEMENT, V10, pS3, DOI 10.1016/j.jalz.2013.12.008
   Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107
   Stevanovic K, 2017, EXP NEUROL, V294, P58, DOI 10.1016/j.expneurol.2017.04.015
   Strachan MWJ, 2014, NAT REV ENDOCRINOL, V10, P258, DOI 10.1038/nrendo.2014.38
   Suh HS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-37
   Sun GZ, 2017, CNS NEUROSCI THER, V23, P748, DOI 10.1111/cns.12720
   Sutherland GT, 2017, J ALZHEIMERS DIS, V59, P393, DOI 10.3233/JAD-161194
   Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012
   Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107
   Takkinen JS, 2017, J CEREBR BLOOD F MET, V37, P2870, DOI 10.1177/0271678X16677990
   Talbot K, 2014, ALZHEIMERS DEMENT, V10, pS12, DOI 10.1016/j.jalz.2013.12.007
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   Taylor CA, 2017, MMWR-MORBID MORTAL W, V66, pS21, DOI 10.15585/mmwr.mm6620a1
   Terni B, 2010, BRAIN PATHOL, V20, P222, DOI 10.1111/j.1750-3639.2009.00266.x
   Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660
   Tracy TE, 2016, NEURON, V90, P245, DOI 10.1016/j.neuron.2016.03.005
   Trinh MA, 2013, NEUROBIOL LEARN MEM, V105, P93, DOI 10.1016/j.nlm.2013.04.013
   Tse KH, 2017, J NEUROCHEM, V143, P432, DOI 10.1111/jnc.14079
   Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023
   UN, 2015, ESAPWP241 UN POP DIV
   Vaccaro V, 2017, EMBO REP, V18, P231, DOI 10.15252/embr.201642710
   Vandal M, 2015, FASEB J, V29, P4273, DOI 10.1096/fj.14-268482
   Velloso LA, 2011, INT J OBESITY, V35, P1455, DOI 10.1038/ijo.2011.56
   Vingtdeux V, 2011, ACTA NEUROPATHOL, V121, P337, DOI 10.1007/s00401-010-0759-x
   Wadman M, 2012, NATURE, V485, P426, DOI 10.1038/485426a
   Wang J, 2015, J ALZHEIMERS DIS, V44, P385, DOI 10.3233/JAD-141506
   Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49
   Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009
   Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105
   Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049
   Weiner MW, 2015, ALZHEIMERS DEMENT, V11, P865, DOI 10.1016/j.jalz.2015.04.005
   Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047
   Williamson JD, 2014, JAMA INTERN MED, V174, P324, DOI 10.1001/jamainternmed.2013.13656
   Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966
   Woodling NS, 2016, BRAIN, V139, P2063, DOI 10.1093/brain/aww117
   WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0
   Wu YT, 2017, NAT REV NEUROL, V13, P327, DOI 10.1038/nrneurol.2017.63
   Xiang XY, 2016, EMBO MOL MED, V8, P992, DOI 10.15252/emmm.201606370
   Yang WZ, 2016, NEUROBIOL AGING, V41, P19, DOI 10.1016/j.neurobiolaging.2016.02.005
   Yin F, 2016, FREE RADICAL BIO MED, V100, P108, DOI 10.1016/j.freeradbiomed.2016.04.200
   Yoon SO, 2012, NEURON, V75, P824, DOI 10.1016/j.neuron.2012.06.024
   Yu SW, 2008, STEM CELLS, V26, P2602, DOI 10.1634/stemcells.2008-0153
   Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043
   Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045
   Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5
   Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029
   Zussy C, 2011, AM J PATHOL, V179, P315, DOI 10.1016/j.ajpath.2011.03.021
NR 286
TC 16
Z9 17
U1 1
U2 10
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1387-2877
EI 1875-8908
J9 J ALZHEIMERS DIS
JI J. Alzheimers Dis.
PY 2018
VL 64
SU 1
BP S405
EP S426
DI 10.3233/JAD-179911
PG 22
WC Neurosciences
SC Neurosciences & Neurology
GA GJ0MX
UT WOS:000434949600028
PM 29562518
DA 2020-12-08
ER

PT J
AU Neves, FS
   Marques, PT
   Barros-Aragao, F
   Nunes, JB
   Venancio, AM
   Cozachenco, D
   Frozza, RL
   Passos, GF
   Costa, R
   de Oliveira, J
   Engel, DF
   De Bem, AF
   Benjamim, CF
   De Felice, FG
   Ferreira, ST
   Clarke, JR
   Figueiredo, CP
AF Neves, Fernanda S.
   Marques, Patricia T.
   Barros-Aragao, Fernanda
   Nunes, Jose Bruno
   Venancio, Aline M.
   Cozachenco, Danielle
   Frozza, Rudimar L.
   Passos, Giselle F.
   Costa, Robson
   de Oliveira, Jade
   Engel, Daiane F.
   De Bem, Andreza F.
   Benjamim, Claudia F.
   De Felice, Fernanda G.
   Ferreira, Sergio T.
   Clarke, Julia R.
   Figueiredo, Claudia P.
TI Brain-Defective Insulin Signaling Is Associated to Late Cognitive
   Impairment in Post-Septic Mice
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Sepsis survivors; Cognitive impairment; Insulin receptor substrate-1
   (IRS-1) inhibition; Glycogen synthase kinase 3 beta (GSK3 beta);
   Liraglutide; TDZD-8; Late cognitive impairment
ID A-BETA OLIGOMERS; GLYCOGEN-SYNTHASE KINASE-3; ALZHEIMERS-DISEASE; SEPSIS
   SURVIVORS; OBJECT RECOGNITION; RECEPTOR SUBSTRATE; AMYLOID OLIGOMERS;
   MEMORY IMPAIRMENT; CRITICAL ILLNESS; NERVOUS-SYSTEM
AB Sepsis survivors frequently develop late cognitive impairment. Because little is known on the mechanisms of post-septic memory deficits, there are no current effective approaches to prevent or treat such symptoms. Here, we subjected mice to severe sepsis induced by cecal ligation and puncture (CLP) and evaluated the sepsis-surviving animals in the open field, novel object recognition (NOR), and step-down inhibitory avoidance (IA) task at different times after surgery. Post-septic mice (30 days post-surgery) failed in the NOR and IA tests but exhibited normal performance when re-evaluated 45 days after surgery. Cognitive impairment in post-septic mice was accompanied by reduced hippocampal levels of proteins involved in synaptic plasticity, including synaptophysin, cAMP response element-binding protein (CREB), CREB phosphorylated at serine residue 133 (CREBpSer(133)), and GluA1 phosphorylated at serine residue 845 (GluA1pSer(845)). Expression of tumor necrosis factor alpha (TNF-alpha) was increased and brain insulin signaling was disrupted, as indicated by increased hippocampal IRS-1 phosphorylation at serine 636 (IRS-1pSer(636)) and decreased phosphorylation of IRS-1 at tyrosine 465 (IRS-1pTyr(465)), in the hippocampus 30 days after CLP. Phosphorylation of Akt at serine 473 (AktpSer(473)) and of GSK3 at serine 9 (GSK3 beta pSer(9)) were also decreased in hippocampi of post-septic animals, further indicating that brain insulin signaling is disrupted by sepsis. We then treated post-septic mice with liraglutide, a GLP-1 receptor agonist with insulinotropic activity, or TDZD-8, a GSK3 beta inhibitor, which rescued NOR memory. In conclusion, these results establish that hippocampal inflammation and disrupted insulin signaling are induced by sepsis and are linked to late memory impairment in sepsis survivors.
C1 [Neves, Fernanda S.; Marques, Patricia T.; Barros-Aragao, Fernanda; Cozachenco, Danielle; Passos, Giselle F.; Costa, Robson; Clarke, Julia R.; Figueiredo, Claudia P.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Barros-Aragao, Fernanda; Nunes, Jose Bruno; Benjamim, Claudia F.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Venancio, Aline M.; de Oliveira, Jade; Engel, Daiane F.; De Bem, Andreza F.] Univ Fed Santa Catarina, Ctr Biol Sci, Florianopolis, SC, Brazil.
   [Frozza, Rudimar L.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP Clarke, JR; Figueiredo, CP (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM juclarke@gmail.com; claufig@gmail.com
RI Benjamim, Claudia/T-5090-2019; Clarke, Julia/AAF-9434-2019; de Oliveira,
   Jade/AAJ-6849-2020; Ferreira, Sergio/AAZ-1576-2020; da Costa,
   Robson/D-7822-2015; de, Andreza/AAA-1523-2019; Figueiredo, Claudia
   P/F-8424-2012; Engel, Daiane F./AAN-9044-2020; Neves,
   Fernanda/AAW-9638-2020; Silva, Jose Bruno Nunes Ferreira/G-7569-2015
OI Benjamim, Claudia/0000-0001-6247-9596; de Oliveira,
   Jade/0000-0003-1454-2866; Ferreira, Sergio/0000-0001-7160-9866; da
   Costa, Robson/0000-0002-1675-4742; de, Andreza/0000-0003-1090-5244;
   Engel, Daiane F./0000-0002-1950-196X; Silva, Jose Bruno Nunes
   Ferreira/0000-0003-4398-3943; Figueiredo, Claudia/0000-0001-9467-9891;
   Gomes de Queiroz Barros-Aragao, Fernanda/0000-0002-1663-8346; Frozza,
   Rudimar Luiz/0000-0003-0918-4128
FU Brazilian funding agency Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro; Brazilian funding agency Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq); Brazilian funding agency
   Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
FX This work was supported by grants from Brazilian funding agencies
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (F.S.N.,
   C.F.B., F.G.D.F, S.T.F, J.R.C., C.P.F.), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (R.L.F., F.B.A., C.F.B.,
   A.F.D.B., F.G.D.F., S.T.F.,, J.R.C., C.P.F.), and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (J.D.O, D.F.E., C.P.F.). We
   thank Maira Oliveira, Katia Laia, and Mariangela M. Viana for the
   technical support, and Ana Claudia Rangel for the competent lab and
   project management.
CR Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1
   Annane D, 2015, LANCET RESP MED, V3, P61, DOI 10.1016/S2213-2600(14)70246-2
   Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194
   Barichello T, 2005, CRIT CARE MED, V33, P1671, DOI 10.1097/01.CCM.0000170192.54682.C1
   Barichello T, 2005, CRIT CARE MED, V33, P221, DOI 10.1097/01.CCM.0000150741.12906.BD
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183
   Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107
   Comim CM, 2011, NEUROCHEM RES, V36, P304, DOI 10.1007/s11064-010-0320-2
   CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0
   DaRocha-Souto B, 2012, NEUROBIOL DIS, V45, P425, DOI 10.1016/j.nbd.2011.09.002
   De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954
   De Felice FG, 2013, EXPERT REV NEUROTHER, V13, P1297, DOI 10.1586/14737175.2013.864824
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475
   Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Figueiredo CP, 2011, J ALZHEIMERS DIS, V24, P61, DOI 10.3233/JAD-2010-101320
   Fu HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106331
   Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340
   Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1
   Gofton TE, 2012, NAT REV NEUROL, V8, P557, DOI 10.1038/nrneurol.2012.183
   Gunther ML, 2012, CRIT CARE MED, V40, P2022, DOI 10.1097/CCM.0b013e318250acc0
   Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025
   Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830
   Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553
   Kremer A, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00017
   Lamar CD, 2011, J NEUROPSYCH CLIN N, V23, P236, DOI 10.1176/appi.neuropsych.23.3.237
   Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037
   Long-Smith CM, 2013, NEUROMOL MED, V15, P102, DOI 10.1007/s12017-012-8199-5
   Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   McClean PL, 2014, NEUROPHARMACOLOGY, V76, P57, DOI 10.1016/j.neuropharm.2013.08.005
   McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633
   Moraes CA, 2015, MOL NEUROBIOL, V52, P653, DOI 10.1007/s12035-014-8868-5
   Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200
   Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372
   Ritter C, 2004, CRIT CARE MED, V32, P342, DOI 10.1097/01.CCM.0000109454.13145.CA
   Ryan GJ, 2011, J CLIN PHARM THER, V36, P260, DOI 10.1111/j.1365-2710.2010.01180.x
   Semmler A, 2013, J NEUROL NEUROSUR PS, V84, P62, DOI 10.1136/jnnp-2012-302883
   Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48
   Sharshar T, 2014, LANCET NEUROL, V13, P534, DOI 10.1016/S1474-4422(14)70064-X
   Singer BH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149136
   Steckert AV, 2013, SYNAPSE, V67, P786, DOI 10.1002/syn.21686
   Sui DM, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/1045657
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   Utton MA, 1997, BIOCHEM J, V323, P741, DOI 10.1042/bj3230741
   Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300
   Weberpals M, 2009, J NEUROSCI, V29, P14177, DOI 10.1523/JNEUROSCI.3238-09.2009
   Widmann CN, 2014, LANCET NEUROL, V13, P630, DOI 10.1016/S1474-4422(14)70017-1
   Yarchoan M, 2014, ACTA NEUROPATHOL, V128, P679, DOI 10.1007/s00401-014-1328-5
   Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723
NR 53
TC 15
Z9 15
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD JAN
PY 2018
VL 55
IS 1
BP 435
EP 444
DI 10.1007/s12035-016-0307-3
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA FV6PC
UT WOS:000424702600042
PM 27966074
DA 2020-12-08
ER

PT J
AU Fortuna, JTS
   Gralle, M
   Beckman, D
   Neves, FS
   Diniz, LP
   Frost, PS
   Barros-Aragao, F
   Santos, LE
   Goncalves, RA
   Romao, L
   Zamberlan, DC
   Soares, FAA
   Braga, C
   Foguel, D
   Gomes, FCA
   De Felice, FG
   Ferreira, ST
   Clarke, JR
   Figueiredo, CP
AF Fortuna, Juliana T. S.
   Gralle, Matthias
   Beckman, Danielle
   Neves, Fernanda S.
   Diniz, Luan P.
   Frost, Paula S.
   Barros-Aragao, Fernanda
   Santos, Luis E.
   Goncalves, Rafaella A.
   Romao, Luciana
   Zamberlan, Daniele C.
   Soares, Felix A. A.
   Braga, Carolina
   Foguel, Debora
   Gomes, Flavia C. A.
   De Felice, Fernanda G.
   Ferreira, Sergio T.
   Clarke, Julia R.
   Figueiredo, Claudia P.
TI Brain infusion of alpha-synuclein oligomers induces motor and non-motor
   Parkinson's disease-like symptoms in mice
SO BEHAVIOURAL BRAIN RESEARCH
LA English
DT Article
DE Intracerebroventricular (i.c.v.) infusion; Olfactory dysfunction;
   Anxiety-like behavior; Olfactory bulb; Dopamine; Tyrosine hydroxylase;
   Parkinson's disease
ID DEPRESSIVE-LIKE BEHAVIOR; COGNITIVE IMPAIRMENT; MOUSE MODEL;
   SUBSTANTIA-NIGRA; ANIMAL-MODELS; DYSFUNCTION; MPTP; DEFICITS; ANXIETY;
   RATS
AB Parkinson's disease (PD) is characterized by motor dysfunction, which is preceded by a number of non-motor symptoms including olfactory deficits. Aggregation of alpha-synuclein (alpha-syn) gives rise to Lewy bodies in dopaminergic neurons and is thought to play a central role in PD pathology. However, whether amyloid fibrils or soluble oligomers of alpha-syn are the main neurotoxic species in PD remains controversial. Here, we performed a single intracerebroventricular (i.c.v.) infusion of a-syn oligomers (alpha-SYOs) in mice and evaluated motor and non-motor symptoms. Familiar bedding and vanillin essence discrimination tasks showed that alpha-SYOs impaired olfactory performance of mice, and decreased TH and dopamine levels in the olfactory bulb early after infusion. The olfactory deficit persisted until 45 days post-infusion (dpi). alpha-SYO-infused mice behaved normally in the object recognition and forced swim tests, but showed increased anxiety-like behavior in the open field and elevated plus maze tests 20 dpi. Finally, administration of alpha-SYOs induced late motor impairment in the pole test and rotarod paradigms, along with reduced TH and dopamine content in the caudate putamen, 45 dpi. Reduced number of TH-positive cells was also seen in the substantii nigra of alpha-SYO-injected mice compared to control. In conclusion, i.c.v. infusion of alpha-SYOs recapitulated some of PD-associated non-motor symptoms, such as increased anxiety and olfactory dysfunction, but failed to recapitulate memory impairment and depressive-like behavior typical of the disease. Moreover, alpha-SY0s i.c.v. administration induced motor deficits and loss of TH and dopamine levels, key features of PD. Results point to alpha-syn oligomers as the proximal neurotoxins responsible for early non-motor and motor deficits in PD and suggest that the i.c.v. infusion model characterized here may comprise a useful tool for identification of PD novel therapeutic targets and drug screening.
C1 [Fortuna, Juliana T. S.; Neves, Fernanda S.; Frost, Paula S.; Barros-Aragao, Fernanda; Clarke, Julia R.; Figueiredo, Claudia P.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Gralle, Matthias; Beckman, Danielle; Santos, Luis E.; Goncalves, Rafaella A.; Braga, Carolina; Foguel, Debora; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Diniz, Luan P.; Frost, Paula S.; Barros-Aragao, Fernanda; Romao, Luciana; Gomes, Flavia C. A.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Santos, Luis E.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Romao, Luciana; Braga, Carolina] Univ Fed Rio de Janeiro, Campus Xerem, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Zamberlan, Daniele C.; Soares, Felix A. A.] Univ Fed Santa Maria, Dept Toxicol Biochem, Santa Maria, RS, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
RP Clarke, JR; Figueiredo, CP (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM juclarke@gmail.com; claufig@gmail.com
RI Neves, Fernanda/AAW-9638-2020; Ferreira, Sergio/AAZ-1576-2020; Soares,
   Felix/AAE-6251-2020; Santos, Luis/B-4961-2015; Clarke,
   Julia/AAF-9434-2019; Soares, Felix AA/K-7611-2012; Figueiredo, Claudia
   P/F-8424-2012; Diniz, Luan/AAN-6788-2020; Beckman, Danielle/J-5331-2015;
   Gomes, Flavia/C-5383-2013
OI Ferreira, Sergio/0000-0001-7160-9866; Soares, Felix/0000-0002-6453-7902;
   Santos, Luis/0000-0002-0694-733X; Soares, Felix AA/0000-0002-6453-7902;
   Diniz, Luan/0000-0002-2986-4043; Foguel, Debora/0000-0001-7312-7115; da
   Silva Frost, Paula/0000-0002-3814-999X; Beckman,
   Danielle/0000-0002-9584-4411; Figueiredo, Claudia/0000-0001-9467-9891;
   Gomes, Flavia/0000-0003-2966-0638; Gomes de Queiroz Barros-Aragao,
   Fernanda/0000-0002-1663-8346
FU Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES; National Institute for Translational Neuroscience (INNT)
FX This work was supported by grants from Brazilian funding agencies
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (F.S.N.,
   C.F.B., L.R., F.C.A.G., F.G.D.F, S.T.F, J.R.C., C.P.F., M.G.), Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (R.L.F., F.B.A.,
   C.F.B., A.F.D.B., L.P.D., F.C.A.G., F.G.D.F., S.T.F., J.R.C., C.P.F.,
   M.G.), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (J.D.O, D.F.E.), and National Institute for Translational Neuroscience
   (INNT) (STF). We thank Maira Oliveira, Katia Laia and Mariangela M.
   Viana for technical support, and Ana Claudia Rangel for competent lab
   and project management.
CR Aarsland D, 2016, PARKINSONISM RELAT D, V22, pS144, DOI 10.1016/j.parkreldis.2015.09.034
   Alerte TNM, 2008, NEUROSCI LETT, V435, P24, DOI 10.1016/j.neulet.2008.02.014
   Amschl D, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-6
   Antony PMA, 2011, MAMM GENOME, V22, P401, DOI 10.1007/s00335-011-9330-x
   Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313
   Beach TG, 2009, ACTA NEUROPATHOL, V117, P169, DOI 10.1007/s00401-008-0450-7
   Beckman D, 2015, J BIOL CHEM, V290, P20488, DOI 10.1074/jbc.M115.666156
   Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618
   Bohnen NI, 2007, J NEUROL, V254, P84, DOI 10.1007/s00415-006-0284-y
   Bonito-Oliva A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00290
   Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9
   Braak H, 2002, J NEUROL S3, V249, P1, DOI DOI 10.1007/S00415-002-1301-4
   Branchi I, 2008, J NEUROSCI RES, V86, P2050, DOI 10.1002/jnr.21642
   Caudal D, 2015, EXP NEUROL, V273, P243, DOI 10.1016/j.expneurol.2015.09.002
   Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7
   Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8
   Chiavegatto S, 2009, MOL PSYCHIATR, V14, P894, DOI 10.1038/mp.2008.43
   Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311
   Crowther RA, 2000, NEUROSCI LETT, V292, P128, DOI 10.1016/S0304-3940(00)01440-3
   Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034
   Dissanayaka NNW, 2010, MOVEMENT DISORD, V25, P838, DOI 10.1002/mds.22833
   Dubois B, 1997, J NEUROL, V244, P2, DOI 10.1007/pl00007725
   Farrell KF, 2014, J NEUROCHEM, V128, P536, DOI 10.1111/jnc.12481
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x
   Follmer C, 2007, BIOCHEMISTRY-US, V46, P472, DOI 10.1021/bi061871+
   Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564
   Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555
   Goldberg NRS, 2015, STEM CELL REP, V5, P791, DOI 10.1016/j.stemcr.2015.09.008
   Graham DR, 2010, J NEUROSCI RES, V88, P1777, DOI 10.1002/jnr.22331
   Haehner A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/450939
   Hansen C, 2013, NEUROBIOL DIS, V56, P145, DOI 10.1016/j.nbd.2013.04.017
   Hisahara S, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/951709
   Jackson-Lewis Vernice, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS183, DOI 10.1016/S1353-8020(11)70057-8
   Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   Kim BW, 2015, NEUROPHARMACOLOGY, V97, P46, DOI 10.1016/j.neuropharm.2015.04.037
   Kim BW, 2015, J ETHNOPHARMACOL, V164, P388, DOI 10.1016/j.jep.2014.11.004
   LAURSEN SE, 1986, J PHARMACOL METHOD, V16, P355, DOI 10.1016/0160-5402(86)90038-0
   Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X
   Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003
   Lindgren HS, 2012, EUR J NEUROSCI, V35, P1894, DOI 10.1111/j.1460-9568.2012.08162.x
   LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180
   Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157
   Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457
   Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462
   Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265
   Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001
   Moretti M, 2015, NEUROTOX RES, V28, P222, DOI 10.1007/s12640-015-9540-1
   Mori A, 2005, NEUROSCI RES, V51, P265, DOI 10.1016/j.neures.2004.11.008
   Neuner J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4915
   Neuner J, 2014, SCI REP-UK, V4, DOI 10.1038/srep03931
   OGAWA N, 1985, RES COMMUN CHEM PATH, V50, P435
   Ozawa T, 2011, NEUROSCI LETT, V497, P37, DOI 10.1016/j.neulet.2011.04.022
   Pagonabarraga J, 2012, NEUROBIOL DIS, V46, P590, DOI 10.1016/j.nbd.2012.03.029
   Paumier KL, 2015, NEUROBIOL DIS, V82, P185, DOI 10.1016/j.nbd.2015.06.003
   Pena-Oliver Y, 2010, BEHAV BRAIN RES, V209, P234, DOI 10.1016/j.bbr.2010.01.049
   Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002
   Petit GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060691
   Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197
   PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0
   Prediger RDS, 2006, EXP NEUROL, V202, P391, DOI 10.1016/j.expneurol.2006.07.001
   Prediger RDS, 2012, NEUROTOX RES, V21, P90, DOI 10.1007/s12640-011-9281-8
   Prediger RDS, 2010, NEUROTOX RES, V17, P114, DOI 10.1007/s12640-009-9087-0
   Pruszak J., 2009, CURR PROTOC STEM CEL, V2, P5, DOI DOI 10.1002/
   Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X
   Qi C, 2017, EXP NEUROBIOL, V26, P97, DOI 10.5607/en.2017.26.2.97
   Rial D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114216
   Santiago RM, 2010, PROG NEURO-PSYCHOPH, V34, P1104, DOI 10.1016/j.pnpbp.2010.06.004
   Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178
   Schintu N, 2012, J PARKINSON DIS, V2, P87, DOI 10.3233/JPD-2012-12076
   Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278
   Celej MS, 2012, BIOCHEM J, V443, P719, DOI 10.1042/BJ20111924
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Stebbins GT, 1999, NEUROPSYCHOLOGIA, V37, P503, DOI 10.1016/S0028-3932(98)00068-2
   Tadaiesky MT, 2008, NEUROSCIENCE, V156, P830, DOI 10.1016/j.neuroscience.2008.08.035
   Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009
   Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006
   Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135
   Vuckovic MG, 2008, NEUROBIOL DIS, V32, P319, DOI 10.1016/j.nbd.2008.07.015
   Walsh K, 2001, POSTGRAD MED J, V77, P89, DOI 10.1136/pmj.77.904.89
   Watson GS, 2010, BRAIN PATHOL, V20, P640, DOI 10.1111/j.1750-3639.2010.00373.x
   Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108
   Yu S, 2004, NEUROSCI LETT, V367, P34, DOI 10.1016/j.neulet.2004.05.118
   Zhang SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119928
   Zhou W, 2008, J BIOL CHEM, V283, P9863, DOI 10.1074/jbc.M710232200
NR 88
TC 12
Z9 12
U1 1
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-4328
EI 1872-7549
J9 BEHAV BRAIN RES
JI Behav. Brain Res.
PD AUG 30
PY 2017
VL 333
BP 150
EP 160
DI 10.1016/j.bbr.2017.06.047
PG 11
WC Behavioral Sciences; Neurosciences
SC Behavioral Sciences; Neurosciences & Neurology
GA FE5ZK
UT WOS:000408289600019
PM 28668282
DA 2020-12-08
ER

PT J
AU da Silva, RAG
   Lyra e Silva, LD
   Peny, JA
   Lima, RA
   Clarke, JR
   Munoz, DP
   Ferreira, ST
   Fraser, P
   De Felice, FG
AF da Silva, R. A. Goncalves
   Lyra e Silva, N. de Menezes
   Peny, J. A.
   Lima Filho, R. A.
   Clarke, J. R.
   Munoz, D. P.
   Ferreira, S. T.
   Fraser, P.
   De Felice, F. G.
TI Hypothalamic dysfunction and metabolic dysregulation in AD animal models
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT ISN-ESN Meeting
CY AUG 20-24, 2017
CL Paris, FRANCE
SP Int Soc Neurochemistry, Amer Soc Neurochemistry, ESN
C1 [da Silva, R. A. Goncalves; Lyra e Silva, N. de Menezes; Peny, J. A.; Lima Filho, R. A.; Clarke, J. R.; Ferreira, S. T.; De Felice, F. G.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
   [Munoz, D. P.; De Felice, F. G.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Fraser, P.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.
RI Clarke, Julia/AAF-9434-2019
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2017
VL 142
SU 1
SI SI
MA WTH07-03
BP 214
EP 214
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA FD3HY
UT WOS:000407425300514
DA 2020-12-08
ER

PT J
AU Kincheski, GC
   Valentim, IS
   Clarke, JR
   Cozachenco, D
   Castelo-Branco, MTL
   Ramos-Lobo, AM
   Rumjanek, VMBD
   Donato, J
   De Felice, FG
   Ferreira, ST
AF Kincheski, Grasielle C.
   Valentim, Isabela S.
   Clarke, Julia R.
   Cozachenco, Danielle
   Castelo-Branco, Morgana T. L.
   Ramos-Lobo, Angela M.
   Rumjanek, Vivian M. B. D.
   Donato, Jose, Jr.
   De Felice, Fernanda G.
   Ferreira, Sergio T.
TI Chronic sleep restriction promotes brain inflammation and synapse loss,
   and potentiates memory impairment induced by amyloid-beta oligomers in
   mice
SO BRAIN BEHAVIOR AND IMMUNITY
LA English
DT Article
DE Sleep; Chronic sleep restriction; Alzheimer's disease; Amyloid-beta
   oligomers; Cytokines; TNF-alpha; IL-1 beta; IL-6; Hippocampus; Synaptic
   proteins; Synaptophysin; PSD-95; Inflammation
ID OBJECT RECOGNITION MEMORY; DEPRESSIVE-LIKE BEHAVIOR;
   CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; ALZHEIMERS-DISEASE;
   TNF-ALPHA; COGNITIVE IMPAIRMENT; GENE-EXPRESSION; DEPRIVATION;
   HIPPOCAMPUS
AB It is increasingly recognized that sleep disturbances and Alzheimer's disease (AD) share a bidirectional relationship. AD patients exhibit sleep problems and alterations in the regulation of circadian rhythms; conversely, poor quality of sleep increases the risk of development of AD. The aim of the current study was to determine whether chronic sleep restriction potentiates the brain impact of amyloid-beta oligomers (ABOs), toxins that build up in AD brains and are thought to underlie synapse damage and memory impairment. We further investigated whether alterations in levels of pro-inflammatory mediators could play a role in memory impairment in sleep-restricted mice. We found that a single intracerebroventricular (i.c.v.) infusion of A beta Os disturbed sleep pattern in mice. Conversely, chronically sleep-restricted mice exhibited higher brain expression of pro-inflammatory mediators, reductions in levels of pre- and post-synaptic marker proteins, and exhibited increased susceptibility to the impact of i.c.v. infusion of a sub-toxic dose of ABOs (1 pmol) on performance in the novel object recognition memory task. Sleep-restricted mice further exhibited an increase in brain TNF-alpha levels in response to A beta Os. Interestingly, memory impairment in sleep-restricted A beta O-infused mice was prevented by treatment with the TNF-alpha neutralizing monoclonal antibody, infliximab. Results substantiate the notion of a dual relationship between sleep and AD, whereby A beta Os disrupt sleep/wake patterns and chronic sleep restriction increases brain vulnerability to A beta Os, and point to a key role of brain inflammation in increased susceptibility to A beta Os in sleep-restricted mice. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Kincheski, Grasielle C.; Valentim, Isabela S.; Cozachenco, Danielle; Rumjanek, Vivian M. B. D.; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo Meis, Rio De Janeiro, RJ, Brazil.
   [Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, Rio De Janeiro, RJ, Brazil.
   [Castelo-Branco, Morgana T. L.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.
   [Ramos-Lobo, Angela M.; Donato, Jose, Jr.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Junior, Jose Donato/ABB-3686-2020;
   Rumjanek, Vivian Mary/V-8741-2019; Donato, Jose/A-9662-2010; Clarke,
   Julia/AAF-9434-2019
OI Ferreira, Sergio/0000-0001-7160-9866; Junior, Jose
   Donato/0000-0002-4166-7608; Kincheski, Grasielle
   Clotildes/0000-0002-7392-3602
FU National Institute for Translational Neuroscience; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq); Fundacao de Amparo a Pesquisa do
   Estado do Rio de JaneiroCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Fundacao de Amparo a
   Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP) [2014/50140-6]
FX We thank Ana Claudia Rangel, Maira Oliveira and Mariangela Viana for
   administrative and technical support. This work was supported by grants
   from National Institute for Translational Neuroscience (to STF),
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (to STF,
   FGF, JRC), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (to
   STF, FGF and JRC), and Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (to JD, # 2014/50140-6).
CR Alzheimer's Association, 2013, ALZHEIMERS DEMENT, V9, P110, DOI 10.1016/j.jalz.2013.02.003
   Ambree O, 2006, NEUROBIOL AGING, V27, P955, DOI 10.1016/j.neurobiolaging.2005.05.009
   Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8
   Baxter MG, 2010, BEHAV NEUROSCI, V124, P706, DOI 10.1037/a0021029
   Bedrosian TA, 2011, P NATL ACAD SCI USA, V108, P11686, DOI 10.1073/pnas.1103098108
   Benedict C, 2015, ALZHEIMERS DEMENT, V11, P1090, DOI 10.1016/j.jalz.2014.08.104
   Benedict C, 2014, SLEEP, V37, P195, DOI 10.5665/sleep.3336
   BLIWISE DL, 1989, BIOL PSYCHIAT, V25, P320, DOI 10.1016/0006-3223(89)90179-0
   BREDER CD, 1993, J COMP NEUROL, V337, P543, DOI 10.1002/cne.903370403
   Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011
   Bruunsgaard H., 2003, IMMUNOL ALLERGY CLIN
   Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x
   Cedernaes J., 2015, SLEEP MED REV
   Chen J, 2013, NEUROSCI LETT, V541, P275, DOI 10.1016/j.neulet.2013.02.005
   Chen WR, 2005, P SOC PHOTO-OPT INS, V5771, P1, DOI 10.1117/12.634654
   Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183
   Czirr E., 2012, J CLIN INVEST
   D'Almeida V, 1998, NEUROREPORT, V9, P2853, DOI 10.1097/00001756-199808240-00031
   Dang-Vu T T, 2006, Pediatr Rehabil, V9, P98, DOI 10.1080/13638490500138702
   De Felice F.G., 2014, DIABETES
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x
   Duncan MJ, 2012, EXP NEUROL, V236, P249, DOI 10.1016/j.expneurol.2012.05.011
   Ehrlich I., 2009, NEURON
   Ferreira S.T., 2011, NEUROBIOL LEARN MEM
   Ferreira S.T., 2014, ALZHEIMERS DEMENT
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Frank MG, 1998, AM J PHYSIOL-REG I, V275, pR148
   Fronczek R, 2012, NEUROBIOL AGING, V33, P1642, DOI 10.1016/j.neurobiolaging.2011.03.014
   Goel N., 2009, SEMIN NEUROL
   Graves L, 2001, TRENDS NEUROSCI, V24, P237, DOI 10.1016/S0166-2236(00)01744-6
   Gruol DL, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6020019
   Gruol DL, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/fncel.2014.00234, 10.3389/1ricel.2014.00234]
   Hedges L. V., 1981, J ED STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]
   Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748
   INOUE S, 1995, BEHAV BRAIN RES, V69, P91, DOI 10.1016/0166-4328(95)00014-K
   Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962
   Kaushal N, 2012, AM J PHYSIOL-REG I, V303, pR19, DOI 10.1152/ajpregu.00025.2012
   Kim DH, 2016, BEHAV BRAIN RES, V311, P384, DOI 10.1016/j.bbr.2016.06.001
   KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905
   Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281
   KRUEGER JM, 1984, AM J PHYSIOL, V246, pR994
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016
   LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lopez J, 2008, NEUROSCIENCE, V153, P44, DOI 10.1016/j.neuroscience.2008.01.072
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Lucey B.P., 2016, JAMA NEUROL
   Maggio M, 2006, J GERONTOL A-BIOL, V61, P575, DOI 10.1093/gerona/61.6.575
   Mayeux R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006239
   McCoy J.G., 2011, NEUROBIOL LEARN MEM
   McCurry SM, 1999, J GERIATR PSYCH NEUR, V12, P53, DOI 10.1177/089198879901200203
   McDermott CM, 2003, J NEUROSCI, V23, P9687
   MCGINTY D, 1990, TRENDS NEUROSCI, V13, P480, DOI 10.1016/0166-2236(90)90081-K
   Medzhitov R., 2010, CELL
   Mignot E., 2008, PLOS BIOL
   Millers D.A., 2010, CEREB CORTEX
   Moran M, 2005, SLEEP MED, V6, P347, DOI 10.1016/j.sleep.2004.12.005
   Mucke L., 2012, COLD SPRING HARB PER, V2
   Mullington J.M., 2010, BEST PRACT RES CLIN
   Musiek ES, 2016, SCIENCE, V354, P1004, DOI 10.1126/science.aah4968
   Novati A, 2012, J SLEEP RES, V21, P3, DOI 10.1111/j.1365-2869.2011.00932.x
   Nowakowski S., 2015, SLEEP MED RES, V4, P1
   Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255
   Ooms S., 2014, JAMA NEUROL
   Osorio R.S., 2011, J AM GERIATR SOC
   Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530
   Pack AI, 2007, PHYSIOL GENOMICS, V28, P232, DOI 10.1152/physiolgenomics.00139.2006
   Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17
   Pike CJ, 2017, J NEUROSCI RES, V95, P671, DOI 10.1002/jnr.23827
   Platt B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027068
   Podcasy JL, 2016, DIALOGUES CLIN NEURO, V18, P437
   Radulovic J, 2010, REV NEUROSCIENCE, V21, P1
   Ramanathan L, 2002, NEUROREPORT, V13, P1387, DOI 10.1097/00001756-200208070-00007
   Reitz C., 2014, BIOCH PHARM
   Roh JH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004291
   Scallon B, 2002, J PHARMACOL EXP THER, V301, P418, DOI 10.1124/jpet.301.2.418
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210
   Shearer WT, 2001, J ALLERGY CLIN IMMUN, V107, P165, DOI 10.1067/mai.2001.112270
   SIEGEL JM, 1995, BEHAV BRAIN RES, V69, P29, DOI 10.1016/0166-4328(95)00023-M
   Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003
   Sterniczuk R, 2010, BRAIN RES, V1348, P139, DOI 10.1016/j.brainres.2010.05.013
   Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011
   Stickgold R, 2006, NATURE, V444, P559, DOI 10.1038/nature05309
   SWAAB DF, 1985, BRAIN RES, V342, P37, DOI 10.1016/0006-8993(85)91350-2
   Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012
   Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011
   Takeshita M, 2015, CYTOKINE, V75, P222, DOI 10.1016/j.cyto.2015.04.011
   Tononi G., 2006, SLEEP MED REV
   VANHULZEN ZJM, 1980, PHYSIOL BEHAV, V25, P807, DOI 10.1016/0031-9384(80)90298-X
   Wadhwa M, 2015, BEHAV BRAIN RES, V294, P95, DOI 10.1016/j.bbr.2015.08.002
   Walker MP, 2008, SLEEP MED, V9, pS29, DOI 10.1016/S1389-9457(08)70014-5
   Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x
   Weil ZM, 2009, EXP NEUROL, V218, P129, DOI 10.1016/j.expneurol.2009.04.018
   Wilson RS, 2007, PSYCHOSOM MED, V69, P47, DOI 10.1097/01.psy.0000250264.25017.21
   Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224
   Yang G, 2014, SCIENCE, V344, P1173, DOI 10.1126/science.1249098
   Zepelin H, 1994, PRINCIPLES PRACTICE, P69
   Zhang J, 2014, J NEUROSCI, V34, P4418, DOI 10.1523/JNEUROSCI.5025-12.2014
   Zielinski MR, 2014, NEUROSCI LETT, V580, P27, DOI 10.1016/j.neulet.2014.07.043
NR 109
TC 41
Z9 41
U1 0
U2 45
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0889-1591
EI 1090-2139
J9 BRAIN BEHAV IMMUN
JI Brain Behav. Immun.
PD AUG
PY 2017
VL 64
BP 140
EP 151
DI 10.1016/j.bbi.2017.04.007
PG 12
WC Immunology; Neurosciences; Psychiatry
SC Immunology; Neurosciences & Neurology; Psychiatry
GA EZ1XR
UT WOS:000404504600015
PM 28412140
DA 2020-12-08
ER

PT J
AU Brito-Moreira, J
   Lourenco, MV
   Oliveira, MM
   Ribeiro, FC
   Ledo, JH
   Diniz, LP
   Vital, JFS
   Magdesian, MH
   Melo, HM
   Barros-Aragao, F
   de Souza, JM
   Alves-Leon, SV
   Gomes, FCA
   Clarke, JR
   Figueiredo, CP
   De Felice, FG
   Ferreira, ST
AF Brito-Moreira, Jordano
   Lourenco, Mychael V.
   Oliveira, Mauricio M.
   Ribeiro, Felipe C.
   Ledo, Jose Henrique
   Diniz, Luan P.
   Vital, Juliana F. S.
   Magdesian, Margaret H.
   Melo, Helen M.
   Barros-Aragao, Fernanda
   de Souza, Jorge M.
   Alves-Leon, Soniza V.
   Gomes, Flavia C. A.
   Clarke, Julia R.
   Figueiredo, Claudia P.
   De Felice, Fernanda G.
   Ferreira, Sergio T.
TI Interaction of amyloid- (A) oligomers with neurexin 2 and neuroligin 1
   mediates synapse damage and memory loss in mice
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Alzheimer disease; amyloid (A); brain; neuron; synapse; amyloid
   oligomers; memory; neurexin; neuroligin
ID A-BETA OLIGOMERS; DEPRESSIVE-LIKE BEHAVIOR; LONG-TERM POTENTIATION;
   ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; BRAIN; RECOGNITION;
   INHIBITION; ADHESION; DYSFUNCTION
AB Brain accumulation of the amyloid- protein (A) and synapse loss are neuropathological hallmarks of Alzheimer disease (AD). A oligomers (AOs) are synaptotoxins that build up in the brains of patients and are thought to contribute to memory impairment in AD. Thus, identification of novel synaptic components that are targeted by AOs may contribute to the elucidation of disease-relevant mechanisms. Trans-synaptic interactions between neurexins (Nrxs) and neuroligins (NLs) are essential for synapse structure, stability, and function, and reduced NL levels have been associated recently with AD. Here we investigated whether the interaction of AOs with Nrxs or NLs mediates synapse damage and cognitive impairment in AD models. We found that AOs interact with different isoforms of Nrx and NL, including Nrx2 and NL1. Anti-Nrx2 and anti-NL1 antibodies reduced AO binding to hippocampal neurons and prevented AO-induced neuronal oxidative stress and synapse loss. Anti-Nrx2 and anti-NL1 antibodies further blocked memory impairment induced by AOs in mice. The results indicate that Nrx2 and NL1 are targets of AOs and that prevention of this interaction reduces the deleterious impact of AOs on synapses and cognition. Identification of Nrx2 and NL1 as synaptic components that interact with AOs may pave the way for development of novel approaches aimed at halting synapse failure and cognitive loss in AD.
C1 [Brito-Moreira, Jordano; Lourenco, Mychael V.; Oliveira, Mauricio M.; Ribeiro, Felipe C.; Ledo, Jose Henrique; Vital, Juliana F. S.; Magdesian, Margaret H.; Melo, Helen M.; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [Lourenco, Mychael V.; Oliveira, Mauricio M.; Ribeiro, Felipe C.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [Diniz, Luan P.; Barros-Aragao, Fernanda; Gomes, Flavia C. A.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [de Souza, Jorge M.; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Div Neurosurg, Clementino Fraga Filho Univ Hosp, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [de Souza, Jorge M.; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Div Neurol, Epilepsy Program, Clementino Fraga Filho Univ Hosp, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [Clarke, Julia R.; Figueiredo, Claudia P.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21947902 Rio De Janeiro, RJ, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21947902 Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Leon, Soniza V Alves/J-7786-2012;
   Clarke, Julia/AAF-9434-2019; Ribeiro, Felipe Campos/W-9758-2019;
   Lourenco, Mychael/G-2614-2014; Figueiredo, Claudia P/F-8424-2012; Gomes,
   Flavia/C-5383-2013
OI Ferreira, Sergio/0000-0001-7160-9866; Ribeiro, Felipe
   Campos/0000-0003-3028-3307; Lourenco, Mychael/0000-0002-1078-0296;
   Figueiredo, Claudia/0000-0001-9467-9891; Gomes de Queiroz Barros-Aragao,
   Fernanda/0000-0002-1663-8346; Gomes, Flavia/0000-0003-2966-0638
FU National Institute for Translational Neuroscience (INNT/Brazil);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Human Frontiers Science ProgramHuman
   Frontier Science Program; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ); CAPES
   (Brazil)CAPES
FX This work was supported by grants from National Institute for
   Translational Neuroscience (INNT/Brazil) (to S. T. F.), the Brazilian
   funding agencies Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ) (to S. T. F. and F. G. F.), and the Human Frontiers
   Science Program (to F. G. F.). The authors declare that they have no
   conflicts of interest with the contents of this article.; Supported by
   predoctoral fellowships from CNPq, FAPERJ, or CAPES (Brazil).
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010
   Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011
   Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159
   Bemben MA, 2015, TRENDS NEUROSCI, V38, P496, DOI 10.1016/j.tins.2015.06.004
   Bie BH, 2014, NAT NEUROSCI, V17, P223, DOI 10.1038/nn.3618
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101
   Chen GQ, 2000, NATURE, V408, P975
   Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016
   Choi YB, 2011, NEURON, V70, P468, DOI 10.1016/j.neuron.2011.03.020
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Dachtler J, 2015, BEHAV NEUROSCI, V129, P765, DOI 10.1037/bne0000108
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Dinamarca MC, 2015, BIOCHEM BIOPH RES CO, V466, P66, DOI 10.1016/j.bbrc.2015.08.107
   Dinamarca MC, 2011, BIOCHEMISTRY-US, V50, P8127, DOI 10.1021/bi201246t
   Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824
   Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Jiang M, 2017, MOL PSYCHIATR, V22, P375, DOI 10.1038/mp.2016.80
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234
   Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016
   Lepeta K, 2016, J NEUROCHEM, V138, P785, DOI 10.1111/jnc.13713
   Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011
   Liu A, 2016, J CELL BIOL, V212, P449, DOI 10.1083/jcb.201509023
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200
   Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200
   MASLIAH E, 1991, ACTA NEUROPATHOL, V81, P428, DOI 10.1007/BF00293464
   Miller MT, 2011, STRUCTURE, V19, P767, DOI 10.1016/j.str.2011.03.011
   MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102
   Nery AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067194
   Nunomura A, 1999, J NEUROSCI, V19, P1959
   Paula-Lima AC, 2013, J NEUROCHEM, V126, P191, DOI 10.1111/jnc.12304
   SanMartin CD, 2012, NEURODEGENER DIS, V10, P34, DOI 10.1159/000334901
   Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Shen HT, 2015, STROKE, V46, P2607, DOI 10.1161/STROKEAHA.115.009729
   Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x
   Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0
   Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108
   Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100
   Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Tristan-Clavijo E, 2015, NEUROBIOL AGING, V36, P3171, DOI 10.1016/j.neurobiolaging.2015.09.004
   Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199
   Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010
NR 64
TC 42
Z9 43
U1 1
U2 19
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 5
PY 2017
VL 292
IS 18
BP 7327
EP 7337
DI 10.1074/jbc.M116.761189
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EU1FY
UT WOS:000400761300005
PM 28283575
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Marcos, ABW
   Forner, S
   Martini, AC
   Patricio, ES
   Clarke, JR
   Costa, R
   Felix-Alves, J
   Vieira, VJ
   de Andrade, EL
   Mazzuco, TL
   Calixto, JB
   Figueiredo, CP
AF Marcos, Ana Beatriz W.
   Forner, Stefania
   Martini, Alessandra C.
   Patricio, Eliziane S.
   Clarke, Julia R.
   Costa, Robson
   Felix-Alves, Joao
   Vieira, Vilberto Jose
   de Andrade, Edineia Lemos
   Mazzuco, Tania Longo
   Calixto, Joao Batista
   Figueiredo, Claudia Pinto
TI Temporal and Regional Expression of Glucose-Dependent Insulinotropic
   Peptide and Its Receptor in Spinal Cord Injured Rats
SO JOURNAL OF NEUROTRAUMA
LA English
DT Article
DE glucose-dependent insulinotropic peptide (GIP); glucose-dependent
   insulinotropic peptide receptor (GIPR); nestin-positive cells; spinal
   cord injury (SCI)
ID CENTRAL-NERVOUS-SYSTEM; POLYPEPTIDE RECEPTOR; SYNAPTIC PLASTICITY;
   STEM-CELLS; REGENERATION; NEUROGENESIS; PROLIFERATION; AXONS;
   LOCALIZATION; MECHANISMS
AB Spinal cord injury (SCI) results in loss of movement, sensibility, and autonomic control at the level of the lesion and at lower parts of the body. Several experimental strategies have been used in attempts to increase endogenous mechanisms of neuroprotection, neuroplasticity, and repair, but with limited success. It is known that glucose-dependent insulinotropic peptide (GIP) and its receptor (GIPR) can enhance synaptic plasticity, neurogenesis, and axonal outgrowth. However, their role in the injury has never been studied. The aim of this study was to evaluate the changes in expression levels of both GIP and GIPR in acute and chronic phases of SCI in rats. Following SCI (2 to 24h after damage), the rat spinal cord showed a lesion in which the epicenter had a cavity with hemorrhage and necrosis. Furthermore, the lesion cavity also showed ballooned cells 14 and 28 days after injury. We found that SCI induced increases in GIPR expression in areas neighboring the site of injury at 6h and 28 days after the injury. Moreover, higher GIP expression was observed in these regions on day 28. Neuronal projections from the injury epicenter showed an increase in GIP immunoreactivity 24h and 14 and 28 days after SCI. Interestingly, GIP was also found in progenitor cells at the spinal cord canal 24h after injury, whereas both GIP and GIPR were present in progenitor cells at the injury epicenter 14 days after in SCI animals. These results suggest that GIP and its receptor might be implicated with neurogenesis and the repair process after SCI.
C1 [Marcos, Ana Beatriz W.; Vieira, Vilberto Jose] Univ Fed Santa Catarina, Ctr Ciencias Saude, Programa Posgrad Ciencias Med, Florianopolis, SC, Brazil.
   [Forner, Stefania; Martini, Alessandra C.; Patricio, Eliziane S.; Felix-Alves, Joao; de Andrade, Edineia Lemos; Calixto, Joao Batista] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Farmacol, Florianopolis, SC, Brazil.
   [Clarke, Julia R.; Costa, Robson; Figueiredo, Claudia Pinto] Univ Fed Rio de Janeiro, Fac Farm, Ctr Ciencias Saude, Rio De Janeiro, RJ, Brazil.
   [Mazzuco, Tania Longo] Univ Estadual Londrina, Ctr Ciencias Saude, Dept Clin Med, Londrina, PR, Brazil.
RP Figueiredo, CP (corresponding author), Univ Fed Rio de Janeiro, Dept Pharmaceut Biotechnol, Ctr Hlth Sci, CCS, Bloco A2,Sala 48,Cidade Univ, Rio De Janeiro, RJ, Brazil.
EM claufig@gmail.com
RI Figueiredo, Claudia P/F-8424-2012; vieira, Vilberto/AAS-6327-2020;
   Forner, Stefania/A-4498-2013; Clarke, Julia/AAF-9434-2019; Mazzuco,
   Tania L/A-5881-2019; da Costa, Robson/D-7822-2015; Mazzuco,
   Tania/AAG-8922-2019
OI Forner, Stefania/0000-0001-7977-4866; Mazzuco, Tania
   L/0000-0002-1669-5623; da Costa, Robson/0000-0002-1675-4742; Mazzuco,
   Tania/0000-0002-1669-5623; Figueiredo, Claudia/0000-0001-9467-9891;
   calixto, joao Batista/0000-0003-4041-7153
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES; Araucaria Research Foundation of Parana State,
   Brazil; FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ)
FX This work was supported by grants from the following Brazilian funding
   agencies: Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES). TLM and CPF received a research productivity grant from the
   Araucaria Research Foundation of Parana State, Brazil, and FAPERJ,
   respectively.
CR Abankwa D, 2002, MOL CELL NEUROSCI, V21, P421, DOI 10.1006/mcne.2002.1183
   Allison DJ, 2015, SPINAL CORD, V53, P14, DOI 10.1038/sc.2014.184
   Amiri F, 2015, CELL STRESS CHAPERON, V20, P237, DOI 10.1007/s12192-014-0560-1
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   Bechara RG, 2013, BEHAV BRAIN RES, V245, P96, DOI 10.1016/j.bbr.2013.02.018
   Buhren BA, 2009, J NEUROSCI RES, V87, P1858, DOI 10.1002/jnr.22001
   Cizkova D, 2009, CELL MOL NEUROBIOL, V29, P999, DOI 10.1007/s10571-009-9387-1
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Faivre E, 2012, EUR J PHARMACOL, V674, P294, DOI 10.1016/j.ejphar.2011.11.007
   Faivre E, 2011, J NEUROPHYSIOL, V105, P1574, DOI 10.1152/jn.00866.2010
   Fehlings Michael G, 2014, Neurosurgery, V61 Suppl 1, P36, DOI 10.1227/NEU.0000000000000412
   Figueiredo CP, 2011, J ALZHEIMERS DIS, V24, P61, DOI 10.3233/JAD-2010-101320
   Figueiredo CP, 2011, PEPTIDES, V32, P781, DOI 10.1016/j.peptides.2010.12.010
   Figueiredo CP, 2010, BEHAV PHARMACOL, V21, P394, DOI 10.1097/FBP.0b013e32833c8544
   Filous AR, 2014, J NEUROSCI, V34, P16369, DOI 10.1523/JNEUROSCI.1309-14.2014
   Foret A, 2010, J NEUROCHEM, V112, P762, DOI 10.1111/j.1471-4159.2009.06500.x
   Franklin RJM, 1997, J NEUROSCI RES, V50, P337, DOI 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3
   Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480
   Gault VA, 2008, J NEUROPHYSIOL, V99, P1590, DOI 10.1152/jn.01161.2007
   Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1
   Hwang DH, 2014, J NEUROSCI, V34, P12788, DOI 10.1523/JNEUROSCI.5359-13.2014
   Kealy J, 2015, BRAIN RES, V1598, P76, DOI 10.1016/j.brainres.2014.12.015
   Kwon BK, 2002, SPINE, V27, P1504, DOI 10.1097/00007632-200207150-00005
   Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007
   Lee DH, 2014, J NEUROSCI, V34, P15347, DOI 10.1523/JNEUROSCI.1935-14.2014
   Leen JLS, 2011, ENDOCRINOLOGY, V152, P436, DOI 10.1210/en.2010-0822
   Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543
   McTigue DM, 1998, J NEUROSCI, V18, P5354
   McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001
   Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182
   Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459
   Monteiro BMM, 2014, HIPPOCAMPUS, V24, P239, DOI 10.1002/hipo.22218
   Nunez-Espinosa C, 2015, CURR STEM CELL RES T, V10, P132, DOI 10.2174/1574888X09666140930130048
   Nyberg J, 2005, J NEUROSCI, V25, P1816, DOI 10.1523/jneurosci.4920-04.2005
   Nyberg J, 2007, J NEUROSCI RES, V85, P2099, DOI 10.1002/jnr.21349
   Obermair FJ, 2008, PHYSIOLOGY, V23, P296, DOI 10.1152/physiol.00017.2008
   Okano H, 2007, J NEUROCHEM, V102, P1459, DOI 10.1111/j.1471-4159.2007.04674.x
   Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281
   Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789
   Rizzi S, 2011, BRAIN RES, V1415, P23, DOI 10.1016/j.brainres.2011.08.007
   Rotz ME, 2015, INT J CLIN PRACT, V69, P531, DOI 10.1111/ijcp.12572
   Salehi M, 2008, ENDOCR REV, V29, P367, DOI 10.1210/er.2007-0031
   Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a
   Santos-Benito FF, 2006, J NEUROTRAUM, V23, P521, DOI 10.1089/neu.2006.23.521
   Sharma HS, 2000, AMINO ACIDS, V19, P351, DOI 10.1007/s007260070066
   Siddle K, 2001, BIOCHEM SOC T, V29, P513, DOI 10.1042/BST0290513
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Silver J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020602
   Spejo AB, 2015, NEUROPHARMACOLOGY, V96, P113, DOI 10.1016/j.neuropharm.2014.11.002
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   UNGER JW, 1991, PROG NEUROBIOL, V36, P343, DOI 10.1016/0301-0082(91)90015-S
   USDIN TB, 1993, ENDOCRINOLOGY, V133, P2861, DOI 10.1210/en.133.6.2861
   Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687
   Vawda R, 2013, CURR STEM CELL RES T, V8, P25, DOI 10.2174/1574888X11308010005
   Winkler T, 2000, ACTA NEUROCHIR SUPPL, V76, P291
   Wu XH, 2007, J NEUROTRAUM, V24, P1502, DOI 10.1089/neu.2006.0228
   Wu Y, 2014, NEUROSCIENCE, V265, P302, DOI 10.1016/j.neuroscience.2014.01.059
   Xu B, 2015, NEUROBIOL DIS, V73, P36, DOI 10.1016/j.nbd.2014.08.030
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
NR 59
TC 2
Z9 2
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0897-7151
EI 1557-9042
J9 J NEUROTRAUM
JI J. Neurotrauma
PD FEB 1
PY 2016
VL 33
IS 3
BP 261
EP 268
DI 10.1089/neu.2015.3877
PG 8
WC Critical Care Medicine; Clinical Neurology; Neurosciences
SC General & Internal Medicine; Neurosciences & Neurology
GA DC9AS
UT WOS:000369513300001
PM 26421658
OA Green Published
DA 2020-12-08
ER

PT J
AU Clarke, JR
   Silva, NMLE
   Figueiredo, CP
   Frozza, RL
   Ledo, JH
   Beckman, D
   Katashima, CK
   Razolli, D
   Carvalho, BM
   Frazao, R
   Silveira, MA
   Ribeiro, FC
   Bomfim, TR
   Neves, FS
   Klein, WL
   Medeiros, R
   LaFerla, FM
   Carvalheira, JB
   Saad, MJ
   Munoz, DP
   Velloso, LA
   Ferreira, ST
   De Felice, FG
AF Clarke, Julia R.
   Lyra e Silva, Natalia M.
   Figueiredo, Claudia P.
   Frozza, Rudimar L.
   Ledo, Jose H.
   Beckman, Danielle
   Katashima, Carlos K.
   Razolli, Daniela
   Carvalho, Bruno M.
   Frazao, Renata
   Silveira, Marina A.
   Ribeiro, Felipe C.
   Bomfim, Theresa R.
   Neves, Fernanda S.
   Klein, William L.
   Medeiros, Rodrigo
   LaFerla, Frank M.
   Carvalheira, Jose B.
   Saad, Mario J.
   Munoz, Douglas P.
   Velloso, Licio A.
   Ferreira, Sergio T.
   De Felice, Fernanda G.
TI Alzheimer-associated A beta oligomers impact the central nervous system
   to induce peripheral metabolic deregulation
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE Alzheimer's disease; ER stress; hypothalamus; inflammation; insulin
   resistance
ID ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE;
   NECROSIS-FACTOR-ALPHA; D-ASPARTATE RECEPTOR; MOUSE MODEL; TNF-ALPHA;
   COGNITIVE IMPAIRMENT; GLUCOSE-HOMEOSTASIS; AMYLOID OLIGOMERS; LONG-TERM
AB Alzheimer's disease (AD) is associated with peripheral metabolic disorders. Clinical/epidemiological data indicate increased risk of diabetes in AD patients. Here, we show that intracerebroventricular infusion of AD-associated A beta oligomers (A beta Os) in mice triggered peripheral glucose intolerance, a phenomenon further verified in two transgenic mouse models of AD. Systemically injected A beta Os failed to induce glucose intolerance, suggesting A beta Os target brain regions involved in peripheral metabolic control. Accordingly, we show that A beta Os affected hypothalamic neurons in culture, inducing eukaryotic translation initiation factor 2 alpha phosphorylation (eIF2 alpha-P). A beta Os further induced eIF2 alpha-P and activated proinflammatory IKK beta/NF-kappa B signaling in the hypothalamus of mice and macaques. A beta Os failed to trigger peripheral glucose intolerance in tumor necrosis factor-alpha (TNF-alpha) receptor 1 knockout mice. Pharmacological inhibition of brain inflammation and endoplasmic reticulum stress prevented glucose intolerance in mice, indicating that A beta Os act via a central route to affect peripheral glucose homeostasis. While the hypothalamus has been largely ignored in the AD field, our findings indicate that A beta Os affect this brain region and reveal novel shared molecular mechanisms between hypothalamic dysfunction in metabolic disorders and AD.
C1 [Clarke, Julia R.; Lyra e Silva, Natalia M.; Frozza, Rudimar L.; Ledo, Jose H.; Beckman, Danielle; Ribeiro, Felipe C.; Bomfim, Theresa R.; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, RJ, Brazil.
   [Clarke, Julia R.; Figueiredo, Claudia P.; Neves, Fernanda S.] Univ Fed Rio de Janeiro, Sch Pharm, Rio De Janeiro, RJ, Brazil.
   [Katashima, Carlos K.; Razolli, Daniela; Carvalho, Bruno M.; Carvalheira, Jose B.; Saad, Mario J.; Velloso, Licio A.] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Campinas, SP, Brazil.
   [Frazao, Renata; Silveira, Marina A.] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, SP, Brazil.
   [Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL USA.
   [Medeiros, Rodrigo; LaFerla, Frank M.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA USA.
   [Munoz, Douglas P.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.
RP De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, RJ, Brazil.
EM felice@bioqmed.ufrj.br
RI Clarke, Julia/AAF-9434-2019; Neves, Fernanda/AAW-9638-2020; Figueiredo,
   Claudia P/F-8424-2012; Velloso, Licio/AAJ-3778-2020; Frazao,
   Renata/D-1374-2012; Ferreira, Sergio/AAZ-1576-2020; Saad,
   Mario/ABD-8262-2020; Beckman, Danielle/B-4656-2015; Ribeiro, Felipe
   Campos/W-9758-2019; Razolli, Daniela S/B-1630-2014; Carvalheira, Jose
   B.C./E-8562-2013; Carvalho, Bruno/G-1255-2012; Katashima, Carlos Kiyoshi
   K/I-5616-2018
OI Ferreira, Sergio/0000-0001-7160-9866; Beckman,
   Danielle/0000-0002-9584-4411; Ribeiro, Felipe
   Campos/0000-0003-3028-3307; Razolli, Daniela S/0000-0002-2217-0946;
   Carvalheira, Jose B.C./0000-0002-0136-0943; Carvalho,
   Bruno/0000-0002-6792-0288; Katashima, Carlos Kiyoshi
   K/0000-0002-3908-127X; Frazao, Renata/0000-0002-0877-8453; Medeiros,
   Rodrigo/0000-0002-9399-7852; Frozza, Rudimar Luiz/0000-0003-0918-4128
FU Human Frontiers Science Program (HFSP)Human Frontier Science Program;
   National Institute for Translational Neuroscience (INNT/Brazil);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Fundacao de Amparo a Pesquisa do Estado de
   Sao PauloFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [FAPESP2012/12202-4]; Canadian Institutes for Health Research
   (CIHR)Canadian Institutes of Health Research (CIHR); Canada Research
   Chair ProgramCanada Research Chairs; CAPESCAPES; CNPqNational Council
   for Scientific and Technological Development (CNPq)
FX This study is dedicated to the memory of Prof. Leopoldo de Meis
   (1938-2014), founder of the Institute of Medical Biochemistry of the
   Federal University of Rio de Janeiro. This work was supported by grants
   from Human Frontiers Science Program (HFSP) (to FGF), National Institute
   for Translational Neuroscience (INNT/Brazil) (to STF), the Brazilian
   funding agencies Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) (to STF, FGF, CPF and JRC), Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ) (to STF, FGF, CPF and
   JRC), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP2012/12202-4 to RF), Canadian Institutes for Health Research
   (CIHR) and Canada Research Chair Program (to DPM). MAS, JRC, NMLS, RLF,
   JHL, DB, FCR, TRB and FSN received fellowships from Brazilian agencies
   CAPES or CNPq. We thank Drs. Matthias Gralle and Jordano Brito-Moreira
   for performing A beta O injections in macaques, Drs. Brito-Moreira and
   Adriano Sebollela for chromatographic characterization of oligomer
   preparations, Dr. Leonardo M. Saraiva for help with hypothalamic
   neuronal cultures and ROS assays, Maira S. Oliveira, Mariangela M.
   Viana, Sandra Bambrilla and Dioze Guadagnini for technical support,
   Prof. Carla Tasca (Federal University of Santa Catarina) for the
   hippocampal sections used as positive controls in Fluorojade staining
   experiments and Ana Claudia Rangel for secretarial and accounting
   support.
CR Arruda AP, 2011, ENDOCRINOLOGY, V152, P1314, DOI 10.1210/en.2010-0659
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166
   Chhatwal JP, 2012, J ALZHEIMERS DIS, V31, pS155, DOI 10.3233/JAD-2012-120730
   Costa RO, 2012, AGING CELL, V11, P823, DOI 10.1111/j.1474-9726.2012.00848.x
   CRAFT S, 1992, J CLIN EXP NEUROPSYC, V14, P253, DOI 10.1080/01688639208402827
   Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137
   Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Denis RG, 2010, NEUROSCIENCE, V170, P1035, DOI 10.1016/j.neuroscience.2010.08.013
   El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Figueiredo CP, 2011, J ALZHEIMERS DIS, V24, P61, DOI 10.3233/JAD-2010-101320
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Frazao R, 2013, J NEUROSCI, V33, P2807, DOI 10.1523/JNEUROSCI.1610-12.2013
   Fronczek R, 2012, NEUROBIOL AGING, V33, P1642, DOI 10.1016/j.neurobiolaging.2011.03.014
   Gomes S, 2014, J NEUROENDOCRINOL, V26, P176, DOI 10.1111/jne.12138
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Hahn TM, 1998, NAT NEUROSCI, V1, P271
   Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002
   Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006
   Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3
   Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474
   Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807
   Jimenez-Palomares M, 2012, AM J PHYSIOL-ENDOC M, V302, pE1373, DOI 10.1152/ajpendo.00500.2011
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   LAURSEN SE, 1986, J PHARMACOL METHOD, V16, P355, DOI 10.1016/0160-5402(86)90038-0
   Le Beyec J, 2014, INT J OBESITY, V38, P1357, DOI 10.1038/ijo.2014.14
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194
   Loskutova N, 2010, J ALZHEIMERS DIS, V20, P313, DOI 10.3233/JAD-2010-1364
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486
   Matsuzaki T, 2010, NEUROLOGY, V75, P764, DOI 10.1212/WNL.0b013e3181eee25f
   Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009
   Milanski M, 2012, DIABETES, V61, P1455, DOI 10.2337/db11-0390
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3
   Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294
   OGOMORI K, 1989, AM J PATHOL, V134, P243
   Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937
   Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Purkayastha S, 2011, P NATL ACAD SCI USA, V108, P2939, DOI 10.1073/pnas.1006875108
   Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874
   Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465
   Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958
   Sanchez-Lasheras C, 2010, FRONT NEUROENDOCRIN, V31, P4, DOI 10.1016/j.yfrne.2009.08.002
   Schwartz MW, 2000, NATURE, V404, P661
   Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541
   Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460
   Shi JQ, 2011, J AM GERIATR SOC, V59, P1142, DOI 10.1111/j.1532-5415.2011.03445.x
   Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053
   Sims-Robinson C, 2010, NAT REV NEUROL, V6, P551, DOI 10.1038/nrneurol.2010.130
   STANDAERT DG, 1991, AM J PATHOL, V139, P681
   Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005
   Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   Thaler JP, 2013, DIABETES, V62, P2629, DOI 10.2337/db12-1605
   Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wang KC, 2012, NEUROEPIDEMIOLOGY, V38, P237, DOI 10.1159/000337428
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143
   Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043
   Zhang Y, 2012, DIABETES, V61, P1434, DOI 10.2337/db11-0499
   Zhang YongJie, 2012, Mycology - An International Journal on Fungal Biology, V3, P2
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zussy C, 2011, AM J PATHOL, V179, P315, DOI 10.1016/j.ajpath.2011.03.021
NR 84
TC 110
Z9 112
U1 0
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD FEB
PY 2015
VL 7
IS 2
BP 190
EP 210
DI 10.15252/emmm.201404183
PG 21
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CD0MG
UT WOS:000350767300006
PM 25617315
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Ferreira, ST
   Clarke, JR
   Bomfim, TR
   De Felice, FG
AF Ferreira, Sergio T.
   Clarke, Julia R.
   Bomfim, Theresa R.
   De Felice, Fernanda G.
TI Inflammation, defective insulin signaling, and neuronal dysfunction in
   Alzheimer's disease
SO ALZHEIMERS & DEMENTIA
LA English
DT Article
DE Inflammation; Alzheimer's disease; Diabetes; Obesity; Insulin signaling;
   Aging
ID NECROSIS-FACTOR-ALPHA; NONSTEROIDAL ANTIINFLAMMATORY DRUGS;
   ENDOPLASMIC-RETICULUM STRESS; TRANSGENIC MOUSE MODEL; ADIPOSE-TISSUE;
   TNF-ALPHA; PERISPINAL ETANERCEPT; COGNITIVE IMPROVEMENT; RECEPTOR
   SUBSTRATE-1; AMYLOID DEPOSITION
AB A link between Alzheimer's disease (AD) and metabolic disorders has been established, with patients with type 2 diabetes at increased risk of developing AD and vice versa. The incidence of metabolic disorders, including insulin resistance and type 2 diabetes is increasing at alarming rates worldwide, primarily as a result of poor lifestyle habits. In parallel, as the world population ages, the prevalence of AD, the most common form of dementia in the elderly, also increases. In addition to their epidemiologic and clinical association, mounting recent evidence indicates shared mechanisms of pathogenesis between metabolic disorders and AD. We discuss the concept that peripheral and central nervous system inflammation link the pathogenesis of AD and metabolic diseases. We also explore the contribution of brain inflammation to defective insulin signaling and neuronal dysfunction. Last, we review recent evidence indicating that targeting neuroinflammation may provide novel therapeutic avenues for AD. (C) 2014 The Alzheimer's Association. All rights reserved.
C1 [Ferreira, Sergio T.; Clarke, Julia R.; Bomfim, Theresa R.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Clarke, Julia/AAF-9434-2019; Ferreira, Sergio/AAZ-1576-2020
OI Ferreira, Sergio/0000-0001-7160-9866
FU National Institute for Translational Neuroscience (INNT/Brazil); Human
   Frontiers Science ProgramHuman Frontier Science Program; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); CNPqNational Council for Scientific and Technological
   Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Ensino
   SuperiorCAPES
FX Work in our laboratory was supported by grants from the National
   Institute for Translational Neuroscience (INNT/Brazil) (STF), the Human
   Frontiers Science Program (FGF), and the Brazilian funding agencies
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (FGF,
   STF, and JRC). TRB is supported by a CNPq predoctoral fellowship and JRC
   is recipient of a postdoctoral fellowship from Coordenacao de
   Aperfeicoamento de Pessoal de Ensino Superior.
CR Acharya NK, 2013, J ALZHEIMERS DIS, V35, P179, DOI 10.3233/JAD-122254
   Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901
   Ahtiluoto S, 2010, NEUROLOGY, V75, P1195, DOI 10.1212/WNL.0b013e3181f4d7f8
   Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819
   Aisen PS, 2002, NEUROLOGY, V58, P1050, DOI 10.1212/WNL.58.7.1050
   Arvanitakis Z, 2008, NEUROLOGY, V70, P2219, DOI 10.1212/01.wnl.0000313813.48505.86
   Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012
   Baggio G, 1998, FASEB J, V12, P433
   Banks WA, 2005, CURR PHARM DESIGN, V11, P973, DOI 10.2174/1381612053381684
   Bate C, 2003, NEUROREPORT, V14, P2099, DOI 10.1097/00001756-200311140-00018
   Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992
   Bikman BT, 2012, CELL MOL LIFE SCI, V69, P2135, DOI 10.1007/s00018-012-0917-5
   Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000
   Breitner JCS, 2009, NEUROLOGY, V72, P1899, DOI 10.1212/WNL.0b013e3181a18691
   Brown KL, 2007, TRENDS IMMUNOL, V28, P260, DOI 10.1016/j.it.2007.04.005
   Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166
   Calay ES, 2013, NAT MED, V19, P265, DOI 10.1038/nm.3114
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Clark I, 2012, PHARMACOL REV, V64, P1004, DOI 10.1124/pr.112.005850
   Combs CK, 2009, J NEUROIMMUNE PHARM, V4, P380, DOI 10.1007/s11481-009-9165-3
   Costello DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031124
   Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112
   Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI 10.1056/NEJMoa1215740
   Czirr E, 2012, J CLIN INVEST, V122, P1156, DOI 10.1172/JCI58656
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   de la Monte SM, 2012, J ALZHEIMERS DIS, V30, pS231, DOI 10.3233/JAD-2012-111727
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Fewlass DC, 2004, FASEB J, V18, P1870, DOI 10.1096/fj.04-2572com
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798
   Gabbita SP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-99
   Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200
   Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292
   Grammas P, 2001, NEUROBIOL AGING, V22, P837, DOI 10.1016/S0197-4580(01)00276-7
   Greco SJ, 2008, BIOCHEM BIOPH RES CO, V376, P536, DOI 10.1016/j.bbrc.2008.09.026
   Green RC, 2009, JAMA-J AM MED ASSOC, V302, P2557, DOI 10.1001/jama.2009.1866
   Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936
   Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126
   in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178
   Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23
   Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200
   KANETY H, 1995, J BIOL CHEM, V270, P23780, DOI 10.1074/jbc.270.40.23780
   Kaufmann WE, 1997, PROSTAG OTH LIPID M, V54, P601, DOI 10.1016/S0090-6980(97)00128-7
   Kitazawa M, 2011, J IMMUNOL, V187, P6539, DOI 10.4049/jimmunol.1100620
   Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008
   Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4
   Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045
   Li YK, 2003, J NEUROSCI, V23, P1605
   Lieb W, 2009, JAMA-J AM MED ASSOC, V302, P2565, DOI 10.1001/jama.2009.1836
   Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Mattson MP, 2012, CELL METAB, V16, P706, DOI 10.1016/j.cmet.2012.08.012
   MCGEER PL, 1992, NEUROLOGY, V42, P447, DOI 10.1212/WNL.42.2.447
   McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425
   Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21
   Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001
   Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200
   Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588
   Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921
   Park KM, 2010, CELL SIGNAL, V22, P977, DOI 10.1016/j.cellsig.2010.01.010
   Pasqualetti P, 2009, AGING CLIN EXP RES, V21, P102, DOI 10.1007/BF03325217
   Paz G, 2010, INT J CLIN PRACT, V64, P1808, DOI 10.1111/j.1742-1241.2010.02536.x
   Perez-Gonzalez R, 2011, J ALZHEIMERS DIS, V24, P17, DOI 10.3233/JAD-2011-102070
   Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17
   Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002
   Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082
   Reines SA, 2004, NEUROLOGY, V62, P66, DOI 10.1212/WNL.62.1.66
   Ruan LF, 2009, CURR ALZHEIMER RES, V6, P531, DOI 10.2174/156720509790147070
   Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934
   Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975
   Ryu JK, 2008, NEUROBIOL DIS, V29, P254, DOI 10.1016/j.nbd.2007.08.019
   Salvioli S, 2006, CURR PHARM DESIGN, V12, P3161, DOI 10.2174/138161206777947470
   Salvioli S, 2013, CURR PHARM DESIGN, V19, P1675
   Samad F, 1999, P NATL ACAD SCI USA, V96, P6902, DOI 10.1073/pnas.96.12.6902
   Scharf S, 1999, NEUROLOGY, V53, P197, DOI 10.1212/WNL.53.1.197
   Shi JQ, 2011, J AM GERIATR SOC, V59, P1142, DOI 10.1111/j.1532-5415.2011.03445.x
   Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053
   Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460
   Sims-Robinson C, 2010, NAT REV NEUROL, V6, P551, DOI 10.1038/nrneurol.2010.130
   Smith QR, 2001, J MOL NEUROSCI, V16, P167, DOI 10.1385/JMN:16:2-3:167
   Sonnen JA, 2009, ARCH NEUROL-CHICAGO, V66, P315, DOI 10.1001/archneurol.2008.579
   Sourris KC, 2009, DIABETES, V58, P1259, DOI 10.2337/db08-1725
   Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012
   Szekely CA, 2008, NEUROLOGY, V70, P17, DOI 10.1212/01.wnl.0000284596.95156.48
   Szekely CA, 2010, CNS NEUROL DISORD-DR, V9, P132, DOI 10.2174/187152710791012026
   Takada Y, 2007, ONCOGENE, V26, P1201, DOI 10.1038/sj.onc.1209906
   Takeda S, 2013, NEUROBIOL AGING, V34, P2064, DOI 10.1016/j.neurobiolaging.2013.02.010
   THOMIS DC, 1993, J VIROL, V67, P7695, DOI 10.1128/JVI.67.12.7695-7700.1993
   Tobar N, 2011, ENDOCRINOLOGY, V152, P4080, DOI 10.1210/en.2011-0249
   Tobinick E, 2007, CURR ALZHEIMER RES, V4, P550, DOI 10.2174/156720507783018217
   Tobinick Edward, 2006, MedGenMed, V8, P25
   Tobinick EL, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-2
   Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873
   Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106
   Une K, 2011, EUR J NEUROL, V18, P1006, DOI 10.1111/j.1468-1331.2010.03194.x
   van Himbergen TM, 2012, ARCH NEUROL-CHICAGO, V69, P594, DOI 10.1001/archneurol.2011.670
   Vitale G, 2013, NAT REV ENDOCRINOL, V9, P228, DOI 10.1038/nrendo.2013.29
   Wang KC, 2012, NEUROEPIDEMIOLOGY, V38, P237, DOI 10.1159/000337428
   Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591
   White MF, 1998, CURR TOP MICROBIOL, V228, P179
   White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001
   Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Yan Q, 2003, J NEUROSCI, V23, P7504
   Yang JYO, 2009, AM J PHYSIOL-HEART C, V296, pH1850, DOI 10.1152/ajpheart.01199.2008
   Yatagai T, 2003, METABOLISM, V52, P1274, DOI 10.1016/S0026-0495(03)00195-1
   Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620
   Zandi PP, 2002, NEUROLOGY, V59, P880, DOI 10.1212/WNL.59.6.880
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045
   Zhu XX, 2003, J MED CHEM, V46, P5222, DOI 10.1021/jm030152f
NR 123
TC 176
Z9 186
U1 1
U2 46
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1552-5260
EI 1552-5279
J9 ALZHEIMERS DEMENT
JI Alzheimers. Dement.
PD FEB
PY 2014
VL 10
SU 1
BP S76
EP S83
DI 10.1016/j.jalz.2013.12.010
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA CN6OW
UT WOS:000358555100010
PM 24529528
DA 2020-12-08
ER

PT J
AU Lourenco, MV
   Clarke, JR
   Frozza, RL
   Bomfim, TR
   Forny-Germano, L
   Batista, AF
   Sathler, LB
   Brito-Moreira, J
   Amaral, OB
   Silva, CA
   Freitas-Correa, L
   Espirito-Santo, S
   Campello-Costa, P
   Houzel, JC
   Klein, WL
   Holscher, C
   Carvalheira, JB
   Silva, AM
   Velloso, LA
   Munoz, DP
   Ferreira, ST
   De Felice, FG
AF Lourenco, Mychael V.
   Clarke, Julia R.
   Frozza, Rudimar L.
   Bomfim, Theresa R.
   Forny-Germano, Leticia
   Batista, Andre F.
   Sathler, Luciana B.
   Brito-Moreira, Jordano
   Amaral, Olavo B.
   Silva, Cesar A.
   Freitas-Correa, Leo
   Espirito-Santo, Sheila
   Campello-Costa, Paula
   Houzel, Jean-Christophe
   Klein, William L.
   Holscher, Christian
   Carvalheira, Jose B.
   Silva, Aristobolo M.
   Velloso, Licio A.
   Munoz, Douglas P.
   Ferreira, Sergio T.
   De Felice, Fernanda G.
TI TNF-alpha Mediates PKR-Dependent Memory Impairment and Brain IRS-1
   Inhibition Induced by Alzheimer's beta-Amyloid Oligomers in Mice and
   Monkeys
SO CELL METABOLISM
LA English
DT Article
ID ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TYROSINE
   KINASE-ACTIVITY; D-ASPARTATE RECEPTOR; INSULIN-RESISTANCE; COGNITIVE
   IMPAIRMENT; SYNAPTIC PLASTICITY; INTRANASAL INSULIN; MOUSE MODEL;
   MOLECULAR-BASIS
AB Alzheimer's disease (AD) and type 2 diabetes appear to share similar pathogenic mechanisms. dsRNA-dependent protein kinase (PKR) underlies peripheral insulin resistance in metabolic disorders. PKR phosphorylates eukaryotic translation initiation factor 2 alpha (eIF2 alpha-P), and AD brains exhibit elevated phospho-PKR and eIF2 alpha-P levels. Whether and how PKR and eIF2 alpha-P participate in defective brain insulin signaling and cognitive impairment in AD are unknown. We report that beta-amyloid oligomers, AD-associated toxins, activate PKR in a tumor necrosis factor alpha (TNF-alpha)dependent manner, resulting in eIF2 alpha-P, neuronal insulin receptor substrate (IRS-1) inhibition, synapse loss, and memory impairment. Brain phospho-PKR and eIF2 alpha-P were elevated in AD animal models, including monkeys given intracerebroventricular oligomer infusions. Oligomers failed to trigger eIF2 alpha-P and cognitive impairment in PKR-/- and TNFR1(-/-) mice. Bolstering insulin signaling rescued phospho-PKR and eIF2 alpha-P. Results reveal pathogenic mechanisms shared by AD and diabetes and establish that proinflammatory signaling mediates oligomer-induced IRS-1 inhibition and PKR-dependent synapse and memory loss.
C1 [Lourenco, Mychael V.; Clarke, Julia R.; Frozza, Rudimar L.; Bomfim, Theresa R.; Forny-Germano, Leticia; Batista, Andre F.; Sathler, Luciana B.; Brito-Moreira, Jordano; Amaral, Olavo B.; Silva, Cesar A.; Freitas-Correa, Leo; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Houzel, Jean-Christophe] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Espirito-Santo, Sheila; Campello-Costa, Paula] Univ Fed Fluminense, Inst Biol, BR-24001970 Niteroi, RJ, Brazil.
   [Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.
   [Holscher, Christian] Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YQ, England.
   [Carvalheira, Jose B.] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, BR-13084761 Campinas, SP, Brazil.
   [Silva, Aristobolo M.] Univ Fed Minas Gerais, Inst Biol Sci, BR-31270901 Belo Horizonte, MG, Brazil.
   [Silva, Aristobolo M.] Fiocruz MS, Rene Rachou Res Ctr, BR-30190002 Belo Horizonte, MG, Brazil.
   [Velloso, Licio A.] Univ Estadual Campinas, DCM FCM UNICAMP, Obes & Comorbid Res Ctr, Lab Cell Signalling, BR-13084761 Campinas, SP, Brazil.
   [Munoz, Douglas P.] Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br; felice@bioqmed.ufrj.br
RI Houzel, Jean Christophe/G-3723-2010; Lourenco, Mychael/G-2614-2014;
   Ferreira, Sergio/AAZ-1576-2020; Amaral, Olavo/B-2874-2009; Velloso,
   Licio/AAJ-3778-2020; Campello-Costa, Paula/J-3251-2012; Clarke,
   Julia/AAF-9434-2019; Carvalheira, Jose B.C./E-8562-2013; Forny-Germano,
   Leticia/D-1342-2017; Houzel, Jean Christophe/M-7936-2019;
   Campello-Costa, Paula/V-7013-2019; Silva, Aristobolo AMS/F-7326-2016;
   Forny-Germano, Leticia/L-6639-2019
OI Houzel, Jean Christophe/0000-0001-5128-438X; Lourenco,
   Mychael/0000-0002-1078-0296; Ferreira, Sergio/0000-0001-7160-9866;
   Amaral, Olavo/0000-0002-4299-8978; Carvalheira, Jose
   B.C./0000-0002-0136-0943; Forny-Germano, Leticia/0000-0001-8301-0711;
   Houzel, Jean Christophe/0000-0001-5128-438X; Forny-Germano,
   Leticia/0000-0001-8301-0711; Holscher, Christian/0000-0002-8159-3260;
   Frozza, Rudimar Luiz/0000-0003-0918-4128; Campello-Costa,
   Paula/0000-0001-5086-4972
FU Human Frontiers Science Program (HFSP)Human Frontier Science Program;
   National Institute for Translational Neuroscience (INNT/Brazil);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Canadian Institutes for Health Research
   (CIHR)Canadian Institutes of Health Research (CIHR); Canada Research
   Chair ProgramCanada Research Chairs; CNPq predoctoral fellowships
FX This work was supported by grants from Human Frontiers Science Program
   (HFSP) (to F. G. D. F.), National Institute for Translational
   Neuroscience (INNT/Brazil), the Brazilian funding agencies Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao
   de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (to S. T. F.
   and F. G. D. F.), Canadian Institutes for Health Research (CIHR), and
   Canada Research Chair Program (to D. P. M.). M. V. L., L. B. S., L.
   F.-G., A. F. B., T. R. B., J.B.-M., and L. F.-C. were supported by CNPq
   predoctoral fellowships. We thank Drs. Matthias Gralle, Wagner Seixas,
   and Claudio A. Masuda (Federal University of Rio de Janeiro, Brazil) for
   insightful discussions and Dr. Claudia P. Figueiredo (Federal University
   of Rio de Janeiro, Brazil) for advice on immunohistochemical analysis of
   monkey brains. W. L. K. is a cofounder of Acumen Pharmaceuticals, which
   has been licensed by Northwestern University to develop ADDL technology
   for Alzheimer's therapeutics and diagnostics.
CR Bao FX, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.003
   Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003
   Birkenfeld AL, 2011, J BIOL CHEM, V286, P36163, DOI 10.1074/jbc.M111.228817
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Bullido MJ, 2008, NEUROBIOL AGING, V29, P1160, DOI 10.1016/j.neurobiolaging.2007.02.023
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Clark I, 2012, PHARMACOL REV, V64, P1004, DOI 10.1124/pr.112.005850
   Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050
   Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Gkogkas C, 2010, J BIOL CHEM, V285, P31913, DOI 10.1074/jbc.R110.154476
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042
   Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814
   Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495
   Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3
   Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006
   Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486
   Mattson MP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3114pe10
   McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011
   Mcnay EC, 2011, NEUROBIOL LEARN MEM, V96, P432, DOI 10.1016/j.nlm.2011.08.005
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058
   Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001
   Nistico R, 2012, NEUROMOL MED, V14, P262, DOI 10.1007/s12017-012-8184-z
   O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047
   Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294
   Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588
   Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C
   Raven JF, 2008, CELL CYCLE, V7, P1146, DOI 10.4161/cc.7.9.5811
   Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016
   Ryan GJ, 2011, J CLIN PHARM THER, V36, P260, DOI 10.1111/j.1365-2710.2010.01180.x
   Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010
   van der Heide LP, 2005, J NEUROCHEM, V94, P1158, DOI 10.1111/j.1471-4159.2005.03269.x
   Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121
   Xu J, 2014, AGING CELL, V13, P19, DOI 10.1111/acel.12145
   Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x
   Yoon SO, 2012, NEURON, V75, P824, DOI 10.1016/j.neuron.2012.06.024
   Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029
NR 63
TC 199
Z9 202
U1 0
U2 37
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD DEC 3
PY 2013
VL 18
IS 6
BP 831
EP 843
DI 10.1016/j.cmet.2013.11.002
PG 13
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 265HJ
UT WOS:000327940800009
PM 24315369
OA Bronze
DA 2020-12-08
ER

PT J
AU Ledo, JH
   Azevedo, EP
   Clarke, JR
   Ribeiro, FC
   Figueiredo, CP
   Foguel, D
   De Felice, FG
   Ferreira, ST
AF Ledo, J. H.
   Azevedo, E. P.
   Clarke, J. R.
   Ribeiro, F. C.
   Figueiredo, C. P.
   Foguel, D.
   De Felice, F. G.
   Ferreira, S. T.
TI Amyloid-beta oligomers link depressive-like behavior and cognitive
   deficits in mice
SO MOLECULAR PSYCHIATRY
LA English
DT Letter
ID ALZHEIMER-DISEASE; A-BETA; RISK; HYPOTHESIS; RECEPTORS; SYMPTOMS
C1 [Ledo, J. H.; Azevedo, E. P.; Clarke, J. R.; Ribeiro, F. C.; Foguel, D.; De Felice, F. G.; Ferreira, S. T.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
   [Figueiredo, C. P.] Univ Fed Rio de Janeiro, Sch Pharm, Rio De Janeiro, Brazil.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Figueiredo, Claudia P/F-8424-2012; Clarke, Julia/AAF-9434-2019; Ribeiro,
   Felipe Campos/W-9758-2019; Azevedo, Estefania/I-3807-2012; Ferreira,
   Sergio/AAZ-1576-2020
OI Ribeiro, Felipe Campos/0000-0003-3028-3307; Ferreira,
   Sergio/0000-0001-7160-9866; Foguel, Debora/0000-0001-7312-7115;
   Figueiredo, Claudia/0000-0001-9467-9891
CR Cirrito JR, 2011, P NATL ACAD SCI USA, V108, P14968, DOI 10.1073/pnas.1107411108
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Geerlings MI, 2008, NEUROLOGY, V70, P1258, DOI 10.1212/01.wnl.0000308937.30473.d1
   Green RC, 2003, ARCH NEUROL-CHICAGO, V60, P753, DOI 10.1001/archneur.60.5.753
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Kepe V, 2006, P NATL ACAD SCI USA, V103, P702, DOI 10.1073/pnas.0510237103
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lorke DE, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-36
   Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530
   Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600
   Zhu CB, 2006, NEUROPSYCHOPHARMACOL, V31, P2121, DOI 10.1038/sj.npp.1301029
NR 11
TC 86
Z9 88
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1359-4184
J9 MOL PSYCHIATR
JI Mol. Psychiatr.
PD OCT
PY 2013
VL 18
IS 10
BP 1053
EP 1054
DI 10.1038/mp.2012.168
PG 2
WC Biochemistry & Molecular Biology; Neurosciences; Psychiatry
SC Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry
GA 222JJ
UT WOS:000324726700003
PM 23183490
OA Green Published
DA 2020-12-08
ER

PT J
AU Figueiredo, CP
   Clarke, JR
   Ledo, JH
   Ribeiro, FC
   Costa, CV
   Melo, HM
   Mota-Sales, AP
   Saraiva, LM
   Klein, WL
   Sebollela, A
   De Felice, FG
   Ferreira, ST
AF Figueiredo, Claudia P.
   Clarke, Julia R.
   Ledo, Jose Henrique
   Ribeiro, Felipe C.
   Costa, Carine V.
   Melo, Helen M.
   Mota-Sales, Axa P.
   Saraiva, Leonardo M.
   Klein, William L.
   Sebollela, Adriano
   De Felice, Fernanda G.
   Ferreira, Sergio T.
TI Memantine Rescues Transient Cognitive Impairment Caused by
   High-Molecular-Weight A beta Oligomers But Not the Persistent Impairment
   Induced by Low-Molecular-Weight Oligomers
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID LONG-TERM POTENTIATION; RECEPTOR-DEPENDENT MECHANISM; SOLUBLE-PROTEIN
   OLIGOMERS; AMYLOID-BETA; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; NMDA
   RECEPTORS; MOUSE HIPPOCAMPUS; PEPTIDE OLIGOMERS; MEMORY LOSS
AB Brain accumulation of soluble amyloid-beta oligomers (A beta Os) has been implicated in synapse failure and cognitive impairment in Alzheimer's disease (AD). However, whether and how oligomers of different sizes induce synapse dysfunction is a matter of controversy. Here, we report that low-molecular-weight (LMW) and high-molecular-weight (HMW) A beta oligomers differentially impact synapses and memory. A single intracerebroventricular injection of LMW A beta Os (10 pmol) induced rapid and persistent cognitive impairment in mice. On the other hand, memory deficit induced by HMW A beta Os (10 pmol) was found to be reversible. While memory impairment in LMW oligomer-injected mice was associated with decreased hippocampal synaptophysin and GluN2B immunoreactivities, synaptic pathology was not detected in the hippocampi of HMW oligomer-injected mice. On the other hand, HMW oligomers, but not LMW oligomers, induced oxidative stress in hippocampal neurons. Memantine rescued both neuronal oxidative stress and the transient memory impairment caused by HMW oligomers, but did not prevent the persistent cognitive deficit induced by LMW oligomers. Results establish that different A beta oligomer assemblies act in an orchestrated manner, inducing different pathologies and leading to synapse dysfunction. Furthermore, results suggest a mechanistic explanation for the limited efficacy of memantine in preventing memory loss in AD.
C1 [Figueiredo, Claudia P.; Ribeiro, Felipe C.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Figueiredo, Claudia P.; Clarke, Julia R.; Ledo, Jose Henrique; Costa, Carine V.; Melo, Helen M.; Mota-Sales, Axa P.; Saraiva, Leonardo M.; Sebollela, Adriano; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM felice@bioqmed.ufrj.br; ferreira@bioqmed.ufrj.br
RI Sebollela, Adriano/O-4385-2014; Clarke, Julia/AAF-9434-2019; Figueiredo,
   Claudia P/F-8424-2012; Ribeiro, Felipe Campos/W-9758-2019; Ferreira,
   Sergio/AAZ-1576-2020
OI Sebollela, Adriano/0000-0002-7444-9156; Ribeiro, Felipe
   Campos/0000-0003-3028-3307; Ferreira, Sergio/0000-0001-7160-9866;
   Figueiredo, Claudia/0000-0001-9467-9891
FU National Institute for Translational Neuroscience (Brazil); Conselho
   Nacional de Desenvolvimento Cientifico e TecnologicoNational Council for
   Scientific and Technological Development (CNPq); Fundacao de Amparo a
   Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Human Frontier
   Science ProgramHuman Frontier Science Program; John Simon Guggenheim
   Memorial Foundation
FX This work was supported by grants from the National Institute for
   Translational Neuroscience (Brazil) (S.T.F.), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (A.S., C.P.F., J.R.C., S.T.F.,
   F.G.D.F.), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (C.P.F., J.R.C., S.T.F., F.G.D.F.), Human Frontier Science Program
   (F.G.D.F.), and John Simon Guggenheim Memorial Foundation (F.G.D.F.). We
   thank Maira S. Oliveira and Mariangela M. Viana for technical support
   and Ana Claudia Rangel for competent lab and project management.
CR ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8
   BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0
   Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028
   Benilova I, 2011, NAT NEUROSCI, V14, P949, DOI 10.1038/nn.2871
   Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]
   Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110
   Brouillette J, 2012, J NEUROSCI, V32, P7852, DOI 10.1523/JNEUROSCI.5901-11.2012
   CHEN HSV, 1992, J NEUROSCI, V12, P4427
   Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q
   Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107
   Creeley C, 2006, J NEUROSCI, V26, P3923, DOI 10.1523/JNEUROSCI.4883-05.2006
   da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   Drever BD, 2007, J ALZHEIMERS DIS, V12, P319
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2011, J ALZHEIMERS DIS, V24, P61, DOI 10.3233/JAD-2010-101320
   Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kervern M, 2012, J ALZHEIMERS DIS, V32, P183, DOI 10.3233/JAD-2012-120394
   Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012
   Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x
   LASSMANN H, 1993, ANN NY ACAD SCI, V695, P59, DOI 10.1111/j.1749-6632.1993.tb23028.x
   LAURSEN SE, 1986, J PHARMACOL METHOD, V16, P355, DOI 10.1016/0160-5402(86)90038-0
   Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011
   MASLIAH E, 1991, ACTA NEUROPATHOL, V81, P428, DOI 10.1007/BF00293464
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   Murphy KPSJ, 1997, J PHYSIOL-LONDON, V504, P379, DOI 10.1111/j.1469-7793.1997.379be.x
   MURPHY TH, 1990, DEV BRAIN RES, V57, P146, DOI 10.1016/0165-3806(90)90195-5
   Pacifici R, 2011, PLOS CURR, V3
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Reed MN, 2011, NEUROBIOL AGING, V32, P1784, DOI 10.1016/j.neurobiolaging.2009.11.007
   Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230
   Schneider LS, 2011, ARCH NEUROL-CHICAGO, V68, P991, DOI 10.1001/archneurol.2011.69
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541
   Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002
   Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754
   Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087
   Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x
   Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010
NR 56
TC 101
Z9 103
U1 0
U2 18
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD JUN 5
PY 2013
VL 33
IS 23
BP 9626
EP U317
DI 10.1523/JNEUROSCI.0482-13.2013
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA 158IS
UT WOS:000319963300006
PM 23739959
OA Bronze, Green Published
DA 2020-12-08
ER

PT J
AU Clarke, JR
   Cammarota, M
   Gruart, A
   Izquierdo, I
   Delgado-Garcia, JM
AF Clarke, Julia Rosauro
   Cammarota, Martin
   Gruart, Agnes
   Izquierdo, Ivan
   Delgado-Garcia, Jose Maria
TI Plastic modifications induced by object recognition memory processing
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE hippocampus; long-term potentiation; memory consolidation and
   reconsolidation; synaptic plasticity
ID LONG-TERM POTENTIATION; SPATIAL MEMORY; RETROGRADE-AMNESIA;
   PROTEIN-SYNTHESIS; CA3-CA1 SYNAPSE; BEHAVING MICE; RECONSOLIDATION;
   HIPPOCAMPUS; CONSOLIDATION; ACQUISITION
AB Long-term potentiation (LTP) phenomenon is widely accepted as a cellular model of memory consolidation. Object recognition (OR) is a particularly useful way of studying declarative memory in rodents because it makes use of their innate preference for novel over familiar objects. In this study, mice had electrodes implanted in the hippocampal Schaffer collaterals-pyramidal CA1 pathway and were trained for OR. Field EPSPs evoked at the CA3-CA1 synapse were recorded at the moment of training and at different times thereafter. LTP-like synaptic enhancement was found 6 h posttraining. A testing session was conducted 24 h after training, in the presence of one familiar and one novel object. Hippocampal synaptic facilitation was observed during exploration of familiar and novel objects. A short depotentiation period was observed early after the test and was followed by a later phase of synaptic efficacy enhancement. Here, we show that OR memory consolidation is accompanied by transient potentiation in the hippocampal CA3-CA1 synapses, while reconsolidation of this memory requires a short-lasting phase of depotentiation that could account for its well described vulnerability. The late synaptic enhancement phase, on the other hand, would be a consequence of memory restabilization.
C1 [Clarke, Julia Rosauro; Cammarota, Martin; Izquierdo, Ivan] Pontificia Univ Catolica Rio Grande do Sul, Inst Pesquisas Biomed, Ctr Mem, BR-90610000 Porto Alegre, RS, Brazil.
   [Gruart, Agnes; Delgado-Garcia, Jose Maria] Univ Pablo Olavide, Div Neurociencias, Seville 41013, Spain.
RP Izquierdo, I (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Inst Pesquisas Biomed, Ctr Mem, BR-90610000 Porto Alegre, RS, Brazil.
EM izquier@terra.com.br
RI Neurociencia, Inct/I-1011-2013; Delgado-Garcia, Jose M./V-1567-2019;
   Clarke, Julia/AAF-9434-2019
OI Izquierdo, Ivan/0000-0002-7208-0869; Cammarota,
   Martin/0000-0001-9741-5074
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); Brazil and the Spanish Ministry of Science and Innovation
   [BFU2008-00899, BFU2008-03390]; Junta de Andaluc a (Spain)Junta de
   Andalucia [BIO-122, CVI-02487]; Fundacion Conocimiento y Cultura of the
   Pablo de Olavide University of Spain; European Community'sEuropean
   Community (EC) [FP7/2007-2013, 201714]; Programa de Pos-graduacao em
   Ciencias Medicas of the Federal University of Rio Grande do Sul
FX We thank M. E. Masferrer, J. A. Navarro, G. Vega, N. Madro al, and T.
   Jurado for assistance in setting the behavioral conditions prior to the
   experiments, M. Sutil for help in animal handling and care, and Roger
   Churchill for editorial help. This work was supported by grants from
   CNPq and CAPES from Brazil and the Spanish Ministry of Science and
   Innovation (BFU2008-00899 and BFU2008-03390), the Junta de Andaluc a
   (Spain, BIO-122 and CVI-02487), and the Fundacion Conocimiento y Cultura
   of the Pablo de Olavide University of Spain. The research leading to
   these results also received funding from the European Community's
   Seventh Framework Program (FP7/2007-2013) under Grant Agreement 201714
   (DEVANX; to A. G. and J. M. D.-G.). J. R. C. is a recipient of a PhD
   degree fellowship in the Programa de Pos-graduacao em Ciencias Medicas
   of the Federal University of Rio Grande do Sul.
CR Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8
   Balderas I, 2008, LEARN MEMORY, V15, P618, DOI 10.1101/lm.1028008
   Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025
   Bliss TVP, 2006, SCIENCE, V313, P1058, DOI 10.1126/science.1132538
   BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274
   Bonini JS, 2007, NEUROSCIENCE, V147, P37, DOI 10.1016/j.neuroscience.2007.04.013
   Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3
   Brun VH, 2001, J NEUROSCI, V21, P356, DOI 10.1523/JNEUROSCI.21-01-00356.2001
   Clark RE, 2000, J NEUROSCI, V20, P8853
   Clarke JR, 2008, NEUROBIOL LEARN MEM, V90, P374, DOI 10.1016/j.nlm.2008.04.009
   Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2
   Diamond DM, 2004, HIPPOCAMPUS, V14, P281, DOI 10.1002/hipo.10186
   Duvarci S, 2008, LEARN MEMORY, V15, P747, DOI 10.1101/lm.1027208
   ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X
   FURINI CR, 2009, HIPPOCAMPUS IN PRESS
   Gaffan D, 1996, J NEUROSCI, V16, P5864
   Gilbert PE, 2002, BEHAV NEUROSCI, V116, P63, DOI 10.1037//0735-7044.116.1.63
   Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739
   Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006
   Hunsaker MR, 2008, HIPPOCAMPUS, V18, P1064, DOI 10.1002/hipo.20464
   Izquierdo I, 2006, TRENDS NEUROSCI, V29, P496, DOI 10.1016/j.tins.2006.07.005
   Kaang BK, 2009, NEUROSCIENTIST, V15, P430, DOI 10.1177/1073858408331374
   Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101
   Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760
   Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049
   Madronal N, 2007, J NEUROSCI, V27, P12139, DOI 10.1523/JNEUROSCI.3397-07.2007
   Mamiya N, 2009, J NEUROSCI, V29, P402, DOI 10.1523/JNEUROSCI.4639-08.2009
   MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419
   Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5
   MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554
   Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038
   Myskiw JC, 2008, NEUROBIOL LEARN MEM, V89, P338, DOI 10.1016/j.nlm.2007.10.002
   Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5
   Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303
   Paxinos G., 2001, MOUSE BRAIN STEREOTA
   Rossato JI, 2007, LEARN MEMORY, V14, P36, DOI 10.1101/lm.422607
   Rossato JI, 2006, LEARN MEMORY, V13, P431, DOI 10.1101/lm.315206
   Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545
   Sacchetti B, 2001, EUR J NEUROSCI, V13, P2291, DOI 10.1046/j.0953-816x.2001.01609.x
   Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73
   Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004
   Tronel S, 2002, LEARN MEMORY, V9, P105, DOI 10.1101/lm.47802
   Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776
   Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134
   Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783
NR 45
TC 151
Z9 152
U1 1
U2 16
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 9
PY 2010
VL 107
IS 6
BP 2652
EP 2657
DI 10.1073/pnas.0915059107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 554AO
UT WOS:000274408100053
PM 20133798
OA Bronze, Green Published
DA 2020-12-08
ER

PT J
AU Clarke, JR
   Rossato, JI
   Monteiro, S
   Bevilaqua, LRM
   Izquierdo, I
   Cammarota, M
AF Clarke, Julia R.
   Rossato, Janine I.
   Monteiro, Siomara
   Bevilaqua, Lia R. M.
   Izquierdo, Ivan
   Cammarota, Martin
TI Posttraining activation of CB1 cannabinoid receptors in the CA1 region
   of the dorsal hippocampus impairs object recognition long-term memory
SO NEUROBIOLOGY OF LEARNING AND MEMORY
LA English
DT Article
DE object recognition memory; consolidation; hippocampus; cannabinoids;
   CB1; CB2; WIN-55,212-2; ACEA; AM251; VDM-11; JWH-015;
   palmitoylethanolamide
ID SPATIAL MEMORY; IN-VIVO; PHARMACOLOGICAL ACTIONS; ENDOCANNABINOID
   SYSTEM; FUNCTIONAL EXPRESSION; SYNAPTIC-TRANSMISSION; SELECTIVE
   ANTAGONIST; WORKING-MEMORY; KNOCKOUT MICE; WATER-MAZE
AB Evidence indicates that brain endocannabinoids are involved in memory processing. However, the participation of CB1 and CB2 cannabinoid receptors in recognition memory has not been yet conclusively determined. Therefore, we evaluated the effect of the posttraining activation of hippocampal cannabinoid receptors on the consolidation of object recognition memory. Rats with infusion cannulae stereotaxically aimed to the CA1 region of the dorsal hippocampus were trained in an object recognition learning task involving exposure to two different stimulus objects. Memory retention was assessed at different times after training. in the test sessions, one of the objects presented during training was replaced by a novel one. When infused in the CA1 region immediately after training, the non-selective cannabinoid receptor agonist WIN-55,212-2 and the endocannabinoid membrane transporter inhibitor VDM-11 blocked long-term memory retention in a dose-dependent manner without affecting short-term memory, exploratory behavior, anxiety state or the functionality of the hippocampus. The amnesic effect of WIN-55,212-2 and VDM-11 was not due to state-dependency and was completely reversed by co-infusion of the CBI receptor antagonist AM-251 and mimicked by the CBI receptor agonist ACEA but not by the CB2 receptor agonists JWH-015 and palmitoylethanolamide. Our data indicate that activation of hippocampal CBI receptors early after training hampers consolidation of object recognition memory. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Clarke, Julia R.; Rossato, Janine I.; Monteiro, Siomara; Bevilaqua, Lia R. M.; Izquierdo, Ivan; Cammarota, Martin] Pontificia Univ Catolica Grande Sul, Inst Pesquisas Biomed, Ctr Memoria, BR-90610000 Porto Alegre, RS, Brazil.
   [Bevilaqua, Lia R. M.] Ctr Univ IPA, BR-90420060 Porto Alegre, RS, Brazil.
RP Cammarota, M (corresponding author), Pontificia Univ Catolica Grande Sul, Inst Pesquisas Biomed, Ctr Memoria, Ipiranga 6690, BR-90610000 Porto Alegre, RS, Brazil.
EM mcammaro@terra.com.br
RI Clarke, Julia/AAF-9434-2019; Neurociencia, Inct/I-1011-2013; Rossato,
   Janine/E-9543-2014
OI Izquierdo, Ivan/0000-0002-7208-0869; Cammarota,
   Martin/0000-0001-9741-5074
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES
FX This work was supported by grants from CNPq and CAPES, Brazil to M.C.,
   L.R.M.B. and I.I. J.R.C. is recipient of a CNPq Research Fellowship at
   the Programa de Pos-Graduacao em Neurociencias of the Universidade
   Federal do Rio Grande do Sul.
CR Alvares LD, 2006, BRAIN RES, V1075, P60, DOI 10.1016/j.brainres.2005.11.101
   Alvares LD, 2005, NEUROBIOL LEARN MEM, V83, P119, DOI 10.1016/j.nlm.2004.10.002
   Bevilaqua LRM, 2005, PHARMACOL BIOCHEM BE, V81, P139, DOI 10.1016/j.pbb.2005.03.005
   Bilkei-Gorzo A, 2005, P NATL ACAD SCI USA, V102, P15670, DOI 10.1073/pnas.0504640102
   Bohme GA, 2000, NEUROSCIENCE, V95, P5
   Bura SA, 2007, BRIT J PHARMACOL, V150, P758, DOI 10.1038/sj.bjp.0707152
   Cannich A, 2004, LEARN MEMORY, V11, P625, DOI 10.1101/lm.77904
   Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879
   CHIU CQ, 2007, NEUROPHARMACOLOGY
   Clark RE, 2000, J NEUROSCI, V20, P8853
   COLLINS DR, 1995, BRIT J PHARMACOL, V115, P869, DOI 10.1111/j.1476-5381.1995.tb15889.x
   D'Argenio G, 2006, FASEB J, V20, P568, DOI 10.1096/fj.05-4943fje
   Da Silva GE, 2002, PROG NEURO-PSYCHOPH, V26, P321, DOI 10.1016/S0278-5846(01)00275-5
   Da Silva WC, 2008, HIPPOCAMPUS, V18, P29, DOI 10.1002/hipo.20362
   Davies SN, 2002, NEUROPHARMACOLOGY, V42, P993, DOI 10.1016/S0028-3908(02)00060-6
   de Lago E, 2004, EUR J PHARMACOL, V484, P249, DOI 10.1016/j.ejphar.2003.11.027
   Degroot A, 2006, MOL PHARMACOL, V70, P1236, DOI 10.1124/mol.106.024661
   Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537
   Di Forti M, 2007, EUR NEUROPSYCHOPHARM, V17, pS101, DOI 10.1016/j.euroneuro.2007.02.005
   Domenici MR, 2006, J NEUROSCI, V26, P5794, DOI 10.1523/JNEUROSCI.0372-06.2006
   ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X
   Ferrari F, 1999, PHARMACOL BIOCHEM BE, V64, P555, DOI 10.1016/S0091-3057(99)00106-9
   Gatley SJ, 1996, EUR J PHARMACOL, V307, P331, DOI 10.1016/0014-2999(96)00279-8
   Hampson RE, 1999, LIFE SCI, V65, P715, DOI 10.1016/S0024-3205(99)00294-5
   Hashimotodani Y, 2007, J NEUROSCI, V27, P1211, DOI 10.1523/JNEUROSCI.4159-06.2007
   HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932
   Hill MN, 2004, EUR J NEUROSCI, V20, P859, DOI 10.1111/j.1460-9568.2004.03522.x
   Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427
   Hohmann AG, 1999, J NEUROPHYSIOL, V81, P575
   Huffman JW, 2000, CURR PHARM DESIGN, V6, P1323, DOI 10.2174/1381612003399347
   Izquierdo LA, 2007, NEUROBIOL LEARN MEM, V88, P160, DOI 10.1016/j.nlm.2007.04.014
   Jaggar SI, 1998, NEUROSCI LETT, V253, P123, DOI 10.1016/S0304-3940(98)00621-1
   Kalant H, 2004, PROG NEURO-PSYCHOPH, V28, P849, DOI 10.1016/j.pnpbp.2004.05.027
   Katona I, 1999, J NEUROSCI, V19, P4544
   Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006
   Kobilo T, 2007, EUR J NEUROSCI, V25, P3417, DOI 10.1111/j.1460-9568.2007.05561.x
   Lambert DM, 1999, BBA-MOL CELL BIOL L, V1440, P266, DOI 10.1016/S1388-1981(99)00132-8
   Lichtman AH, 2000, EUR J PHARMACOL, V404, P175, DOI 10.1016/S0014-2999(00)00615-4
   Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045
   Lovinger DM, 2007, J MOL NEUROSCI, V33, P87, DOI 10.1007/s12031-007-0043-2
   Maccarrone M, 2002, EUR J NEUROSCI, V15, P1178, DOI 10.1046/j.1460-9568.2002.01957.x
   Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839
   Martin M, 2002, PSYCHOPHARMACOLOGY, V159, P379, DOI 10.1007/s00213-001-0946-5
   MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0
   MISKYW JC, 2007, NEUROBIOLOGY LEARNIN, V89, P338
   Misner DL, 1999, J NEUROSCI, V19, P6795, DOI 10.1523/JNEUROSCI.19-16-06795.1999
   Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006
   MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0
   NOWICKY AV, 1987, BRAIN RES BULL, V19, P663, DOI 10.1016/0361-9230(87)90052-9
   Onaivi ES, 2006, ANN NY ACAD SCI, V1074, P514, DOI 10.1196/annals.1369.052
   Paton GS, 1998, NEUROPHARMACOLOGY, V37, P1123, DOI 10.1016/S0028-3908(98)00096-3
   PAXINOS G, 1986, RAT BRAIN STEREOTAXI, P119
   PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7
   Pertwee RG, 2005, HANDB EXP PHARMACOL, V168, P1
   Pettit DAD, 1998, J NEUROSCI RES, V51, P391
   Pop E, 1999, CURR OPIN CHEM BIOL, V3, P418, DOI 10.1016/S1367-5931(99)80062-3
   Ranganathan M, 2006, PSYCHOPHARMACOLOGY, V188, P425, DOI 10.1007/s00213-006-0508-y
   Reibaud M, 1999, EUR J PHARMACOL, V379, pR1, DOI 10.1016/S0014-2999(99)00496-3
   Riedel G, 2005, HANDB EXP PHARMACOL, V168, P445
   Riesenhuber M, 2002, CURR OPIN NEUROBIOL, V12, P162, DOI 10.1016/S0959-4388(02)00304-5
   Robinson L, 2007, BRIT J PHARMACOL, V151, P688, DOI 10.1038/sj.bjp.0707273
   Rossato JI, 2007, LEARN MEMORY, V14, P36, DOI 10.1101/lm.422607
   Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989
   Slanina KA, 2005, NEUROPHARMACOLOGY, V49, P660, DOI 10.1016/j.neuropharm.2005.04.021
   Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015
   Sullivan JM, 1999, J NEUROPHYSIOL, V82, P1286
   Sullivan JM, 2000, LEARN MEMORY, V7, P132, DOI 10.1101/lm.7.3.132
   Terranova JP, 1996, PSYCHOPHARMACOLOGY, V126, P165, DOI 10.1007/BF02246352
   TERRANOVA JP, 1995, N-S ARCH PHARMACOL, V352, P576, DOI 10.1007/BF00169393
   Thiermann G, 2007, NEUROBIOL LEARN MEM, V88, P416, DOI 10.1016/j.nlm.2007.07.013
   Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X
   Varvel SA, 2002, J PHARMACOL EXP THER, V301, P915, DOI 10.1124/jpet.301.3.915
   Varvel SA, 2001, PSYCHOPHARMACOLOGY, V157, P142
   Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076
NR 74
TC 62
Z9 62
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1074-7427
EI 1095-9564
J9 NEUROBIOL LEARN MEM
JI Neurobiol. Learn. Mem.
PD SEP
PY 2008
VL 90
IS 2
BP 374
EP 381
DI 10.1016/j.nlm.2008.04.009
PG 8
WC Behavioral Sciences; Neurosciences; Psychology; Psychology,
   Multidisciplinary
SC Behavioral Sciences; Neurosciences & Neurology; Psychology
GA 347BT
UT WOS:000259114700010
PM 18524639
DA 2020-12-08
ER

EF